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ABSTRACT 
 
Catalysis lies at the heart of green chemistry, providing essential tools for the 
synthesis of valuable products in a sustainable manner. Today a major challenge lies 
in the identification and development of efficient heterogeneous catalytic processes 
that can achieve cost-effective and eco-friendly production of fine, commodity, and 
pharmaceutical chemicals. Therefore, the search for highly selective and active 
catalysts, espe cially those that can be readily recycled, is vital for the development of 
sustainable chemical processes. Hence, continuous efforts have been devoted toward 
the development of heterogeneous catalysts which are recyclable, cost effective and 
contain highly accessible active sites.  
For more than a century, heterocycles have constituted one of the largest areas of 
research in organic chemistry. Their immense contribution towards the development 
of society from a biological and industrial point of view has vastly improved the 
quality of life. Among the approximately 20 million chemical compounds identified 
by the end of the second millennium, more than two-thirds are fully or partially 
aromatic and approximately half are heterocyclic. As a majority of drug-like 
compounds and natural products contain a heterocyclic nucleus at their core, ever 
increasing attention has been paid towards the development of novel clean processes 
employing nontoxic reagents, catalysts and solvents for the synthesis of important 
heterocycles. 
In this context, the thesis entitled “Synthesis and Applications of Green Catalysts 
in Organic Synthesis: Heterogeneous Catalysis by Solid Supported Compounds 
and Nanoparticles” clearly reflects the objective, which is to develop the green 
heterogeneous catalysts and evaluation of their catalytic activity by synthesizing 
biologically relevant heterocyclic compounds such as pyridine, pyrimidine, piperidine 
and tetrazole derivatives. The research work described in the thesis is divided into five 
chapters. The chapter wise organization of the thesis is as follows: 
CHAPTER 1 
General Introduction 
Green chemistry is a philosophy that puts forward sustainable concepts which are 
designed to reduce or eliminate chemicals and chemical processes that have negative 
environmental impacts. Over the last decade the environmental setup for synthetic 
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organic chemists has changed to a considerable degree and the main focus has now 
shifted towards more environment friendly and sustainable synthesis. Therefore, the 
development of environmentally benign organic reactions has become a crucial and 
demanding research area in modern organic chemical research. Developing green 
chemistry methodologies is a challenge that may be viewed through the framework of 
the “Twelve Principles of Green Chemistry. These principles identify catalysis as one 
of the most important tools for implementing green chemistry. In recent years, 
heterogeneous catalysts have gained much attention, as a result of economic and 
environmental benefits. They make synthetic processes clean, safe and high-yielding. 
The use of heterogeneous solid catalysts being in a different phase than the reagents 
and products has an obvious advantage in terms of easy separation from the reaction 
mixture, allowing the recovery of the solid and eventually its reuse.  
Nano-catalysis has emerged as a sustainable and competitive alternative to 
conventional catalysis since the nanoparticles possess a high surface-to-volume ratio, 
which enhances their activity and selectivity, while at the same time maintaining the 
intrinsic features of a heterogeneous catalyst. These high reactivities are due to high 
surface areas combined with unusually reactive morphologies when compared to their 
bulk counterparts. Therefore, with the developments in nanotechnology, a wide 
variety of nanostructured catalysts or supported nanostructured catalysts have been 
applied to various organic transformations. Thus, this chapter describes scope of the 
present work giving insights about heterogeneous catalysis and green pathways for 
organic transformations. 
CHAPTER 2 
Sustainable nano-catalytic transformation of β-enaminones to pyridine 
derivatives 
β-Enaminones are versatile intermediates used for the synthesis of heterocyclic 
compounds and drug intermediates. Because of the presence of nucleophilic character 
of enamine moiety and the elctrophilic character of enone moiety, they have been 
used as synthons for the synthesis of pyrroles, oxazoles, pyridinones, tricyclic 
benzo[a]quinolizines, benzodiazepines, pyrimidines, pyrazoles, isoxazoles and 
quinolines. In view of the mentioned properties and importance of enaminones in 
heterocyclic synthesis, this chapter is divided into two sections involving synthesis of 
novel 1,4-dihydropyridines and pyridine derivatives from β-enaminones under green 
reaction conditions using heterogeneous nano-catalysts. 
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Section A: Synthesis of 1,4-dihydropyridines from β-enaminones using meso 
alumina– sulphuric acid (Al-OSO3H) as catalyst in water 
1,4-Dihydropyridine (1,4 DHPs) derivatives represent an important class of 
compounds with remarkable pharmacological efficiency. Most importantly they have 
been used as effective calcium channel modulators for the treatment of cardio-
vascular disorders. The other biological profiles of 1,4 DHPs are selective adenosine-
A3 receptor antagonism, sirtuin activation and inhibition, anticonvulsant, and 
radioprotective activities.  
Immobilization of catalysts on solid support provides an ideal method for combining 
the advantages of homogeneous catalysts with the advantages of heterogeneous 
catalysts. Therefore, the development of solid acid catalysts has received great deal of 
attention in organic chemistry and chemical industries. In this context, this section 
deals with the synthesis of mesoporous alumina sulphuric acid as a heterogeneous and 
recyclable solid acid catalyst and evaluation of its activity for the synthesis of novel 
1,4-dihydropyridine derivatives (3a-n) via pseudo four component addition and 
cyclisation involving β-enaminone (1a-b), aldehydes (2a-g) and ammonium acetate in 
aqueous media (Scheme 2). The catalyst  showed  excellent  catalytic  activity  giving  
products  in  high  yields (81-90%)  and  could  be  reused  for  seven successive  
catalytic  cycles. The  catalyst  was  characterized  by  FT-IR,  XRD,  FE-SEM,  EDX  
and  TG  analyses. The  mesoporosity  of  alumina  was  determined  by  BET  and  
TEM  analyses. The amount of acid groups present on alumina was calculated by 
using neutralization titration method and was found to be 3.6 meq/g. 
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Section B: ZnO nanoparticles catalysed solvent-free synthesis of novel pyridines 
via β-enaminones 
Pyridine derivatives constitute one of the most important classes of heterocyclic 
compounds which widely occur as key structural subunits in numerous natural 
products that exhibit many interesting biological activities. The prevalence of 
pyridines in nature (e.g., in the coenzyme vitamin B6 family and in numerous 
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alkaloids) and their central role as versatile building blocks in the synthesis of natural 
products as well as biologically active compounds has led to a continued interest in 
the development of practical synthesis for these derivatives. These derivatives possess 
large spectrum of biological activities like anti-prion, anti-hepatitis B virus, anti-
bacterial and anti-cancer. Recently, some of these compounds have been recognized 
as potential targets for the development of new drugs for the treatment of Parkinson’s 
disease, hypoxia, asthma, kidney disease, epilepsy, cancer, and Creutzfeldt–Jacob 
disease. 
The use of nano-sized inorganic solid oxides as heterogeneous catalysts has received 
much attention because of their high level of chemoselectivity, environmental 
compatibility, simplicity of operation, and availability at low cost. Catalytic efficiency 
depends on the surface area of the catalyst. As nanoparticles provide a very large 
surface area because of their high surface to volume ratio and low-coordinated sites, 
their use as catalysts is quite encouraging. ZnO NPs have been explored as powerful 
catalysts for several organic transformations due to their eco-friendly nature. 
Therefore, this section deals with ZnO nanoparticles catalyzed synthesis of pyranyl 
pyridine derivatives (5a-p) involving β-enaminone (1a, 1c), active methylene 
compounds (4a-i) and ammonium acetate under solvent-free conditions (Scheme 4). 
ZnO nanoparticles were characterized by XRD, SEM and TEM analyses. The catalyst 
was found to retain good catalytic activity up to six cycles. 
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CHAPTER 3:  
Sulphated silica tungstic acid: an efficient and recyclable heterogeneous catalyst 
for the synthesis of tetrahydropyrimidines and dihydropyrimidines 
Tetrahydropyrimidines (THPMs)/ Dihydropyrimidines (DHPMs) represent an 
important group of highly valuable heterocyclic motifs in the field of medicinal 
chemistry. THPMs are found in both natural as well as synthetic organic compounds. 
Many THPMs containing an amino acid show interesting and diverse 
pharmacological profiles like HIV protease inhibiting, antineoplastic, 
antiproleferative, herbicidal, muscarinic agonist, anti-inflammatory and antiviral 
activities. DHPMs usually display various biological activities such as calcium 
channel modulators, adrenergic receptor antagonist, mitotic kinesin inhibitor, 
antiviral, antibacterial, etc. and compounds such as enastron, monastrol and 
piperastrol are well known biologically active DHPMs which have already been 
developed into drugs.  
Immobilization of catalysts on solid support is an ideal method for combining the 
advantages of homogeneous catalysts with the advantages of heterogeneous catalysts 
which leads to clean chemical synthesis from both environmental and commercial 
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point of view. In modern material science, silica is the ubiquitous inorganic platform 
used in systems designed for catalysis, separation, filtration, sensing, optoelectronics 
and environmental technology. Due to the favourable chemical and physical 
properties of silica surfaces, it is possible to impart nearly any reactive functional 
group that one requires on a silica surface (e.g., sulfonic, amine, carboxyl, thiol, 
epoxy, and so forth) through well-known silane chemistry. Taking advantages of the 
mentioned properties of silica, in this chapter, we have described the synthesis of 
sulphated silica immobilized tungstic acid (SSTA) and used it for three-component 
synthesis of THPMs/DHPMs (8a-w) by using aldehydes (2a-b, 2d-g, 6a-f), active 
methylene compounds (4a-b, 7a-b) and urea under solvent-free conditions (Scheme 
7). The catalyst was characterized by FT-IR, XRD and SEM-EDX analyses. The 
stability of the catalyst was evaluated by TG analysis. The optimum concentration of 
H+ of SSTA was found to be 0.40 meq/gram of the support. The catalyst can be 
reused for six cycles without any significant loss of activity. 
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CHAPTER 4:  
Chitosan as a support for dispersion of catalytically active lanthanides 
In recent years, biopolymers have gained a lot of attention for their use as supporting 
materials. Chitosan, a biodegradable polymer derived from marine waste in very large 
quantities, is optimally suited for this purpose. The interesting chemo-physical and 
biological properties of chitosan like, hydrophilic character, biodegradability, non-
toxicity and biocompatibility provide a wide spectrum of opportunities for the 
development of functional materials. Inertness toward air and moisture, and easy 
chemical modifications due to the presence of both amino and hydroxyl groups, make 
it a versatile supporting material. This chapter is divided into two sections involving 
immobilization of Ce(III) and Dy(III) nanoparticles on chitosan and their application 
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as catalysts for the synthesis of spiropiperidine and hexahydropyrimidine derivatives 
under green reaction conditions. 
Section A:  Sustainable synthesis of spiropiperidine derivatives using cerium(III) 
immobilised chitosan as an efficient and recyclable heterogeneous catalyst 
The piperidine ring unit forms the core of a large family of alkaloids and natural 
products with strong medicinal and interesting structural properties. Recently spiro-
substituted piperidines have received considerable attention due to their important 
pharmacological profiles like selective and potent σ receptor ligands which can be 
used in the treatment of cocaine abuse, depressions, and epileptic disorders and 5-
HT2B receptor antagonists. In addition various plant alkaloids (sibirine, nitramine, 
isonitramine and nitrabirine) and animal toxins also contain spiropiperidine ring 
systems. 
Cerium(III) halides have been found to be effective Lewis acid catalysts for organic 
transformations. Their water tolerant nature, low toxicity, easy to handle, easy 
availability and property of reusability without further purification have made them 
ideal choice for sustainable organic synthesis. Irrespective of these properties, their 
use in stoichiometric amounts is the main limitation from economic and 
environmental view point. Therefore, it is very important to develop a heterogenised 
version of Ce(III) salts to make them more environment friendly. In this context, this 
section describes the use of chitosan as a support for Ce(III) chloride and its 
application for the synthesis of spiropiperidine derivatives (10a-o) via 
multicomponent reaction of anilines (9a-e), formaldehyde and active methylene 
compounds (4c-d, 4j) at room temperature in PEG-200 (Scheme 10). The catalyst 
was characterized by FT-IR, XRD, SEM, EDX, TEM and ICP-AES analyses. The 
catalyst was found to retain its activity for a minimum of five catalytic cycles. 
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Scheme 10 
Section B:  Dysprosium(III) on chitosan:  A recyclable heterogeneous catalyst for 
the synthesis of hexahydropyrimidines in water 
Hexahydropyrimidines are one of the most commonly encountered heterocycles in 
medicinal chemistry with various biological profiles such as antibacterial, antiviral, 
antitumor and anti-inflammatory activities. These derivatives are also found in a 
number of alkaloids such as verbamethine and verbametrine. N-Substituted 
hexahydropyrimidines serve as key synthetic intermediates for spermidine-
nitroimidazole drugs used for the treatment of A549 lung carcinoma. New 
trypanothione reductase inhibiting ligands used for the regulation of oxidative stress 
in parasite cells also contain this structural unit. Recently, appropriately substituted 
hexahydropyrimidines were found to be potent hepatitis C virus inhibitors. 
Dysprosium (III) is an extremely mild and efficient Lewis acid catalyst having the 
ability to promote various types of carbon-carbon bond forming reactions, 
electrocyclizations and cycloadditions. It also exhibits similar stability towards air and 
water, ease of handling, Lewis acidity and oxophilicity as compared to other 
lanthanides. In this context, this section describes chitosan supported Dy(III) 
catalyzed eco-friendly synthesis of hexahydropyrimidine derivatives (11a-l) using 
aromatic amines (9a-d ,9f), formaldehyde and active methylene compounds 
(4b,4c,7a) at room temperature in water (Scheme 13). The catalyst was characterized 
by FT-IR, XRD, SEM, EDX, elemental mapping, TEM, ICP-AES and TG analyses. 
The catalyst was found to be recyclable up to six catalytic cycles. 
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CHAPTER 5: Silica molybdic acid (SMA) catalysed multicomponent synthesis of 
tetrazole derivatives under microwave irradiation in aqueous media 
Among various heterocycles tetrazoles and their derivatives represent an important 
class of N-containing heterocycles. 5-substituted tetrazoles are reported to possess 
biological profiles like potential drugs against schizophrenia and cerebral ischemia, 
antidiabetic, antiviral, antibacterial and antihypertensive activities. These compounds 
are regarded as important synthetic intermediates in synthetic organic chemistry and 
also show very good coordination properties. Being resistant to biological 
degradation, these derivatives have been used as isosteric substitutes for various 
functional groups in order to develop them as potential medicinal agents. 
Heterogeneous catalysis is clearly on the rise in chemical industries due to increasing 
concerns about the development of new processes that minimize pollution. Among 
various heterogeneous catalysts developed over the past decades, silica supported 
catalysts have been the favourites, due to many advantageous properties of silica like 
excellent chemical and thermal stability, high surface area, good accessibility, and 
active components can be robustly anchored to the surface to provide well dispersed 
catalytic centres. Therefore, this chapter describes the synthesis of silica supported 
molybdic acid (SMA) and evaluation of its catalytic activity for the synthesis of 
functionalized tetrazole derivatives (12a-l) via three component reaction of aldehydes 
(6a-c, 6e-i, 2b-c, 2e, 2i), malononitrile (7c) and sodium azide in water under 
microwave irradiation (Scheme 16). The use of microwave (MW) irradiations as a 
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heat source represents a good alternative to conventional heating in the context of 
reducing the environmental impact of a synthetic process. The presented protocol 
tolerated aldehydes with diverse structural motifs giving corresponding tetrazoles in 
excellent yields (89-95%) and the catalyst was found to maintain good activity for a 
minimum of seven reaction cycles. The catalyst was characterized by FT-IR, XRD, 
XRF, SEM, EDX, elemental mapping and TG analyses. The amount of H+ of the 
catalyst, calculated by back titration analysis, was found to be equal to 0.23 meq/gm 
of the catalyst. 
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PREFACE 
 
Green chemistry, also known as sustainable chemistry, is the design of chemical 
products and processes that reduce or eliminate the use or generation of hazardous 
substances. Green chemistry can be defined as the practice of chemical science and 
manufacturing in a manner that is sustainable, safe, non-polluting and consumes 
minimum amount of materials and energy. Developing green chemistry 
methodologies is a challenge that may be viewed through the framework of the 
‘Twelve Principles of Green Chemistry’. These principles identify catalysis as one of 
the most important tools for implementing green chemistry. In recent years, 
heterogeneous catalysts have gained much attention as a result of economic and 
environmental benefits. They make synthetic processes clean, safe and high-yielding. 
Therefore, the development of selective and reusable solid catalysts for organic 
reactions has been a very active area of research. 
Heterocycles constitute one of the largest areas of research in organic chemistry. The 
majority of pharmaceuticals and agrochemicals are heterocycles while countless 
additives and modifiers used in industries ranging from cosmetics, information 
storage and plastics are also heterocyclic in nature. As a majority of drug-like 
compounds and natural products contain a heterocyclic nucleus at their core, ever 
increasing attention has been paid towards the development of novel clean processes 
employing nontoxic reagents, catalysts and solvents for the synthesis of important 
heterocycles. 
The work embodied in the thesis entitled “Synthesis and Applications of Green 
Catalysts in Organic Synthesis: Heterogeneous Catalysis by Solid Supported 
Compounds and Nanoparticles” deals with the design and synthesis of 
heterogeneous catalysts and their applications for the synthesis of biologically 
relevant heterocyclic compounds. To discuss systematically, the thesis is divided into 
five chapters, which are as follows: 
CHAPTER 1 
Application of clean technologies in chemical synthesis has currently been the major 
area of focus in green chemistry. The eco-friendly and reusable heterogeneous 
catalysts have till now been the leaders in providing such clean technologies. 
Therefore, the catalysts which make the organic reactions environmentally benign and 
economically feasible are extremely demanded by the chemical industries. This 
II 
 
chapter describes the scope of the present work and gives insights about green 
chemistry and its importance in organic synthesis, heterogeneous catalysis by 
supported compounds and nanoparticles, nitrogen containing heterocycles and their 
biological importance, and green chemical pathways viz multicomponent reactions, 
solvent-free reactions and reactions in sustainable media. 
CHAPTER 2 
β-Enaminones are readily obtainable, versatile reagents used for the synthesis of 
novel heterocyclic compounds and drug intermediates. These compounds show both 
the nucleophilic and electrophilic characters and have therefore, been used as 
synthetic intermediates for the synthesis of many biologically important compounds. 
This chapter is dedicated to the synthesis of different kinds of heterocycles under 
different conditions and contains two sections-A and B. 
Section A 
Among the many nitrogen containing heterocycles, 1,4-dihydropyridine substructures 
are among the most prevalent having versatile biological profiles such as selective 
adenosine-A3 receptor antagonism, sirtuin activation and inhibition, antitumor, 
antidiabetic, anticonvulsant photosensitizing and radioprotective activities. The 
immobilization of a homogeneous catalyst on a solid surface is one of the major 
challenges in catalysis as it facilitates the separation of the catalyst and the reaction 
products, and also gives rise to reusability of the catalyst. In this section, we have 
synthesised mesoporous alumina sulphuric acid as a heterogeneous and recyclable 
solid acid catalyst and evaluated its catalytic efficiency for the synthesis of 1,4-
dihydropyridine derivatives (3a-n) via pseudo four component addition and 
cyclisation involving β-enaminone (1a-b), different aldehydes (2a-g) and ammonium 
acetate in aqueous media. The catalyst  showed  excellent  catalytic  activity  giving  
products  in  high  yields (81-90%)  and  could  be  reused  for  seven successive  
catalytic  cycles. The substrate scope of the reaction was demonstrated by successful 
tolerance of aromatic aldehydes with electron donating/electron withdrawing groups 
as well as aliphatic/alicyclic aldehydes. The  catalyst  was  characterized  by  FT-IR,  
XRD,  FE-SEM,  EDX  and  TG  analyses. The  mesoporosity  of  alumina  was  
determined  by  BET  and  TEM  analyses. 
Section B 
Pyridine derivatives widely occur as key structural subunits in various natural 
products that exhibit many interesting biological profiles like anti-prion, anti-hepatitis 
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B virus, anti-bacterial and anti-cancer activities. These derivatives are also present in 
drugs used for the treatment of Parkinson’s disease, hypoxia, asthma, kidney disease, 
epilepsy, cancer, and Creutzfeldt–Jacob disease. ZnO NPs, due to their cheapness, 
easy to synthesise, requirement of mild conditions and non-toxic nature have proven 
to be successful catalysts for several organic transformations. Therefore, in this 
section, the synthesis of pyranyl pyridine derivatives (5a-p) involving the reaction of 
β-enaminone (1a, 1c), active methylene compounds (4a-i) and ammonium acetate 
under solvent-free conditions, using ZnO NPs as catalyst has been described. The 
catalyst showed excellent catalytic activity giving pyridine derivatives in excellent 
yields (91-96%) and was recyclable up to six cycles. ZnO nanoparticles were 
characterized by XRD, SEM and TEM analyses, and the final products were 
characterized by using IR, 1H, 13C NMR, ESI-MS and elemental analyses techniques. 
CHAPTER 3  
Tetrahydropyrimidines (THPMs)/ Dihydropyrimidines (DHPMs) represent an 
important group of highly valuable heterocyclic motifs in the field of medicinal 
chemistry showing diverse pharmacological profiles like calcium channel modulators, 
HIV protease inhibiting, antineoplastic, anti-inflammatory, antiviral, antiproleferative, 
herbicidal, and antibacterial activities. Silica supported catalysts are innovative 
heterogeneous catalysts which have found a special place in green chemistry. Because 
of many advantageous properties of silica like excellent chemical and thermal 
stability, high surface area and good accessibility, its use as supporting material has 
grown manifold. In this chapter we have discussed the synthesis and catalytic 
application of sulphated silica immobilized tungstic acid (SSTA). The catalyst was 
evaluated for its catalytic activity by synthesizing THPMs/DHPMs (8a-w) from 
aldehydes (2a-b, 2d-g, 6a-f) active methylene compounds (4a-b, 7a-b) and urea 
under solvent-free conditions. The catalyst was found to be highly efficient affording 
the products in excellent yield (82-96%) in short time period (8-31 min). The catalyst 
was characterized by FT-IR, XRD SEM-EDX and TG analyses. The structures of the 
final products were elucidated by using IR, 1H, 13C NMR, ESI-MS and elemental 
analyses techniques. 
CHAPTER 4  
In the last decades, lanthanides as Lewis acids have found widespread use in the 
development of green chemistry as mild and efficient catalysts. A prominent feature 
of lanthanides is their stability and activity in protic media, making them ideal for use 
IV 
 
as stable Lewis acids in water. Chitosan, a biodegradable polymer has gained a lot of 
attention for its use as supporting material in catalysis. It’s interesting chemo-physical 
properties like, hydrophilic character, biodegradability, non-toxicity, inertness toward 
air and moisture, and easy chemical modifications due to the presence of both amino 
and hydroxyl groups make it a versatile supporting material. This chapter describes 
synthesis of spiropiperidines and hexahydropyrimidines under different reaction 
conditions and is divided into sections-A and B. 
Section A 
Ce(III) salts as Lewis acids have been extensively used in reduction, C−C, C−N and 
C−O bond formation reactions. This extensive use of Ce(III) salts is attributed to their 
properties like moderate to low toxicity, water tolerance, easy to handle, availability 
at moderate cost and suitability for use without purification. Spiro-substituted 
piperidines have received considerable attention because of their important 
pharmacological profiles like selective and potent σ receptor ligands that can be used 
in the treatment of cocaine abuse, depression and epileptic disorders, and 5-HT2B 
receptor antagonists. These motifs are also found in large family of alkaloids and 
natural products with strong biological profiles and interesting structural properties. In 
this section chitosan has been used as a support for the dispersion of catalytically 
active Ce(III) species and used for the synthesis of spiropiperidine derivatives (10a-o) 
via multicomponent reaction of substituted anilines (9a-e), formaldehyde and 
different active methylene compounds (4c-d, 4j) at room temperature in PEG-200. 
The catalyst was characterized by FT-IR, XRD, SEM, EDX, TEM and ICP-AES 
analyses. The structures of spiropiperidines were characterized by IR, 1H & 13C NMR, 
ESI-MS and elemental analyses techniques. The catalyst was found to retain its 
activity for a minimum of five catalytic cycles. 
Section B 
In the field of medicinal chemistry hexahydropyrimidine derivatives are one of the 
most commonly encountered structures with various biological profiles such as 
antibacterial, antiviral, antitumor and anti-inflammatory activities. These derivatives 
are found in a number of alkaloids and also serve as key synthetic intermediates for 
spermidine-nitroimidazole drugs. Dysprosium(III) is an extremely mild and efficient 
Lewis acid catalyst having the ability to promote various types of carbon–carbon bond 
forming reactions, electrocyclizations and cycloadditions. In this context, this section 
deals with the catalytic evaluation of chitosan supported Dy(III) species for the 
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synthesis of hexahydropyrimidine derivatives (11a-l) employing amines (9a-d, 9f), 
formaldehyde and active methylene compounds (4b,4c,7a) at room temperature in 
water. The structures of the final products were elucidated by using spectral (IR, 1H, 
13C NMR and ESI-MS) and elemental analysis data. The catalyst was characterized 
by FT-IR, XRD, SEM, EDX, Elemental mapping, TEM, ICP-AES and TG analyses. 
The catalyst was found to be recyclable up to six catalytic cycles. 
CHAPTER 5 
Tetrazole derivatives represent an important class of N-containing heterocycles 
reported to possess biological profiles like potential drugs against schizophrenia and 
cerebral ischemia, antidiabetic, antiviral, antibacterial and antihypertensive activities. 
The close similarity between the acidity of tetrazole group and carboxylic group has 
led to their development as potential bioisosteric replacements for carboxylic acid 
groups. They also serve as important synthons in synthetic organic chemistry and as 
ligands in coordination chemistry. In modern material science, silica is the most 
commonly used inorganic supporting material in systems designed for catalysis. Due 
to the favourable chemical and physical properties of silica surfaces, it is possible to 
impart nearly any reactive functional group through well-known silane chemistry. In 
this context, this chapter deals with the synthesis of silica supported molybdic acid 
(SMA) and evaluation of its catalytic activity for the synthesis of functionalized 
tetrazole derivatives (12a-l) via three component reaction of aldehydes (6a-c, 6e-i, 
2b-c, 2e, 2i), malononitrile (7c) and sodium azide in water using microwave 
irradiation. The presented protocol tolerated aldehydes with diverse structural motifs 
giving corresponding tetrazoles in excellent yield (89-95%). The catalyst was 
characterized by FT-IR, XRD, XRF, SEM, EDX, elemental mapping and TG 
analyses, and was found to maintain good activity for a minimum of seven reaction 
cycles. 
vi 
 
Abbreviations and Symbols 
AcOH  Acetic acid 
Aq.      Aqueous 
BET     Brunauer–Emmett–Teller 
Bz     Benzyl 
CDCl3     Deuterated chloroform 
CHCl3     Chloroform 
CSA     Camphor sulfonic acid 
DCM     Dichloromethane 
DMF     N, N-Dimethylformamide 
DMSO     Dimethyl sulfoxide 
EtOH     Ethanol 
FT-IR     Fourier transform infrared 
g     Gram 
h or hrs    Hours 
Hz     Hertz 
Me     Methyl 
MeOH     Methanol 
mg     Milligram 
mL     Millilitre 
mmol     Millimole 
M.p.     Melting point 
meq.     milliequivalent 
M.W.     Molecular weight 
MW     Microwave 
NMR     Nuclear magnetic resonance 
PEG     Poly ethylene glycol 
p-TSA/TsOH    para-Toluenesulfonic acid 
RT     Room temperature 
SMA     Silica molybdic acid 
STA     Silica tungstic acid 
SSTA     Sulphated silica tungstic acid 
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GENERAL REMARKS 
Ø Melting points were determined on a Reichert Thermovar instrument and are 
uncorrected. 
Ø The 1H NMR and 13C NMR spectra were recorded on Bruker DRX-300 and Bruker 
Avance II-400 Spectrometer using tetramethyl silane (TMS) as an internal standard, 
DMSO-d6/CDCl3 as solvent. Chemical shifts are reported in ppm downfield from TMS 
as internal standard and coupling constants J are given in Hz. 
Ø The micro-analytical data were collected on an Elementar vario EL III elemental 
analyser and their results were found to be in agreement with the calculated values. 
Ø FT-IR spectra were obtained using a Perkin–Elmer RXI spectrometer in KBr. The 
spectra were recorded in the 400–4000 cm-1 wave-number range. 
Ø Mass spectra were obtained on Micromass Quattro II (ESI) and THERMO Finnigan 
LCQ Advantage max ion trap mass (ESI-MS) spectrometer. 
Ø All starting materials of commercial grade were purchased from Sigma-Aldrich 
(Switzerland), Merck (Mumbai, India) and used without further purification. 
Ø The purity of all compounds was checked by TLC on glass plates coated with silica gel 
(E-Merck G254). The plates were run in chloroform-methanol (3:1) mixture as mobile 
phase and were visualized by iodine vapours. 
Ø X-ray diffractograms (XRD) of the catalyst were recorded in the 2θ range of 10–80° 
(scan rate of 4° min-1) on a Rigaku Miniflex X-ray diffractometer with Ni-filtered Cu Kα 
radiation at a wavelength of 1.54060°A. 
Ø The SEM-EDX analyses was done using a JEOL JSM-6510 scanning electron 
microscope equipped with energy dispersive X-ray spectrometer (acc. voltage: 20 kV) at 
different magnification. 
Ø Transmission electron microscope (TEM) images were obtained using JEM-2100 F 
model (acc. voltage: 200 kV) with magnification up to 100000x. 
Ø Thermogravimetric (TG) analysis data was obtained with a DTG-60H, with a heating 
rate of 25 °C min-1 from 100 to 1000 °C under N2 atmosphere. 
Ø Nitrogen adsorption–desorption isotherms were obtained using a Quantachrome 
Autosorb 1C at 77 K. 
Ø ICP-AES analysis was performed on ARCOS from M/s. Spectro, Germany. 
Ø The FE-SEM characterization of the catalyst was performed on QUANTA 200 FEG 
from FEI Netherlands. 
Ø Microwave synthesis was carried out using Microwave Synthesis Reactor, monowave 
300 (Anton paar). 
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GENERAL INTRODUCTION 
It is widely acknowledged that there is a growing need for more environmentally 
acceptable processes in the chemical industry. This trend towards what has become 
known as ‘Green Chemistry’ puts forward sustainable concepts, which are designed to 
reduce or eliminate chemicals and chemical processes that have negative 
environmental impacts. A reasonable definition of green chemistry is formulated as: 
Green chemistry efficiently utilizes (preferably renewable) raw materials, eliminates 
waste and avoids the use of toxic and/or hazardous reagents and solvents in the 
manufacture and application of chemical products.1 Green chemistry addresses the 
environmental impact of both chemical products and the processes by which they are 
produced. It primarily aims to eliminate waste at source rather than at the end. An 
alternative term, which is currently favoured by the chemical industry, is sustainable 
technologies. Sustainable development has been defined as meeting the needs of the 
present generation without compromising the ability of future generations to meet 
their own needs.2  
1.1. Heterogeneous catalysis: 
Catalysis is one of the main pillars of “green chemistry”, and the development of 
environmentally benign catalysts is one of the vital challenges faced by the chemists.3 
A sustainable and “green” catalyst must, therefore, possess specific features including 
low preparation cost, high activity, great selectivity, high stability, efficient recovery, 
and recyclability. Heterogeneous catalysis involves a system in which a catalyst exists 
in a different phase to that of the reactants. Generally, the catalyst is usually a solid 
and the reactants are either gases or liquids. In recent years, heterogeneous catalysts 
have gained much attention, as a result of economic and environmental benefits. They 
make synthetic processes clean, safe and high-yielding.4 The use of heterogeneous 
solid catalysts being in a different phase than the reagents and products have an 
obvious advantage in terms of easy separation from the reaction mixture, allowing the 
recovery of the solid and eventually its reuse, provided that the solid (catalyst) has not 
become deactivated during the course of the reaction.5  
The development of selective and reusable solid catalysts for organic reactions has 
been a very active area of research. Acid catalysed processes play a key role in 
pharmaceutical, agrochemical and oil refining industries.6-7 They are also used in the 
manufacture of a wide variety of specialty chemicals such as, flavours and 
fragrances.8 Many of these processes involve the use of traditional Brønsted acids 
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(H2SO4, HF, HCl, p-toluenesulfonic acid etc.) or Lewis acids (AlCl3, ZnCl2, BF3 etc.) 
as catalysts under homogeneous conditions and their subsequent neutralization leads 
to the generation of inorganic salts which eventually end up in aqueous waste streams. 
Therefore, the promising solution to this problem of salt generation is the replacement 
of traditional Brønsted and Lewis acids with recyclable solid acids and bases.9-13 The 
benefits of using the recyclable acid catalysts are outlined below: 
· Facilitation of separation and recycling which results in simpler processes and 
less production costs. 
· Solid acids are safer and easier to handle than their highly corrosive and 
expensive liquid counterparts, e.g. H2SO4, HF. 
· Use of solid acid evades the contamination of products by avoiding neutralization. 
With the advancement in nanoscience and nanotechnology, a wide variety of nano-
catalysts or solid-supported nano-catalysts have been applied to various 
transformations.14 These catalysts have proven to be highly successful because of 
their high activity and selectivity due to their small size (1–100 nm) and exposed 
active sites. However, the decrease in the size to nanometer scale causes rise in the 
surface free energy which leads to aggregation of the particles into small clusters and 
degrades the catalytic efficiency. Further, as the size of particles decreases to nano 
scale, separation through conventional means becomes difficult. Thus, in order to 
harness full potential of these nanoparticles it is very important to employ suitable 
support materials which will lead to the development of efficient and recyclable 
catalytic systems. 
1.2. Nitrogen-containing heterocycles: 
Heterocycles by far form the largest of classical divisions of organic chemistry and 
have immense biological and industrial applications. The majority of pharmaceuticals 
and agrochemicals are heterocycles15 while countless additives and modifiers used in 
industries ranging from cosmetics, information storage and plastics are also 
heterocyclic in nature. Nitrogen-containing heterocycles are widely distributed in 
nature and play a vital role in the metabolism of all living cells. Among nitrogen 
containing heterocycles, pyridine derivatives are important as they are present in 
many pharmacologically active compounds.16-18 These derivatives possess large 
spectrum of biological activities such as anti-bacterial, anti-prion, anti-hepatitis B 
virus, and anti-cancer.19 Some derivatives have become lead compounds in the search 
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of new drugs for Parkinson’s disease, hypoxia, asthma, kidney disease, epilepsy, 
cancer, and Creutzfeldt–Jacob disease.20-22 Naturally occurring compounds such as 
vitamins, niacin and pyridoxine, and a number of alkaloids including nicotine contain 
the pyridine nucleus. Due to their applications as herbicides, fungicides or 
bactericides these derivatives are also very important for the agrochemical 
industry.23,24 The presence of pyridine ring in about 7000 drugs demonstrates the 
significance of these derivatives in pharmaceutical industries.25,26 
The pyrimidine nucleus has wide occurrence in nature and is found in nucleotides, 
thiamine (vitamin B1) and alloxan (diabetes inducing compound).27 Many synthetic 
compounds such as barbiturates and the HIV drug, zidovudine contain this nucleus. 
The presence of pyrimidine nucleus as base in thymine, cytosine and uracil, which are 
the essential binding blocks of DNA and RNA, is one possible reason for their 
activity. Many of the promising biological profiles shown by pyrimidine derivatives 
are anti-microbial, analgesic, anti-viral, anti-inflammatory, anti-HIV, anti-tubercular, 
anti-tumour, anti-neoplastic, anti-malarial and cardiovascular activities.28 
1.3. Green pathways: 
(i) Multicomponent reactions (MCRs): 
Multicomponent reactions (MCRs) have recently gained much importance in 
synthetic organic chemistry.  MCRs are defined as one-pot reactions in which at least 
three different substrates join through covalent bonds to give the product. They allow 
the creation of several bonds in a single operation and offer remarkable advantages 
like good synthetic efficiency, high intrinsic atom economy, good selectivity, and 
procedural simplicity. They are very important from green chemistry view point as 
they reduce the number of steps in a reaction, decrease energy consumption and 
minimize waste generation. The MCRs have been successfully used for the creation 
of diverse range of chemical libraries of drug-like compounds and therefore are 
widely used in pharmaceutical industries. Therefore, the design of new MCRs with 
improved efficiencies has been an area of great interest.29 
(ii) Solvent-free reactions: 
Due to growing concerns about the environment and human health, solvent-free 
organic synthesis has become a major area of focus in organic chemistry. Toxic, 
flammable and expensive nature of organic solvents have put the spot light on 
solvent-free reactions.30 As solvents constitute the major part of waste generation in 
organic synthesis, solvent-free approach contributes to sustainability by eliminating or 
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minimising the waste generation. Overall, the advantages of solvent-free organic 
synthesis are shorter reaction times, cleaner reaction products and environmentally 
more benign conditions as compared with the classical reactions.31 
(iii) Green solvents: 
(a) Polyethylene glycols (PEGs): 
Polyethylene glycols (PEGs) are inexpensive, non-toxic, non-volatile, thermally 
stable compounds which serve as suitable media for environmentally sustainable 
organic transformations. They are available in a wide range of molecular weights, and 
their complete toxicity profiles are also available. They are components in many 
consumer products such as shampoos and other personal care items, and have been 
approved by the U.S. Food and Drug Agency for internal consumption. Their 
solubility in water leads to easy separation and recovery of products from the reaction 
medium.32-34 
(b) Water: 
Water is the most abundant and environmentally benign solvent in nature and 
possesses the remarkable ability to catalyse chemical transformations between some 
insoluble organic reactants. This phenomenon is termed as “on-water” catalysis by 
Sharpless and co-workers and was first observed in the late 1930s and is only now 
being widely adopted.35-38 Subsequent mechanistic studies have established that this 
behaviour results from enforced hydrophobic interactions39 and stabilization of the 
activated complex by hydrogen-bond formation.40 Therefore, performing the reactions 
in water constitutes a very important challenge for green chemistry, as the 
combination of the synthetic efficiency of multicomponent protocols and the 
environmental benefits of using water as the reaction medium, lead the processes 
close to the ideal synthetic reaction. 
Keeping in view the importance of heterogeneous catalysts in the field of green 
chemistry and pharmaceutical industries, the research work undertaken involves the 
design and synthesis of heterogeneous catalysts and evaluation of their catalytic 
activity by synthesizing biologically relevant heterocyclic compounds. All the 
processes developed are highly efficient, green and environment friendly. 
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2.1. INTRODUCTION 
β-Enaminones are versatile synthetic intermediates that have been extensively utilized 
as building blocks in organic synthesis.1 These compounds possess a nitrogen 
functionality and an   electron-withdrawing carbonyl group on adjacent alkene 
carbons (Figure 1), and thus show both the nucleophilic and electrophilic characters. 
In these compounds the amine group pushes and the carbonyl group pulls electron 
density, which make them a typical push-pull ethylenes. Moreover, the carbonyl 
group, conjugated to the enamine moiety, gives this system enough stability to be 
easily prepared and can be isolated and stored under normal conditions. Thus, these 
compounds have served as synthons for the synthesis of many therapeutic agents such 
as antitumor, antibacterial, antimalarial, and anti-inflammatory as well as 
anticonvulsant agents.2-3 
 
Fig. 1. Complementary electronic interaction of enaminones with 
electrophile/nucleophile. 
Synthesis of some of the important six membered N-heterocyclic compounds from β-
enaminones is outlined below (Figure 2).4 
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Fig. 2. Synthesis of some important six membered N-heterocycles from β-
enaminones. 
In this chapter we have described the synthesis of various novel 1,4-dihydropyridines 
and pyridine derivatives employing β-enaminones as synthons under green reaction 
conditions using heterogeneous nano-catalysts. 
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SECTION A 
SYNTHESIS OF 1,4-DIHYDROPYRIDINES FROM β-ENAMINONES USING 
MESO ALUMINA–SULPHURIC ACID (Al-OSO3H) AS CATALYST IN 
WATER  
Among nitrogen containing heterocycles, 1,4-dihydropyridines (1,4-DHPs) are among 
the most predominant and are found in many biologically active pharmaceuticals and 
natural products. Well known calcium agonists Felodipine, Nicardipine, Nimodipine, 
Nifedipine (Figure 3) and NADPH contain this structural motif. DHPs also exhibit 
interesting biological profiles such as selective adenosine-A3 receptor antagonism, 
sirtuin activation and inhibition, antitumor, antidiabetic, anticonvulsant 
photosensitizing and radioprotective activities.5-7 Conventionally, Hantzsch reaction, 
reduction of pyridines, addition to pyridines or cycloadditions are the main routes for 
the synthesis of 1,4-DHPs, but Hantzsch reaction still remains the commonly used 
approach for the synthesis of these compounds.8  
 
Fig. 3. Some important biologically active 1,4-dihydropyridines. 
2.2. REVIEW OF LITERATURE 
Recently, 1,4-DHPs  have been synthesised via enaminones and few reports available 
in literature employ L-Proline/MeOH, TMSCl, TsOH/DCE, NaAuCl4 and AcOH
9-12 
as catalytic systems. However, these methods exhibit limited substrate tolerance and 
                                                          
 Nayeem Ahmed, Zeba N. Siddiqui, Journal of Molecular Catalysis A: Chemical, 394 (2014) 232. 
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reactivity, suffer from low yields, and use of toxic solvents. Hence it is highly 
desirable to develop a new protocol for the synthesis of 1,4-DHPs using enaminones, 
which is highly efficient, environmentally benign and tolerates wide range of 
substrates. 
Some recent and important methods of synthesizing 1,4-dihydropyridine 
derivatives via enaminones are discussed below: 
2.2.1. Synthesis of pyrazolyl dihydropyridine derivatives.13 
 R. Sridhar and P. T. Perumal developed a 3,4,5-trifluorobenzeneboronic acid 
catalysed, ionic liquid mediated mild, simple and environmentally benign protocol for 
the synthesis of dihydropyridines. The reaction involves cyclocondensation of ethyl 3-
aminocrotonate, pyrazole carbaldehyde and a β-keto ester to afford dihydropyridine 
derivatives in very good yields. 
 
2.2.2. Synthesis of dihydropyridine C-glycoconjugates by organocatalytic 
Hantzsch cyclocondensation.9 
D. R. B. Ducatti et al. reported the synthesis of dihydropyridine C-glycoconjugates 
via the reaction of C-glycosyl aldehyde, enamino ester and β-ketoester using L-
proline as a catalyst in methanol. The protocol successfully applied for the synthesis 
of symmetrically and unsymmetrically substituted DHP C-glycoconjugates of 
biological relevance. The noteworthy feature of this protocol is very high 
stereoselectivity (de >95%) of the reaction. 
 
2.2.3. One-pot synthesis of 1,4-dihydropyridine derivatives using Me3SiCl and 
Et3SiI as catalysts.
10 
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M. Mirza-Aghayana et al. reported the synthesis of 1,4-dihydropyridine derivatives 
by one-pot cyclocondensation of methyl 3-aminocrotonate and a range of aldehydes 
in the presence of chlorotrimethylsilane as a catalyst under solvent-free conditions. 
Short reaction time and high yield of products are the highlights of this protocol. 
 
2.2.4. An efficient acid-catalysed synthesis of 1,4-dihydropyridines via the 
reaction of enaminones with aldehydes.11 
J. Yang et al. developed an efficient method for the synthesis of 1,4-DHPs without 
substituents at the C-2 and C-6 positions through an acid-catalysed reaction of 
enaminones with aldehydes. The reaction involves formation of divinylmethanes and 
their subsequent intramolecular cyclization to afford 1,4-dihydropyridines. 
 
2.2.5. Regioselective synthesis of unsymmetrical 1,4-dihydropyridines and 1,2-
dihydropyridines.14 
J. P. Wan et al.  described the reaction of α,β-unsaturated aldehydes, amines, and 
enaminones leading to the synthesis of various (1,3,4-trisubstituted)-1,4-
dihydropyridines in aqueous DMF along with 1,2-dihydropyridines. The steric and 
electronic effects originating from the amino group were the reasons for the 
regioselectivity shown by the reaction.  
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2.2.6. An efficient multicomponent synthesis of 4-aryl dihydropyridines using 
enaminones.12 
An efficient three component synthesis of 4-aryl 1,4-dihydropyridines via the reaction 
of enaminones, primary amines and aldehydes has been reported by N. A. Al-Awadi 
et al. Appropriately substituted derivatives exhibited an interesting 
photoluminescence behaviour suggesting their potential application as suitable 
photoinduced intramolecular electron-transfer systems.  
 
2.3. PRESENT WORK 
Many industrial processes are catalysed by strong Brønsted acid catalysts including 
sulfuric acid, p-toluenesulfonic acid etc. However, such homogeneous acids result in 
considerable energy wastage and the generation of large amounts of chemical waste. 
Moreover, they require neutralization, cannot be regenerated from homogeneous 
reaction mixtures and are also harmful to the environment. Therefore, a very 
promising solution to this problem is by replacing such conventional ‘‘homogeneous 
Brønsted acids” with recyclable solid acids and the simplest strategy to perform this 
task is by immobilization on the surface of an insoluble solid.15 Among various 
catalytic nanomaterials, ɣ-Al2O3 is an important supporting material in heterogeneous 
catalysis due to its porous morphology, ultrafine crystallite size, large surface area 
and, high thermal and chemical stabilities. Fine dispersion of active species because 
of large surface area and open porosity enable efficient contact of the catalyst with the 
reactant molecules.16 In the present work, taking advantages of the above mentioned 
properties of mesoporous alumina, we have designed the synthesis of mesoporous 
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alumina sulphuric acid (Meso-Al-OSO3H ) as a heterogeneous and recyclable catalyst 
and used it for the synthesis of novel 1,4-dihydropyridine derivatives via pseudo four 
component addition and cyclisation involving β-enaminone, aldehydes and 
ammonium acetate in aqueous media. 
2.4. RESULTS AND DISCUSSION 
The sulfonic acid functionalised alumina catalyst was prepared by reaction of 
mesoporous alumina with chlorosulfonic acid (Scheme 1). The amount of acid groups 
present on alumina was calculated by using neutralization titration method and was 
found to be 3.6 meq/g. 
Scheme 1: Schematic representation of the synthesis of the Meso-Al-OSO3H. 
2.4.1. Characterization of the catalyst 
2.4.1a. FT-IR spectral analysis 
The FT-IR spectra of the alumina nanoparticles (Figure 4a) and meso-Al-OSO3H 
(Figure 4b) are shown in Figure 4. In the spectrum of alumina, the characteristic 
stretching frequency of surface OH group was obtained at 3400 cm-1. The bending 
and stretching vibrations of Al–O group were present in the range 500–1000 cm-1.17 In 
the spectrum of functionalized alumina, the asymmetric and symmetric stretching 
modes of O=S=O group were obtained as a broad band at 1120 cm-1. Whereas the S–
O stretching band at 600–700 cm-1 merged with the bending and stretching bands of 
Al–O group.18 The functionalization of alumina by sulfonic acid groups also lead to 
decrease in the intensity of bands centred around 500–1000 cm-1. The IR spectra thus, 
confirmed the successful functionalization of alumina nanoparticles by sulfonic acid 
groups. 
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Fig. 4. FT-IR spectra of (a) Mesoporous alumina and (b) Meso-Al-OSO3H  
2.4.1b. XRD analysis 
The XRD analysis was performed in order to observe the formation of γ-Al2O3 and 
meso-Al-OSO3H (Figure 5). The XRD pattern of alumina (Figure 5a) shows 
diffraction peaks corresponding to γ-Al2O3 (broad peaks around 30, 45, 60 and 65°) 
and α-Al2O3 (sharp peaks around 25, 35, 40, 50, 55°) phases.
19 Meso-Al-OSO3H 
(Figure 5b) showed similar XRD pattern to that of γ-Al2O3. However, some extra 
peaks and slight changes in the nature of peaks were observed, which may be due the 
presence of sulfonic acid groups on the surface of alumina. 
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Fig. 5. Powder XRD spectra of (a) γ-Al2O3 (b) meso-Al-OSO3H and (c) meso-Al-
OSO3H after seven catalytic cycles. 
2.4.1c. FE-SEM and EDX analysis 
The spherical shape of the synthesised mesoporous alumina nanoparticles was 
observed by FE-SEM analysis (Figure 6a & b) which showed the particle size in the 
range of 400 nm. The surface of alumina after functionalization with sulfonic acid 
groups is shown in Figure 6c. It was observed that shape and surface morphology of 
alumina particles is retained after being functionalized with sulfonic acid groups. The 
successful functionalization was further confirmed by EDX analysis (Figure 6d) 
which showed the presence of S in addition to Al and O elements. 
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Fig. 6. FE-SEM images (a & b) of freshly synthesised γ-Al2O3 at different 
magnifications (c) of meso-Al-OSO3H and (d) EDX analysis of meso-Al-OSO3H. 
2.4.1d. BET and TEM analysis 
The mesoporous structure of ɣ-alumina was confirmed by N2 adsorption/desorption 
isotherms (Figure 7a). The sample showed the presence of type IV isotherm 
(definition by IUPAC)20 which is a characteristic of mesoporous material. The surface 
area of the sample was found to be 529.54 m2/g. The pore size distributions were also 
obtained from these adsorption isotherms and the pore volume and average pore size 
were 0.5 cc/g and 5.5 nm respectively (Figure 7b). The less broadening in the pore 
width peak denotes the presence of uniform size pores. In order to further confirm the 
mesoporous structure of the synthesized alumina particles, TEM analysis (Figure 8) 
was performed. The images showed wormhole-like porous structure of the molecules 
with uniform pore size distribution. All these analyses proved the mesoporous nature 
of synthesized alumina nanoparticles. 
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Fig. 7. (a) Nitrogen adsorption isotherm and (b) pore size distribution of mesoporous 
alumina. 
 
Fig. 8. TEM images of mesoporous alumina showing uniform pore distribution. 
2.4.1e. TG Analysis 
TG analysis was performed in order to evaluate the thermal stability and successful 
incorporation of sulfonic acid groups on mesoporous alumina surface. The TGA curve 
of mesoporous alumina (Figure 9b) showed a weight loss of 8.97 % up to 180 ° C 
due to the evaporation of moisture trapped in alumina framework. The TG curve then 
did not show any further weight loss up to 600 °C. In the TG curve of meso-Al-
OSO3H (Figure 9a), the first weight loss below 100 °C (13.7 % up to 200 °C) was 
due to the removal of solvent and water molecules trapped in alumina matrix. Another 
weight loss of 8.9 % beginning from 300 °C up to 600 °C was attributed to the 
decomposition of sulfonic acid groups from the mesoporous alumina surface. The TG 
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curve, thus, showed successful incorporation of sulfonic acid groups on the alumina 
surface. 
 
Fig. 9. TG analysis (a) of meso-Al-OSO3H acid [MAS] and (b) of mesoporous 
alumina [MA]. 
2.4.2. Optimization of reaction conditions 
2.4.2a. Optimization of catalysts 
Keeping in view the environmental concerns as well as the vast utility and scope of 
reactions carried out in water, we chose water as the preferred solvent for our 
reaction. Catalyst optimization experiments were done in order to find right catalyst 
for our reaction. The reaction between enaminone 1b, benzaldehyde (2a) and 
ammonium acetate was chosen as the model reaction. When the reaction was tried in 
the absence of any catalyst no product formation was observed, indicating the need of 
a catalyst. When ZnO, MgO, meso-Al2O3, AcOH and H2SO4 were used as catalysts, 
unsatisfactory results were obtained (Table 1, entries 1-5). An improvement in the 
yields of the product was observed when heterogenized sulphuric acid catalysts were 
tried. Among silica, zirconia and alumina supported sulphuric acid, alumina sulphuric 
acid catalysed reaction showed better results (Table 1, entries 6-8). Sulphuric acid 
supported on organic polymers also showed poor results in comparison to alumina 
sulphuric acid (Table 1, entries 11 & 12). We then tried the reaction using sulphuric 
acid supported on silica and alumina nanoparticles (Table 1, entries 13 & 14) the 
yields of the product increased substantially with decrease in time taken for 
completion of the reaction. The results obtained showed that the nano-alumina 
sulphuric acid (Table 1, entry 14) was the most efficient catalyst for this reaction. 
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The higher activity shown by alumina supported sulphuric acid may be due to fine 
dispersion of sulfonic acid groups on the surface of alumina as compared to other 
supports. In order to further improve our catalytic system, we used mesoporous 
alumina as a support for functionalizing sulphuric acid, the results obtained were very 
promising and lesser amount of the catalyst was needed to efficiently catalyse this 
reaction (Table 1, entry 16). This higher activity shown by mesoporous alumina 
sulphuric acid is due to the porous structure generating a very high surface area which 
in turn leads to higher number of sites being available for functionalization with 
sulfonic acid group. 
Table 1: Effect of various catalysts on the model reaction. 
 
Entry Catalyst Condition Time Yield (%) 
1 ZnO (10 mol%) H2O /reflux 8.4 h 54 
2 MgO (10 mol%) H2O /reflux 9.5 h 48 
3 Meso-Al2O3 (10 mol%) H2O /reflux 12.5 h 29 
4 AcOH (10 mol%) H2O /reflux 7.0 h 61 
5 H2SO4 (10 mol%) H2O /reflux 6.2 h 58 
6  H2SO4-SiO2 (200mg) H2O /reflux 3.5 h 72 
7  H2SO4-ZrO2 (200mg) H2O /reflux 4.2 h 62 
8  H2SO4-Al2O3 (200mg) H2O /reflux 3.0 h 75 
9  NH2SO3H-SiO2 (200mg) H2O /reflux 3.4 h 66 
10  TsOH-SiO2 (200mg) H2O /reflux 4.1 h 64 
11  H2SO4-Cellulose (200mg) H2O /reflux 5.8 h 59 
12  H2SO4-Xanthan (200mg) H2O /reflux 5.2 h 61 
13 H2SO4-nanoSiO2 (100mg) H2O /reflux 2.2 h 78 
14 H2SO4-nanoAl2O3 (100mg) H2O /reflux 1.8 h 81 
15 H2SO4-Meso-Al2O3 (100mg) H2O /reflux 45 min 90 
16 H2SO4-Meso-Al2O3 (50mg) H2O /reflux 45 min 90 
 
2.4.2b. Effect of solvents/Hydrophobic effect 
In order to establish water as a preferred solvent, the model reaction was studied using 
different solvents (Table 2). Using AcOH, MeOH and EtOH as solvents, 
unsatisfactory yield of product was obtained (Table 2, entries 2-4). CHCl3 and DMF 
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as solvents again showed unsatisfactory results (Table 2, entries 5&6). Excellent 
results in short span of time were obtained by using water as a solvent for the reaction 
(Table 2, entry 7). This enhanced reactivity can be attributed to the strong hydrogen 
bond interaction at the organic/water interface, which stabilizes the reaction 
intermediates and enhances the rate of reaction.21 To further understand this 
impressive rate enhancement for on-water reactions, controlled experiments were 
undertaken. Firstly, under neat conditions the reaction completed in 1.5 h with 77% 
product yield (Table 2, entry 1). We then performed the reaction by using different 
concentrations of various solvents with water. Mixing of 0.5 mL of EtOH to the water 
containing the reaction mixture produced no effect. Addition of further 1-2 mL of 
EtOH again did not display any remarkable effect (Table 2, entries 8 & 9). Addition 
of 3-4 mL of EtOH turned the reaction mixture homogeneous, and then the rate of 
reaction decreased considerably (Table 2, entry 10). We then tried this experiment 
with MeOH and found similar results. Upon examining the results we found that the 
large rate enhancements occurred if the reaction was conducted in heterogeneous 
conditions than in homogeneous aqueous solution and hydrophobic effects act 
prominently as neat reaction was not as faster as reaction using water. These studies 
established the supremacy of water as a solvent for this reaction. 
Table 2: Effect of different solvents on the model reaction. 
 
Entry Solvent Time Yield (%) 
1 Neat 1.5 h 77 
2 AcOH (5mL) 4 h 56 
3 MeOH (5mL) 5 h 53 
4 EtOH (5mL) 5 h 61 
5 CHCl3 (5mL) 5 h Incomplete  
6 DMF (5mL) 3 h 48 
7 H2O (5mL) 45 min 90 
8 H2O (5mL)/ EtOH (1mL) 45 min 88 
9 H2O (5mL)/ EtOH (2mL) 50 min 86 
10 H2O (5mL)/ EtOH (3mL) 3.5 h 73 
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2.4.2c. Catalyst loading 
In order to obtain maximum yield in lesser amount of time, effect of the catalyst 
loading on the model reaction was studied. It was found that the yield of the product 
increased from 76% to 90% when the catalyst amount was increased from 0.03 g to 
0.05 g. Further increase of catalyst amount to 0.1 g did not improve product yield 
(Table 3). 
Table 3: Effect of catalyst loading on the model reaction. 
 
Entry Catalyst loading (g) Time (min) Yield (%) 
1 0.03 63 76 
2 0.05 45 90 
3 0.10 45 90 
4 0.15 45 88 
5 0.20 45 86 
 
2.4.2d. Catalytic reaction 
With these encouraging results in hand, we then explored the scope of the reaction by 
using different aromatic aldehydes (2a-g), enaminones (1a, 1b) and ammonium 
acetate as substrates under the optimized reaction conditions (Table 4). Aromatic 
aldehydes with electron donating/electron withdrawing groups as well as 
aliphatic/alicyclic aldehydes reacted successfully to furnish the final products (3a-n) 
in good yields (Scheme 2). The structure of the final product was well characterized 
by using spectral (IR, 1H, 13C NMR and ESI-MS) and elemental analysis data. I.R. 
spectrum of 3h (Figure 10) showed broad peak due to NH stretching at 3431 cm-1. 
Absorption band at 1731 cm-1 was assigned to stretching of two C=O groups (C1”) 
connected to dihydropyridine ring, whereas, absorption band for six C=O groups 
(C2’, C4’, C6’) of two pyrimidinetrione moieties appeared at 1672 cm-1. The C=C 
stretching band was observed at 1604 cm-1. The 1H NMR spectrum (Figure 11) 
showed a broad singlet for NH proton of dihydropyridine ring at δ 10.28. Five 
aromatic protons in the form of multiplet at δ 7.4-7.8 were clearly discernible. H2, H6 
protons of dihydropyridine ring appeared as a singlet at δ 7.25, whereas H4 proton 
was present as a singlet at δ 5.29. 13C NMR (Figure 12) showed signals at δ 184.63, 
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172.11 and 165.21 for C1”, C4’/ C6’ and C2’ carbons respectively. Other peaks were 
present at their normal values and are provided in experimental section. Further 
structural confirmation was made by ESI-Mass spectrum (Figure 13) which showed 
the molecular ion peak as the base peak at m/z 522.1 (M++1). 
 
Scheme 2: General scheme for the synthesis of dihydropyridines (3a-n) 
Table 4: Synthesis of dihydropyridines 
Entry Enaminone Aldehyde Product 
Time 
(min) 
Yield 
(%) 
1 
   
 
53 
 
89 
2 
 
 
 
 
51 
 
86 
3 
 
  
 
57 
 
85 
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51 
 
87 
23 
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83 
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65 84 
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90 
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Fig. 10. FT-IR spectrum of 3h 
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Fig. 11. 1H-NMR spectrum of 3h 
 
 
Fig. 12. 13C-NMR spectrum of 3h 
 
26 
 
 
Fig. 13. ESI-Mass spectrum of 3h 
 
2.4.3. Reaction mechanism 
The plausible mechanism is proposed in scheme 3. First the catalyst activates the 
aldehyde group of 2a after which it undergoes nucleophilic addition of double bond of 
enaminone 1b to form B. Intermediate C then undergoes benzylic substitution by 
another molecule of enaminone 1b followed by loss of water molecule to generate 
divinylic compound D. This divinylic compound then undergoes Michael addition 
with ammonia followed by elimination of dimethyl amine to give F. Cyclisation of F 
by intramolecular Michael addition with amine followed by elimination of another 
molecule of dimethyl amine generates the product 3h. The catalyst could be 
regenerated in the last step and reused for further catalytic cycles.8c 
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Scheme 3: Plausible reaction mechanism for the formation of 3h. 
2.4.4. Hot filtration test 
A hot-filtration test was performed using mesoporous alumina sulphuric acid as a 
catalyst in order to check any leaching of catalyst into the solution during the reaction. 
A mixture of β-enaminone 1b (1 mmol), aldehyde 2a (0.5 mmol), ammonium acetate 
(0.7 mmol) and catalyst (50 mg) in 5 mL ethanol was refluxed for 30 min and 
immediately filtered under hot reaction conditions. The obtained reaction mixture 
without any catalyst was then further refluxed for 6 h under the same reaction 
conditions and it was observed that there was no further product formation and the 
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reaction could not proceed to completion. This result clearly demonstrates the 
heterogeneous nature of the prepared catalyst. 
2.4.5. Catalyst recyclability 
In order to explore the extent of recyclability of our catalytic system, the catalyst was 
recovered by filtration from the reaction mixture of enaminone 1b, benzaldehyde (2a) 
and ammonium acetate in water, washed with ethanol (3×15 mL), ethyl acetate (2×10 
mL), dried at 100 °C for 1.5 h, and reused in subsequent runs. The catalyst was found 
to retain its activity for a minimum of seven reaction cycles and displayed almost high 
catalytic performance with over 85% product yield (Table 5). The XRD (Figure 3c) 
of the catalyst after seven runs showed that the structure of the catalyst is not altered 
during its reuse. 
Table 5: Recycling data of mesoporous alumina sulphuric acid for the model 
reaction. 
No. of runs Run 1 Run 2 Run 3 Run 4 Run 5 Run 6 Run 7 
Time (min) 45 45 45 45 45 45 45 
Yield (%) 90 90 90 87 85 83 83 
 
2.5. CONCLUSION 
In summary, mesoporous alumina sulphuric acid has been synthesised and evaluated 
as a catalyst for the preparation of new 1,4-dihydropyridines via β-enaminones in 
water. This new efficient, green and convenient method provides an opportunity to 
use water and avoid environmentally harmful conventional organic solvents. The 
substrate scope of the reaction is also demonstrated by the tolerance of alicyclic and 
aliphatic aldehydes in addition to aromatic aldehydes. Thus, this simple procedure is a 
better and more practical alternative to existing methods in view of green chemistry. 
2.6. EXPERIMENTAL 
2.6.1. Preparation of mesoporous alumina 
In a typical synthesis, N-Cetyl-N,N,N-trimethylammonium bromide (CTAB) (0.2 
mmol), Al2(SO4)3.18H2O (1mmol), CO(NH2)2 (4 mmol), and sodium tartrate (0.7 
mmol) were dissolved in distilled water to form a clear solution (36 mL) under 
vigorous stirring for 0.5 h. The solution was placed in an autoclave with a Teflon liner 
and was maintained at 165 °C for 8 h. The autoclave was then allowed to cool and the 
white precipitate obtained was collected, washed thoroughly with distilled water and 
then dried at 80 °C for 12 h. The sample was then calcined at 550 °C for 3 h to 
remove the template.22 
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2.6.2. Preparation of mesoporous alumina supported sulphuric acid 
A 0.5 L suction flask was equipped with a constant pressure dropping funnel. The gas 
outlet was connected to a vacuum system through an adsorbing solution of alkali trap. 
Mesoporous alumina (1g) was added into the flask and stirred for 10 min in dry 
CH2Cl2 (20 mL). Chlorosulfonic acid (1mL) was added drop wise over a period of 30 
min at room temperature. After complete addition of chlorosulfonic acid, the reaction 
mixture was stirred for 90 min, while the residual HCl was eliminated by suction. The 
mesoporous alumina sulphuric acid obtained as solid, was separated from the reaction 
mixture by filtration and washed several times with dried CH2Cl2, ethanol. Finally the 
catalyst was dried at 120 °C for three hours. 
2.6.3. Determination of H+ ion concentration of mesoporous alumina sulphuric 
acid 
H+ ion concentration of the catalyst was determined by neutralization titration 
analysis. 100 mg of catalyst was stirred in 20 mL of 0.1N NaOH solution for 30 min 
in an Erlenmeyer flask. The excess amount of base was then neutralised by the 
addition of 0.1N HCl solution to the equivalence point of titration. The amount of 
acid groups was found to be 3.6 meq/g. 
2.6.4. General procedure for “On water” synthesis of dihydropyridines 
A mixture of β-enaminone (10 mmol), aldehyde (5 mmol), ammonium acetate (7 
mmol) and catalyst (250 mg) in 10 mL water was refluxed in an oil bath for 
appropriate period of time (Table 4). After completion of reaction (monitored by 
TLC), the reaction mixture was allowed to cool and added ethyl acetate to extract the 
product. The catalyst as insoluble solid was separated by filtration, washed with ethyl 
acetate (3 x 10 mL) and reused for further catalytic cycles. The filtrate was washed 
with water (3 × 10 mL), dried over anhydrous Na2SO4 and evaporated under reduced 
pressure. The crude product was recrystallized from suitable solvent (Ethanol or 
DMSO) to afford pure product. 
 
 
 
 
2.6.5. Spectral data of synthesised compounds 
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3,5-Bis(4-hydroxy-1-benzopyran-2-one-3-carbonyl)-4-
phenyl-1,4-dihydropyridine. 
Yellow solid, M.P. 240-245 °C. Anal. Calcd (C31H19NO8): 
C, 69.79; H, 3.59; N, 2.63. Anal. Found (C31H19NO8) C, 
69.75; H, 3.63; N, 2.58. IR (KBr, cm-1): 3594 (OH), 3479 
(NH), 1709 (COO), 1676 (CO), 1610 (C=C). 1H NMR (400 
MHz, DMSO-d6): δ 10.22 (s, 1H, NH), 7.31-8.37 (m, Ar-H, 
13H), 7.11 (s, 2H), 5.48 (s, 1H). 13C NMR (100 MHz, 
DMSO-d6): δ 186.28, 175.36, 162.76, 154.47, 148.56, 
143.17, 135.22, 132.76, 127.13, 126.75, 125.21, 123.07, 
122.51, 120.15, 118.12, 101.33, 55.21. ESI-MS m/z 534.1 
(M++1).  
 
3,5-Bis(4-hydroxy-1-benzopyran-2-one-3-carbonyl)-4-(4-
chloro)phenyl-1,4-dihydropyridine. 
Yellow solid, M.P. 230-235 °C. Anal. Calcd 
(C31H18ClNO8) C, 65.56; H, 3.19; N, 2.47. Anal. Found 
(C31H18ClNO8) C, 65.62; H, 3.14; N, 2.42. IR (KBr, cm
-1): 
3623 (OH), 3430 (NH), 1710 (COO), 1677 (CO), 1610 
(C=C). 1H NMR (400 MHz, DMSO-d6): δ 10.39 (s, 1H, 
NH), 7.29-8.35 (m, Ar-H, 12H), 7.08 (s, 2H), 5.34 (s, 1H). 
13C NMR (100 MHz, DMSO-d6): δ 184.55, 173.71, 160.63, 
154.21, 149.07, 143.13, 136.26, 132.09, 131.32, 127.41, 
126.92, 125.27, 123.53, 122.11, 120.72, 100.94, 55.61. ESI-
MS m/z 568.1 (M++1). 
 
3,5-Bis(4-hydroxy-1-benzopyran-2-one-3-carbonyl)-4-(4-
methoxy)phenyl-1,4-dihydropyridine. 
Yellow solid, M.P. 225-230 °C. Anal. Calcd (C32H21NO9) 
C, 68.21; H, 3.76; N, 2.49. Anal. Found (C32H21NO9) C, 
68.25; H, 3.71; N, 2.52. IR (KBr, cm-1): 3638 (OH), 3448 
(NH), 1726 (COO), 1662 (CO), 1600 (C=C). 1H NMR (400 
MHz, DMSO-d6): δ 10.54 (s, 1H, NH), 7.28-8.33 (m, Ar-H, 
12H), 6.99 (s, 2H), 5.42 (s, 1H), 4.12 (s, 3H). 13C NMR 
(100 MHz, DMSO-d6): δ 185.25, 172.11, 161.28, 159.54, 
155.21, 148.47, 144.14, 136.89, 132.21, 128.51, 125.18, 
124.21, 123.75, 122.09, 120.76, 101.02, 68.23, 56.18. ESI-
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MS m/z 564.2 (M++1). 
 
3,5-Bis(4-hydroxy-1-benzopyran-2-one-3-carbonyl)-4-(4-
hydroxy)phenyl-1,4-dihydropyridine. 
Yellow solid, M.P. 228-233 °C. Anal. Calcd. (C31H19NO9) 
C, 67.76; H, 3.49; N, 2.55. Anal. Found (C31H19NO9) C, 
67.80; H, 3.44; N, 2.51. IR (KBr, cm-1): 3641 (OH), 3437 
(NH), 1721 (COO), 1661 (CO), 1607 (C=C). 1H NMR (400 
MHz, DMSO-d6): δ 10.42 (s, 1H, NH), 7.26-8.32 (m, Ar-H, 
12H), 7.02 (s, 2H), 5.44 (s, 1H). 13C NMR (100 MHz, 
DMSO-d6): δ 184.55, 173.14, 162.04, 159.22, 154.72, 
148.71, 141.25, 134.14, 131.22, 128.03, 124.88, 124.03, 
123.25, 121.91, 120.17, 101.33, 55.64. ESI-MS m/z 550.1 
(M++1). 
 
3,5-Bis(4-hydroxy-1-benzopyran-2-one-3-carbonyl)-4-(3-
nitro)phenyl-1,4-dihydropyridine. 
Orange solid, M.P. 240-245 °C. Anal. Calcd (C31H18N2O10) 
C, 64.36; H, 3.14; N, 4.84. Anal. Found (C31H18N2O10) C, 
64.31; H, 3.18; N, 4.79.  IR (KBr, cm-1): 3638 (OH), 3425 
(NH), 1712 (COO), 1673 (CO), 1610 (C=C). 1H NMR (400 
MHz, DMSO-d6): δ 10.38 (s, 1H, NH), 7.31-8.35 (m, Ar-H, 
12H), 7.14 (s, 2H), 5.51 (s, 1H). 13C NMR (100 MHz, 
DMSO-d6): δ 181.23, 172.41, 161.73, 159.22, 149.17, 
146.54, 145.25, 133.11, 131.03, 129.23, 128.22, 127.52, 
124.76, 123.53, 122.78, 121.49, 119.2, 100.41, 56.61. ESI-
MS m/z 579.1 (M++1). 
 
3,5-Bis(4-hydroxy-1-benzopyran-2-one-3-carbonyl)-4-
(Phenylmethyl)-1,4-dihydropyridine. 
Yellow solid, M.P. 250-255 °C. Anal. Calcd (C32H21NO8) 
C, 70.20; H, 3.87; N, 2.56. Anal. Found (C32H21NO8) C, 
70.24; H, 3.82; N, 2.60. IR (KBr, cm-1): 3645 (OH), 3437 
(NH), 1714 (COO), 1676 (CO), 1616 (C=C). 1H NMR (400 
MHz, DMSO-d6): δ 10.19 (s, 1H, NH), 7.29-8.36 (m, Ar-H, 
13H), 7.13 (s, 2H), 4.41 (t, 1H), 3.11 (d, 2H). 13C NMR 
(100 MHz, DMSO): δ 182.28, 171.54, 161.36, 157.76, 
150.47, 141.56, 131.76, 127.23, 126.27, 125.41, 123.13, 
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122.16, 120.11, 118.65, 101.01, 42.11, 35.21, 33.11. ESI-
MS m/z 548.2 (M++1). 
 
3,5-Bis(4-hydroxy-1-benzopyran-2-one-3-carbonyl)-4-ethyl-
1,4-dihydropyridine. 
Light yellow solid, M.P. 280-285 °C. Anal. Calcd 
(C27H19NO8) C, 66.80; H, 3.95; N, 2.89. Anal. Found 
(C27H19NO8) C, 66.76; H, 3.99; N, 2.84. IR (KBr, cm
-1): 
3639 (OH), 3431 (NH), 1713 (COO), 1672 (CO), 1611 
(C=C). 1H NMR (400 MHz, DMSO-d6): δ 10.22 (s, 1H, 
NH), 7.28-7.98 (m, Ar-H, 8H), 7.01 (s, 2H), 4.53 (t, 1H), 
2.07 (m, 2H), 1.12 (t, 3H). 13C NMR (100 MHz, DMSO): δ 
183.13, 171.96, 161.76, 156.48, 148.92, 129.23, 127.44, 
126.42, 125.17, 120.10, 118.68, 102.13, 45.12, 29.24, 18.76. 
ESI-MS m/z 486.1 (M++1). 
 
3,5-Bis(1,3-dimethyl-2,4,6-pyrimidinetrione-5-carbonyl)-4-
phenyl-1,4-dihydropyridine. 
Yellow solid, M.P. 250-255 °C. Anal. Calcd (C25H23N5O8) 
C, 57.58; H, 4.45; N, 13.43. Anal. Found (C25H23N5O8) C, 
57.53; H, 4.50; N, 13.39. IR (KBr, cm-1): 3431 (NH), 1731 
(CO), 1672 (CO), 1604 (C=C). 1H NMR (400 MHz, 
DMSO-d6): δ 10.28 (s, 1H, NH), 7.41-7.83 (m, 5H, Ar-H), 
7.25 (s, 2H), 5.29 (s, 1H), 4.32 (s, 2H), 3.37 (s, 12H, 4 x 
CH3). 
13C NMR (100 MHz, DMSO-d6): δ 184.63, 172.11, 
165.21, 151.62, 145.65, 133.30, 131.52, 128.77, 121.25, 
66.73, 44.91, 31.52. ESI-MS m/z 522.1 (M++1). 
 
3,5-Bis(1,3-dimethyl-2,4,6-pyrimidinetrione-5-carbonyl)-4-
(4-chlorophenyl)-1,4-dihydropyridine. 
Yellow solid, M.P. 245-250 °C. Anal. Calcd 
(C25H22ClN5O8) C, 54.01; H, 3.99; N, 12.60. Anal. Found 
(C25H22ClN5O8) C, 54.05; H, 4.02; N, 12.56. IR (KBr, cm
-
1): 3435 (NH), 1742 (CO), 1666 (CO), 1615 (C=C). 1H 
NMR (400 MHz, DMSO-d6): δ 10.48 (s, 1H, NH), 7.48-
7.82 (m, 4H, Ar-H), 7.15 (s, 2H), 5.41 (s, 1H), 4.71 (s, 2H), 
3.22 (s, 12H, 4 x CH3). 
13C NMR (100 MHz, DMSO-d6): δ 
186.12, 174.42, 166.52, 150.91, 145.54, 134.29, 132.15, 
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128.63, 121.82, 65.97, 44.07, 32.14. ESI-MS m/z 556.2 
(M++1). 
 
3,5-Bis(1,3-dimethyl-2,4,6-pyrimidinetrione-5-carbonyl)-4-
(4-methoxyphenyl)-1,4-dihydropyridine. 
Yellow solid, M.P. 230-235 °C. Anal. Calcd (C26H25N5O9) 
C, 56.62; H, 4.57; N, 12.70. Anal. Found (C26H25N5O9) C, 
56.65; H, 4.52; N, 12.66. IR (KBr, cm-1): 3442 (NH), 1728 
(CO), 1665 (CO), 1611 (C=C). 1H NMR (400 MHz, 
DMSO-d6): δ 10.31 (s, 1H, NH), 7.41-7.83 (m, 4H, Ar-H), 
7.11 (s, 2H), 5.37 (s, 1H), 4.65 (s, 2H), 3.88 (s, 3H), 3.27 (s, 
12H, 4 x CH3). 
13C NMR (100 MHz, DMSO-d6): δ 188.43, 
172.06, 167.19, 159.22, 152.16, 144.26, 134.07, 131.36, 
120.18, 64.66, 59.73, 45.11, 32.87. ESI-MS m/z 552.1 
(M++1). 
 
3,5-Bis(1,3-dimethyl-2,4,6-pyrimidinetrione-5-carbonyl)-4-
(4-hydroxyphenyl)-1,4-dihydropyridine. 
Yellow solid, M.P. 245-250 °C. Anal. Calcd (C25H23N5O9) 
C, 55.87; H, 4.31; N, 13.03. Anal. Found (C25H23N5O9) C, 
55.91; H, 4.27; N, 12.99. IR (KBr, cm-1): 3450 (NH), 3068 
(OH), 1730 (CO), 1641 (CO), 1613 (C=C). 1H NMR (400 
MHz, DMSO-d6): δ 10.52 (s, 1H, NH), 7.27-7.81 (m, 5H, 
Ar-H), 7.03 (s, 2H), 5.44 (s, 1H), 4.69 (s, 2H), 3.37 (s, 12H, 
4 x CH3). 
13C NMR (100 MHz, DMSO-d6): δ 184.04. 
172.12, 159.38, 153.17, 141.23, 138.44, 133.57, 120.22, 
119.54, 71.33, 43.29, 34.78. ESI-MS m/z 538.1 (M++1). 
 
3,5-Bis(1,3-dimethyl-2,4,6-pyrimidinetrione-5-carbonyl)-4-
(3-nitrophenyl)-1,4-dihydropyridine. 
Orange solid, M.P. 240-245 °C. Anal. Calcd. 
(C25H22N6O10) C, 53.01; H, 3.91; N, 14.84. Anal. Found 
(C25H22N6O10) C, 53.06; H, 3.88; N, 14.79. IR (KBr, cm
-1): 
3426 (NH), 1722 (CO), 1661 (CO), 1593 (C=C). 1H NMR 
(400 MHz, DMSO-d6): δ 10.44 (s, 1H, NH), 7.51-7.84 (m, 
4H, Ar-H), 7.18 (s, 2H), 5.47 (s, 1H), 4.78 (s, 2H), 3.21 (s, 
12H, 4 x CH3). 
13C NMR (100 MHz, DMSO-d6): δ 187.11, 
173.72, 165.44, 152.04, 146.87, 142.64, 134.14, 131.88, 
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129.79, 120.53, 65.37, 43.84, 32.02. ESI-MS m/z 567.1 
(M++1). 
 
3,5-Bis(1,3-dimethyl-2,4,6-pyrimidinetrione-5-carbonyl)-4-
(Phenylmethyl)-1,4-dihydropyridine. 
Yellow solid, M.P. 285-290 °C. Anal. Calcd (C26H25N5O8) 
C, 58.31; H, 4.71; N, 13.08. Anal. Found (C26H25N5O8) C, 
58.36; H, 4.68; N, 13.04. IR (KBr, cm-1): 3473 (NH), 1735 
(CO), 1651 (CO), 1607 (C=C). 1H NMR (400 MHz, 
DMSO-d6): δ 10.14 (s, 1H, NH), 7.29-7.61 (m, 5H, Ar-H), 
6.95 (s, 2H), 5.17 (t, 1H), 4.24 (s, 2H), 3.24 (d, 2H), 3.01 (s, 
12H, 4 x CH3). 
13C NMR (100 MHz, DMSO-d6): δ 182.87, 
172.54, 161.79, 141.32, 139.72, 131.11, 129.35, 127.07, 
115.27, 78.57, 44.75, 37.11, 29.82. ESI-MS m/z 536.1 
(M++1). 
 
3,5-Bis(1,3-dimethyl-2,4,6-pyrimidinetrione-5-carbonyl)-4-
ethyl-1,4-dihydropyridine. 
Yellow solid, M.P. >300 °C. Anal. Calcd (C21H23N5O8) C, 
53.28; H, 4.90; N, 14.79. Anal. Found (C21H23N5O8) C, 
53.24; H, 4.86; N, 14.74. IR (KBr, cm-1): 3431 (NH), 1725 
(CO), 1667 (CO), 1610 (C=C). 1H NMR (400 MHz, 
DMSO-d6): δ 10.22 (s, 1H, NH), 7.05 (s, 2H), 4.54 (s, 2H), 
4.49 (t, 1H), 3.32 (s, 12H, 4 x CH3), 2.12 (m, 2H), 1.17 (t, 
3H). 13C NMR (100 MHz, DMSO-d6): δ 185.13, 171.32, 
161.04, 139.25, 115.77. 72.23, 41.42, 36.52, 29.57, 18.71. 
ESI-MS m/z 474.1 (M++1). 
  
35 
 
REFERENCES: 
1. (a) B. Stanovnik, J. Svete, Chem. Rev. 104 (2004) 2433; (b) A. Z. A. Elassara, 
A. A. El-Khairb, Tetrahedron 59 (2003) 8463; (c) S. Muthusaravanan, C. 
Sasikumar, B. D. Bala, S. Perumal, Green Chem. 16 (2014) 1297; (d) W. J. 
Hao, J. Q. Wang, X. P. Xu, S. L. Zhang, S. Y. Wang, S. J. Ji, J. Org. Chem. 78 
(2013) 12362. 
2. (a) J. E. Foster, J. M. Nicholson, R. Butcher, J. P. Stables, I. O. Edafiogho, A. 
M. Goodwin, M. C. Henson, C. A. Smith, K. R. Scott, Bioorg. Med. Chem. 7 
(1999) 2415; (b) J. P. Michael, C. B. Koning, G. D. Hosken, T. V. Stanbury, 
Tetrahedron 57 (2001) 9635. 
3. (a) D. L. Boger, T. Ishizaki, J. R. J. Wysocki, S. A. Munk, P. A. Kitos, O. 
Suntornwat, J. Am. Chem. Soc. 111 (1989) 6461; (c) I. O. Edafiogho, K. V. V. 
Ananthalakshmi, S. B. Kombian, Bioorg. Med. Chem. 14 (2006) 5266; (d) N. 
D. Eddington, D. S. Cox, R. R. Roberts, J. P. Stables, C. B. Powell, K. R. 
Scott, Curr. Med. Chem. 7 (2000) 417; (e) N. N. Salama, N. D. Eddington, D. 
Payne, T. L. Wilson, K. R. Scott, Curr. Med. Chem. 11 (2004) 2093. 
4. (a) S. Muthusaravanan, S. Perumal, A. I. Almansour, Tetrahedron Lett. 53 
(2012) 1144; (b) A. A. E. Hassan, Int. j. Org. Chem. 4 (2014) 68; (c) S. 
Muthusaravanan, B. D. Bala, S. Perumal, Tetrahedron Lett. 54 (2013) 5302. 
5. (a) R. Lavilla, J. Chem. Soc. Perkin Trans. 1 (2002) 1141; (b) J. Moreau, J. P. 
Hurvois, M. D. Mbaye, J. L. Renaud, Targets Heterocycl. Syst. 13 (2009) 201. 
6. (a) C. O. Kappe, Eur. J. Med. Chem. 35 (2000) 1043; (b) T. Godfraind, R. 
Miller, M. Wibo, Pharmacol. Rev. 38 (1986) 321. 
7. (a) A. Sausins, G. Duburs, Heterocycles 27 (1988) 269; (b) M. F. Gordeev, D. 
V. Patel, B. P. England, S. Jonnalagadda, J. D. Combs, E. M. Gordon, Bioorg. 
Med. Chem. 6 (1998) 883; (c) M. F. Gordeev, D. V. Patel, E. M. Gordon, J. 
Org. Chem. 61 (1996) 924. 
8. (a) D. M. Stout, A. I. Meyers, Chem. Rev. 82 (1982) 223; (b) A. Sausins, G. 
Duburs, Heterocycles 27 (1988) 269. (c) J. P. Wan, Y. Liu, RSC Adv. 2 
(2012) 9763. 
9. D. R. B. Ducatti, A. Massi, M. D. Noseda, M. E. R. Duarte, A. Dondoni, Org. 
Biomol. Chem. 7 (2009) 1980. 
10. M. Mirza-Aghayana, M. K. Langrodi, M. Rahimifard, R. Boukherroub, Appl. 
Organometal. Chem. 23 (2009) 267. 
36 
 
11. J. Yang, C. Wang, X. Xie, H. Li, Y. Li, Eur. J. Org. Chem. (2010) 4189.  
12. N. A. Al-Awadi, M. R. Ibrahim, M. H. Elnagdi, E. John, Y. A. Ibrahim, 
Beilstein J. Org. Chem. 8 (2012) 441. 
13. R. Sridhar, P. T. Perumal, Tetrahedron 61 (2005) 2465. 
14. J. -P. Wan, S. F. Gan, G. L. Sun, Y. J. Pan, J. Org. Chem. 74 (2009) 2862. 
15. (a) M. J. Climent, A. Corma, S. Iborra, Chem. Rev. 111 (2011) 1072; (b) M. 
A. Zolfigol, Tetrahedron 57 (2001) 9509; (c) B. M. Reddy, P. M. Sreekanth, P. 
Lakshmanan, J. Mol. Cat. A: Chem. 237 (2005) 93; (d) A. Praminik, S. Bhar, 
Catal. Commun. 20 (2012) 17. 
16. S. H. Cai, S. N. Rashkeev, S. T. Pantelides, K. Sohlberg, Phys. Rev. B 67 
(2003) 224104.  
17. (a) A. D. Cross, An Introduction to Practical IR Spectroscopy, 2nd ed., 
Butterworth, London, 1964. (b) A. Teimouri, A. N. Chermahini, H. Salavati, 
L. Ghorbanian, J. Mol. Cat. A: Chem. 373 (2013) 38. 
18. (a) M. A Zolfigol, A. Khazaei, M. Mokhlesi, F. Derakhshan-Panah, J. Mol. 
Cat. A: Chem. 370 (2013) 111. (b) A. R. Kiasat, S. Noorizadeh, M. 
Ghahremani, S. J. Saghanejad, J. Mol. Str. 1036 (2013) 216. 
19. X. Su, S. Chen, Z. Zhou, Appl. Surf. Sci. 258 (2012) 5712. 
20. S. J. Gregg, K. S. W. Sing, Adsorption, Surface Area and Porosity, Academic 
Press, London, 1982. 
21. (a) R. Breslow, Acc. Chem. Res. 24 (1991) 159. (b) J. Chandrasekhar, S. 
Shariffskul, W. L. Jorgensen, J. Phys. Chem. B. 106 (2002) 8078. 
22. M. B. Yue, T. Xue, W. B. Jiao, Y. M. Wang, M. Y. He, Solid State Sci. 13 
(2011) 409. 
  
37 
 
SECTION B 
ZnO NANOPARTICLES CATALYSED SOLVENT-FREE SYNTHESIS OF 
NOVEL PYRIDINES VIA β-ENAMINONES 
Pyridine derivatives are among one of the most important nitrogen-containing 
heterocycles. These derivatives are found in numerous medicinally important natural 
products1-3 and exhibit many interesting biological profiles like anti-HIV, anti-viral, 
anti-bacterial, anti-diabetic, antimalarial and anti-cancer activities.4 These derivatives 
have been of specific interest to pharmaceutical industries and there are a number of 
drugs in market containing this nucleus.5 Isoniazide is an antibiotic used for 
tuberculosis treatment, dermatitis herpetiformis is treated by Sulphapyridine, 
Rabeprazole is used as an antiulcer drug, Niaprazine is used as an antihistamine, 
bronchodilator and sedative, Piroxicam is used to relieve the pain, tenderness, 
inflammation and stiffness caused by arthritis, Niflumic acid shows antirheumatic and 
analgesic effects, Doxylamine is an antihistamine used for short-term treatment of 
insomnia and also to treat allergy, colds and respiratory infections. Some 
representative structures are given in figure 14. Pyridine derivatives (polyvinyl 
pyridine etc.) have also found use in polymer industries.5b  
Traditionally, pyridine derivatives have been synthesised via condensation of amine 
and carbonyl compounds, [5+1] condensation of 1,5-dicarbonyls with ammonia, 
Bohlmann-Rahtz pyridine synthesis, Hantzsch pyridine synthesis and recently aza-
Diels–Alder reaction between enamines and 1,2,4-triazine led to the formation of 
pyridines.6 
 
Fig. 14. Representative drugs based on pyridines 
                                                          
 Zeba N. Siddiqui, Nayeem Ahmed, Farheen Farooq, Kulsum Khan, Tetrahedron Letters, 54 (2013) 
3599. 
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2.7. Review of literature 
Some recent examples of the synthesis of pyridine derivatives via β-enaminones 
2.7.1. Regioselective synthesis of pyridine derivatives using enaminones.7 
S. Kantevari et al. reported a regioselective one-pot, three-component condensation of 
enaminones, dicarbonyl compounds and ammonium acetate in the presence of a 
catalytic amount of K5CoW12O40.3H2O in isopropyl alcohol (IPA). This protocol has 
merits like short reaction time, high yield, simple work-up procedure and the catalyst 
recyclability. 
2.7.2. Synthesis of 2,3,6-trisubstituted pyridines via enaminones in AcOH.8 
B. Al-Saleh et al. reported an efficient method for the synthesis of 2,3,6-trisubstituted 
pyridines by refluxing a mixture of enaminone, acetyl acetone or ethyl acetoacetate 
and ammonium acetate in acetic acid.  
 
2.7.3. Synthesis of 2,3-disubstituted-6-arylpyridines from enaminones using 
Montmorillonite K10.9 
G. J. Reddy et al. described an efficient method for the synthesis of 2,3-disubstituted-
6-arylpyridines from enaminones in isopropyl alcohol (IPA) using montmorillonite 
K10 as a solid acid heterogeneous catalyst. Simple experimental and product isolation 
procedures coupled with high purity and yield of the products are the highlights of the 
presented protocol. 
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2.7.4. Diversity-oriented synthesis of novel aryl and heteroaryl tethered 
pyridines.10 
S. Kantevari et al. presented diversity oriented synthesis of substituted pyridines and 
dihydro-6H-quinolin-5-ones tethered with aryls and heteroaryls in very good yields 
using CeCl3.7H2O-NaI as a catalyst in refluxing isopropyl alcohol. Appropriately 
substituted derivatives were found to be promising antitubercular agents. 
2.7.5. Silica supported sodium hydrogen sulphate (NaHSO4–SiO2) catalysed 
synthesis of pyridines.11 
Z. N. Siddiqui and F. Farooq reported the use of NaHSO4–SiO2 as an efficient, mild 
and reusable catalyst for the synthesis of novel pyridine derivatives via heterocyclic 
β-enaminone. The remarkable features of this methodology are high yields, simple 
experimental and work-up procedures and solvent-free conditions. 
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2.7.6. Chitosan catalysed synthesis of novel uracil based pyridine derivatives.12 
Z. N. Siddiqui reported an efficient chitosan catalysed synthesis of novel uracil based 
pyridine derivatives using β-enaminone. The remarkable features of this protocol are 
chitosan as a biodegradable catalyst, solvent-free conditions and high yields. 
 
2.8. PRESENT WORK 
The application of metal nanoparticles (NPs) in organic synthesis has attracted 
immense attention in recent years as one of the most promising solution towards 
efficient reactions under mild and environmentally benign conditions in the context of 
Green Chemistry.13 Nano-sized inorganic solid oxides have shown a lot of promise as 
heterogeneous catalysts due to their properties like high level of chemoselectivity, 
environmental compatibility, simplicity of operation, presence of both Lewis acid and 
Lewis base character at their surface, and availability at low cost.14 Nanoparticles 
have a characteristic high surface to volume ratio, and as a result large fraction of 
surface atoms are exposed to reactant molecules, therefore, their use as catalysts is 
quite promising.15 ZnO NPs as heterogeneous catalyst has received considerable 
attention because of its cheapness, easy to synthesise, requirement of mild conditions, 
non-toxic nature and environmental advantages i.e., minimum execution time, low 
corrosion, waste minimization, recycling, easy transport and disposal of the catalyst.16 
Therefore, their use as powerful catalyst for several organic transformations has been 
quite encouraging.17-20  
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In this section, we have described ZnO nanoparticles catalyzed efficient, solvent-free, 
regioselective synthesis of novel pyridines through Michael addition, 
cyclodehydration and elimination sequence. 
2.9. RESULTS AND DISCUSSION 
2.9.1. Characterization of ZnO nanoparticles 
2.9.1a. XRD analysis 
Freshly synthesized ZnO nanoparticles showed XRD peaks which corresponded to 
hexagonal wurtzite structure (Figure 15a). The crystallite size of the nanoparticles 
was calculated using Debye Scherrer formula 
D = K λ/β COS θ  
Where, K is constant, λ is the wavelength of employed x-rays (1.54056 Å), β is 
corrected full width at half maximum and θ is Bragg’s angle. 
The 2θ value from the equation comes out to be at 35.815 and therefore, the 
calculated crystallite size of the powder particles was found to be 25 nm. The strong 
and narrow diffraction peaks indicated that the product has good crystallinity. 
 
Fig. 15. (a) XRD pattern of synthesized nanoparticles and (b) XRD spectrum of ZnO 
NPs after six catalytic cycles. 
2.9.1b. SEM and TEM analyses 
The confirmation of the nanostructured morphology of ZnO particles was obtained 
from the analysis of SEM and TEM micrographs. SEM micrograph (Figure 16a) 
showed the size of nanoparticles in nanometers and TEM micrograph (Figure 16b) 
confirmed the average size between 15-25 nm.  
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Fig. 16. (a) SEM image and (b) TEM image of synthesized nanoparticles. 
2.9.2. Optimization of reaction conditions  
2.9.2a. Effect of different catalysts and solvents 
To recognize the optimization of the reaction conditions, the reaction was studied by 
employing a series of catalysts and solvents as well as solvent-free conditions with the 
expectation to maximize the product yield in short reaction times (Table 6). Initially, 
β-enaminone 1a, ethyl acetoacetate (4b) and ammonium acetate were refluxed in the 
presence of AcOH as the solvent without any catalyst. The reaction took longer time 
period of 24 h to complete and afforded product in less yield (Table 6, entry 1). 
Taking AcOH as a solvent the reaction was carried out using different Brønsted acids 
like sulfamic and sulfuric acid (Table 6, entries 2 & 5) but the catalysts failed to 
promote these reactions. These catalysts were then used with different solvent like 
water and EtOH (Table 6, entries 3, 4 & 6) but again these catalysts failed to 
promote the reaction. We then tried the reaction with Zn-proline as a catalyst in water 
but the reaction failed to produce any yield (Table 6, entry 14). However Zn-proline 
in AcOH gave product in moderate yield (Table 6, entry 15). L-Proline in AcOH also 
failed to catalyse the reaction (Table 6, entry 16). The reactions were then tried with 
different Lewis acid catalysts like P2O5, Al2O3, P2O5-silica, P2O5-alumina, ZnO and 
MgO using EtOH as a solvent or under solvent free conditions and the results are 
given in Table 6 (entries 7-12 & 17-19). When the reaction was tried using NaHSO4-
SiO2 as catalyst under solvent free condition (Table 6, entry 13), the reaction 
completed in 2.5 h giving a moderate product yield of 75%. The reactions done under 
solvent-free condition gave better product yields in less reaction time. Encouraged by 
these results we then tried these reactions with ZnO nanoparticles using solvents like 
AcOH, EtOH and surprisingly the results were satisfactory (Table 6, entries 20, 21). 
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In non-polar solvent like hexane (entry 22), ZnO NPs could not catalyse the reaction. 
We then tried the reaction using ZnO NPs under solvent free conditions and the 
results obtained were excellent as the yield was 96% and time taken was only 40 min 
at 70 °C (Table 6, entry 23). Analyzing the above results we found that the Lewis 
acids catalyzed the reaction very efficiently under solvent free conditions and among 
these Lewis acids ZnO nanoparticles proved to be most efficient catalyst for the 
mentioned reaction. 
Table 6: Effect of different catalysts and solvents on model reaction. 
 
Entry Catalyst Solvent Temp (°C) Time Yield (%) 
1 nil AcOH reflux 24 hrs 65 
2 Sulfamic acid (10 mol%) AcOH reflux 24 hrs No 
reaction 
3 Sulfamic acid (10 mol%) H2O reflux 24 hrs No 
reaction 
4 Sulfamic acid (10 mol%) EtOH reflux 24 hrs No 
reaction 
5 Sulfuric acid (0.1 mL) AcOH reflux 24 hrs No 
reaction 
6 Sulfuric acid (0.1 mL) EtOH reflux 24 hrs No 
reaction 
7 P2O5 (10 mol%) EtOH reflux 13 hrs 68 
8 P2O5 (10 mol%) Solvent-free 100 6 hrs 73 
9 Alumina (10 mol%) Solvent-free 100 5.4 hrs 76 
10 P2O5-Silica (200 mg) EtOH reflux 8 hrs 71 
11 P2O5-Silica (200 mg) Solvent-free 100 2 hrs 84 
12 P2O5-Alumina (200 mg) Solvent-free 100 1.5 hrs 87 
13 NaHSO4-Silica (200 mg) Solvent-free 70 2.5 hrs 75 
14 Zn-Proline (10 mol%) H2O reflux 24 hrs No 
reaction 
15 Zn-Proline (10 mol%) AcOH reflux 10 hrs 78 
16 L-Proline (10 mol%) AcOH reflux 24 hrs No 
reaction 
17 ZnO(Bulk) (10 mol%) EtOH reflux 5 hrs 78 
18 ZnO(Bulk) (10 mol%) Solvent-free 90 2.5 hrs 85 
19 MgO(Bulk) (10 mol%) Solvent-free 90 3.2 hrs 83 
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20 ZnO NPs (10 mol%) EtOH reflux 4 hrs 88 
21 ZnO NPs (10 mol%) AcOH reflux 6 hrs 76 
22 ZnO NPs (10 mol%) Hexane reflux 24 hrs No 
reaction 
23 ZnO NPs (10 mol%) Solvent-free 70 40 min 96 
 
2.9.2b. Effect of catalyst loading 
Taking ZnO nanoparticles as the right catalyst, we then concentrated our attention 
towards optimization of the amount of the catalyst for the reaction (Table 7). The 
results indicated that the use of 10 mol% ZnO NPs was optimum to produce the best 
results of 96% product yield. The use of 5 mol% ZnO NPs diminished the product 
yield, whereas increasing the amount of catalyst to 15-20 mol% did not had any 
profound effect on the reaction. 
Table 7: Effect of catalyst loading on model reaction. 
 
Entry Amount of catalyst Time (min) Yield (%) 
1 5 mol% 65 92 
2 10 mol% 40 96 
3 15 mol% 40 94 
4 20 mol% 40 93 
 
2.9.2c. Effect of temperature 
The effect of temperature on the rate of reaction was studied by conducting the 
reaction at RT, 40 °C , 70 °C, 100 °C and 120 °C under the standard reaction 
conditions using ZnO NPs as catalyst (Table 8). The results showed that the catalytic 
performance of the catalyst strongly increased with the reaction temperature. It was 
found that at 70 °C maximum product yield was obtained. 
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Table 8: Effect of temperature on the model reaction using ZnO nanoparticles. 
 
Entry Temp (°C) Time (min) Yield (%) 
1 Room Temp 2h No reaction 
2 40 2h No reaction 
3 70 40 96 
4 100 40 92 
5 120 40 89 
 
2.9.2d. Catalytic reaction 
Therefore, at a constant temperature of 70°C under solvent-free condition, 10 mol% 
ZnO NPs were used as catalyst for this reaction as the maximum yield (96%) was 
obtained under these conditions. Hence, these optimized conditions were applied for 
all experiments taking appropriate amounts of β-enaminone, active methylene 
compounds and ammonium acetate under solvent-free conditions in the presence of 
10 mol% ZnO NPs (Scheme 4).  
 
Scheme 4: Synthesis of pyridine derivatives. 
46 
 
All the reactions proceeded smoothly and afforded a library of pyridine derivatives 
(5a-p) in excellent yields (89-96%) (Table 9). The reactions were consistently carried 
out at the 1 mmol scale. However, no change of product yield was observed when the 
reactions were carried out at more than 1 mmol scale (up to the 10 mmol scale). From 
the view point of green chemistry, it was positive to find that the final products could 
be isolated, almost in pure form, by filtration due to insolubility of catalyst in safe 
organic solvents. As the synthesis of pyridines involves nucleophilic attack of active 
methylene compound followed by attack of ammonia and then cyclization step , the 
hindrance produced by the fusion of benzene ring to the pyran moiety can be the 
reason for the increased time period (40-59 min) for benzopyran substituted pyridines 
(5a-h) compared to pyran substituted pyridines (5i-p) (4-15 min). 
Table 9: Synthesis of heteroaryl pyridine derivatives. 
Entry 4a-i Product Time 
(min) 
Yield 
(%) 
 
1 
 
 
 
48 
 
95 
 
2 
 
 
 
40 
 
96 
 
3 
 
 
 
45 
 
96 
 
4 
 
 
 
53 
 
91 
47 
 
 
5 
 
 
 
59 
 
92 
 
6 
 
 
 
43 
 
93 
 
7 
 
 
 
56 
 
91 
 
8 
 
 
 
54 
 
91 
 
9 
 
 
 
5 
 
94 
 
10  
 
 
 
4 
 
91 
48 
 
 
11 
 
 
 
8 
 
92 
 
12 
 
 
 
9 
 
90 
 
13 
 
 
 
12 
 
89 
 
14 
 
 
 
15 
 
92 
 
15 
 
 
 
10 
 
93 
 
16 
 
 
 
15 
 
92 
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The structures of the final products were well characterized by IR, 1H, 13C NMR, ESI-
MS and elemental analysis techniques. I.R. spectrum of 5b (Figure 17) showed 
stretching for OH group of benzopyran moiety at 3200cm-1. Coumarin carbonyl and 
carbonyl group of ethyl ester showed absorption bands at 1714 cm-1 and 1690 cm-1, 
respectively. In the 1H-NMR spectrum (Figure 18), OH proton appeared as singlet at 
δ 19.32. The presence of distinctive doublets at δ 9.02 and δ 8.47 for Ha and Hb 
protons confirmed the formation of pyridine ring. 13C-NMR (Figure 19) showed 
distinctive peaks for CH3 and CH2 carbons of ester functionality at δ14.27 and 61.87, 
respectively. The peaks at δ 163.79 and 156.26 were assigned to carbonyl carbons of 
ethyl ester and coumarin moiety, respectively. All other peaks were obtained at their 
correct values and are given in experimental section. Further structural confirmation 
was provided by ESI-Mass spectrum (Figure 20) which showed the molecular ion 
peak as a base peak at m/z 326.1(M++1).  
 
Fig. 17. FT-IR spectrum of 5b 
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Fig. 18. 1H-NMR spectrum of 5b 
 
 
Fig. 19. 13C-NMR spectrum of 5b 
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Fig. 20. ESI-Mass spectrum of 5b 
 
A plausible mechanism for the reaction in the presence ZnO NPs has been shown in 
Scheme 5. The mechanism involves Michael addition in which activated 4b attacks 
on the activated double bond of β-enaminone (1a) to give adduct (I). Attack of NH3 
on carbonyl group of adduct (I) gives intermediate (J), which undergoes further 
intramolecular cyclization to generate intermediate (K). Loss of dimethyl amine 
followed by aromatization of K gives the final product 5b. 
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Scheme 5: Plausible mechanism for the formation of pyridine derivative 5b. 
2.9.3. Catalyst recyclability 
Recyclability of the catalyst was evaluated by the model reaction comprising β-
enaminone 1a, ethyl acetoacetate 4b, and ammonium acetate in the presence of 10 
mol% ZnO NPs under solvent-free conditions. After completion of reaction, the 
catalyst was recovered, washed with ethanol and dried at 120 °C. The catalyst was 
then reused for subsequent cycles and was found to retain good catalytic activity up to 
six cycles (Figure 21). The XRD pattern after six catalytic cycles indicated that the 
crystallinity of ZnO nanoparticles was preserved during the course of reaction 
(Figure 15b). 
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Fig. 21. Recycling data of ZnO nanoparticles for the model reaction. 
2.10. CONCLUSION 
In conclusion, ZnO nanoparticles were found to be an efficient catalyst for simple, 
cost effective and green synthesis of novel benzopyran substituted pyridines via β-
enaminones under solvent-free conditions. Recyclable catalyst, high yield of products, 
ease of work-up, and the ecologically clean procedure, will make the present method 
a sustainable alternative to the existing methodologies for the synthesis of substituted 
pyridines.  
2.11. EXPERIMENTAL 
2.11.1. Preparation of ZnO nanoparticles 
ZnO nanoparticles were synthesised by sol-gel method by the following procedure. 
To 100 mL double distilled water, citric acid was added in order to maintain the pH of 
the solution at 2. Then 20 g of zinc acetate was added to this solution with constant 
stirring. After adding zinc acetate, 10 mL of PEG-600 was added and the solution was 
continuously stirred for 45 min at a constant temperature of 40 °C. Ammonia solution 
was then added drop wise till white precipitate is obtained. The precipitate, as 
obtained was centrifuged, dried at 120 °C and calcined at 600 °C for two hours. The 
nanoparticles were then grinded, characterized and used as catalyst. 
2.11.2. General procedure for the synthesis of substituted pyridine derivatives 
A mixture of β-enaminones 1a, 1c (1mmol), active methylene compounds 4a-i 
(1mmol), ammonium acetate (6 mmol) and10 mol% ZnO nanoparticles was taken in a 
round bottom flask and heated at a constant temperature of 70 °C with continuous 
stirring, under solvent free condition, for a specified period of time (Table 9). After 
completion of the reaction (monitored by TLC), the reaction mixture was allowed to 
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cool and added ethanol or DMSO depending on the solubility of the compound. The 
mixture was filtered in order to recover the catalyst, which was then washed with 
ethanol, dried in oven at 120 °C and reused for subsequent cycles. The compounds 
were recrystallized from ethanol or DMSO. 
2.11.3. Spectral data of synthesized compounds 
 
3-Acetyl-6-(4-hydroxy-1-benzopyran-2-one-3-yl)-2-methyl-
pyridine 
Light yellow crystals, M.P. 290-295 °C.  Anal. Calcd 
(C17H13NO4): C, 69.21; H, 4.41; N, 4.74 Anal. Found 
(C17H13NO4): C, 69.23; H, 4.42; N, 4.72. IR (KBr, cm
-1): 
3354 (OH), 1694, 1615 (C=O). 1H NMR (400 MHz, DMSO-
d6): δ 2.12 (3H,s), 2.65 (3H,s), 7.25-8.05 (4H,m,Ar-H), 8.59 
(1H,d,Hb, J=9.1), 8.95 (1H,d,Ha, J=9.1), 19.02 (1H,s,OH).
 13C 
NMR (100 MHz, DMSO-d6): δ 171.95, 162.94, 157.83, 
153.76, 150.13, 147.43, 133.91, 131.89, 127.73, 120.96, 
119.48, 116.21, 112.11, 105.68, 103.23, 32.76, 27.95. ESI-
MS: (m/z) 296 (M++1). 
 
3-Ethoxycarbonyl-6-(4-hydroxy-1-benzopyran-2-one-3-yl)-2-
methyl-pyridine 
Light yellow crystals, M.P. 255-258 °C. Anal. Calcd 
(C18H15NO5): C, 66.52; H, 4.62; N, 4.30 Anal. Found 
(C18H15NO5): C, 66.51; H, 4.63; N, 4.28. IR (KBr, cm
-1): 
3200 (OH), 1714, 1691 (C=O). 1H NMR (400MHz, DMSO-
d6): δ  1.43 (3H,t,), 2.99 (3H,s), 4.4 (2H,q), 7.2-8.1(4H,m,Ar-
H), 8.47 (1H,d,Hb, J=9.2), 9.02 (1H,d,Ha, J=8.8), 19.32 
(1H,S,OH). 13C NMR (100 MHz, DMSO-d6): δ 179.79, 
163.79, 156.26, 153.54, 150.88, 142.53, 133.74, 125.51, 
123.74, 120.47, 120.31, 119.89, 116.68, 92.43, 61.87, 21.36, 
14.27. ESI-MS: (m/z) 326.1 (M++1).  
 
7,7-Dimethyl-5-oxo-2-(4-hydroxy-1-benzopyran-2-one-3-yl)-
5,6,7,8 tetrahydroquinoline 
Yellow crystals, M.P. >300 °C. Anal. Calcd (C20H17NO4): C, 
71.70; H, 5.07; N, 4.17 Anal. Found (C20H17NO4): C, 71.72; 
H, 5.08; N, 4.15. IR (KBr, cm-1): 3368 (OH), 1652, 1615 
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(C=O). 1H NMR (400MHz, DMSO-d6): δ  1.13 (6H,s), 2.58 
(2H,s), 3.18 (2H,s), 7.2-8.04 (4H,m,Ar-H), 8.42 (1H,d,Hb, 
J=9.5), 8.92 (1H,d,Ha, J=9.1), 18.86 (1H,s,OH).
 13C NMR 
(100 MHz, DMSO-d6): δ 193.40, 178.83, 176.05, 170.67, 
156.55, 153.30, 138.08, 133.82, 130.32, 125.25, 123.59, 
122.62, 120.29, 116.16, 102.28, 62.89, 50.54, 32.81, 27.57. 
ESI-MS: (m/z) 336 (M++1). 
 
2-(4-hydroxy-1-benzopyran-2-one-3-yl)-pyrido[2,3-b]-
chroman-5-one 
Yellow solid, M.P. 290-295 °C. Anal. Calcd (C21H11NO5): 
C, 70.65; H, 3.08; N, 3.92 Anal. Found (C21H11NO5): C, 
70.66; H, 3.11; N, 3.90. IR (KBr, cm-1): 3364 (OH), 1723, 
1671 (C=O). 1H NMR (400MHz, DMSO-d6): δ 7.16-8.23 
(8H,m,Ar-H), 8.35 (1H,d,Hb, J=9.2), 8.75 (1H,d,Ha, J=9.1), 
18.72 (1H,d,OH). 13C NMR (100 MHz, DMSO-d6): δ 175.25, 
170.11, 164.28, 160.21, 156.47, 154.14, 148.89, 136.21, 
130.51, 125.18, 124.21, 123.75, 122.09, 120.76, 119.22, 
118.08, 117.55, 116.16, 110.38, 108.72, 101.02. ESI-MS: 
(m/z) 358 (M++1). 
 
(4-hydroxy-1-benzopyran-2-one-3-yl)-5,6,7,8 
tetrahydroquinoline 
Yellow solid, M.P. 250-253 °C. Anal. Calcd (C18H15NO3): 
C, 73.78; H, 5.12; N, 4.77. Anal. Found (C18H15NO3): C, 
73.76; H, 5.14; N, 4.78. IR (KBr, cm-1): 3283 (OH), 1706 
(C=O). 1H NMR (400MHz, DMSO-d6): δ 1.2 (4H,q), 2.5 
(2H,t), 3.29 (2H,d), 7.16-7.95 (4H,m,Ar-H), 8.16 (1H,d,Hb, 
J=9.2), 8.61 (1H,d,Ha J=9.1), 18.49 (1H,s,OH). 
13C NMR 
(100 MHz, DMSO-d6): δ 176.28, 168.36, 156.76, 152.47, 
148.56, 138.22, 135.76, 127.23, 125.44, 123.17, 122.06, 
120.10, 118.68, 101.21, 35.21, 32.11, 28.11, 26.89. ESI-MS: 
(m/z) 294 (M++1). 
1,3-Dimethyl-7-(4-hydroxy-1-benzopyran-2-one-3-yl)-1H,3H-
pyrido[2,3-d] pyrimidine-2,4-dione 
Orange solid, M.P. 280-285 °C. Anal. Calcd (C18H13N3O5): 
C, 61.59; H, 3.70; N, 11.91 Anal. Found (C18H13N3O5): C, 
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 61.57; H, 3.72; N, 11.93. IR (KBr, cm-1): 3150 (OH), 1690, 
1626 (C=O). 1H NMR (400MHz, DMSO-d6): δ 3.15 (3H,S), 
3.26 (3H,S), 7.2-7.9 (4H,m,Ar-H), 8.3 (1H,d,Hb, J=9.3), 8.6 
(1H,d,Ha, J=9.4), 18.1 (1H,S,OH).
 13C NMR (100 MHz, 
DMSO-d6): δ 176.96, 162.14, 158.13, 153.51, 149.33, 138.78, 
137.21, 133.36, 124.98, 123.34, 115.81, 107.31, 105.19, 
27.10, 26.14. ESI-MS: (m/z) 352 (M++1). 
 
7-(4-hydroxy-1-benzopyran-2-one-3-yl)-1H,3H-pyrido[2,3-
d]pyrimidine-2,4-dione 
Orange solid, M.P. >300 °C. Anal. Calcd (C16H9N3O5): C, 
59.51; H, 2.78; N, 13.00 Anal. Found (C16H9N3O5): C, 59.51; 
H, 2.75; N, 13.02. IR (KBr, cm-1): 3172 (OH), 1701, 1618 
(C=O). 1H NMR (400MHz, DMSO-d6): δ 6.9 (1H,s,NH), 
7.07 (1H,s,NH), 7.25-8.13 (4H,m,Ar-H), 8.24 (1H,d,Hb, 
J=9.2), 8.58 (1H,d,Ha, J=9.4), 18.06 (1H,s,OH).
 13C NMR 
(100 MHz, DMSO-d6): δ 183.29, 180.93, 168.32, 160.16, 
153.36, 151.12, 148.48, 133.53, 125.00, 123.06, 118.85, 
115.86, 109.75, 104.40, 97.34, 96.56.  ESI-MS: (m/z) 324 
(M++1). 
 
2-Thioxo-7-(4-hydroxy-1-benzopyran-2-one-3-yl)-1H,3H-
pyrido[2,3-d]pyrimidine-4-one 
Orange solid, M.P. >300 °C. Anal. Calcd (C16H9N3O5): C, 
56.68; H, 2.65; N, 12.39 Anal. Found (C16H9N3O5): C, 56.65; 
H, 2.67; N, 12.38. IR (KBr, cm-1): 3170 (OH), 1723, 1619 
(C=O). 1H NMR (400MHz, DMSO-d6): δ 6.96 (1H,s,NH), 
7.15-7.99 (4H,m,Ar-H), 8.09 (1H,s,NH), 8.36 (1H,d,Hb, 
J=9.3), 8.53 (1H,d,Ha, J=9.4), 18.37 (1H,s,OH).
 13C NMR 
(100 MHz, DMSO-d6): δ 185.13, 175.96, 167.76, 158.62, 
153.51, 147.65, 144.62, 140.12, 133.93, 125.08, 123.21, 
118.49, 115.98, 106.81, 98.21, 97.11. ESI-MS: (m/z) 340 
(M++1). 
3-Ethoxycarbonyl-6-(4-hydroxy-6-methyl-2-oxo-2H-1-pyran-
3-yl)-2-methyl-pyridine11  
Light yellow solid, M.P. 201°C. Anal. Calcd (C15H15NO5): 
C, 62.34; H, 5.23; N, 4.84; Anal. Found (C15H15NO5): C, 
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 62.22; H, 5.14; N, 4.71. IR (KBr, cm-1):   3065 (OH), 1717 
(C=O), 1697 (C=O). 1H NMR (400 MHz, CDCl3): δ 1.42 
(3H, t), 2.22 (3H, s), 2.92 (3H, s), 4.44 (2H, q, J = 7.2 Hz), 
5.86 (1H, s), 8.44 (1H, d, J = 9.3 Hz, Hb), 8.85 (1H, d, J = 9.3 
Hz, Ha). 
13C NMR (100 MHz, DMSO-d6): δ 182.5. 164.4, 
163.4, 163.2, 156.19, 151.2, 142.2, 120.2, 119.7, 106.2, 91.9, 
61.7, 21.5, 20.0, 14.2. ESI-MS: (m/z) 290.1 (M++1).  
 
3-Acetyl-6-(4-hydroxy-6-methyl-2-oxo-2H-1-pyran-3-yl)-2-
methyl-pyridine11  
Light yellow solid, M.P. 130 °C. Anal. Calcd (C14H13NO4): 
C, 64.92; H, 5.05; N, 5.40; Anal. Found (C14H13NO4): C, 
64.81; H, 4.92; N, 5.28. IR (KBr, cm-1): 3336 (OH), 1695 
(C=O), 1672 (C=O). 1H NMR (400 MHz, CDCl3): δ 2.17 
(3H, s), 2.69 (3H, s), 2.75 (3H, s), 5.96 (1H, s), 8.62 (1H, d, J 
= 9.0 Hz, Hb), 8.68 (1H, d, J = 9.3 Hz, Ha). 
13C NMR (100 
MHz, DMSO-d6): δ 196.76. 180.29, 163.4, 163.2, 156.2, 
151.2, 142.3, 121.5, 120.0, 105.27, 92.4, 21.7, 20.2, 14.3. 
ESI-MS: (m/z) 260.1 (M++1). 
 
7,7-Dimethyl-5-oxo-2-(4-hydroxy-6-methyl-2-oxo-2H-1-
pyran-3-yl)-5,6,7,8 tetrahydroquinoline11  
Light yellow solid, M.P. >300 °C. Anal. Calcd (C17H17NO4): 
C, 68.28; H, 5.73; N, 4.54; Anal. Found (C17H17NO4): C, 
68.15, H, 5.61; N, 4.54. IR (KBr, cm-1): 3088 (OH), 1722, 
1686 (C=O). 1H NMR (400 MHz, CDCl3): δ 1.17 (6H, s), 
2.22 (3H, s), 2.57 (2H, s), 3.02 (2H, s), 5.93 (1H, s), 8.42 (1H, 
d, J = 9.0 Hz, Hb), 8.93 (1H, d, J = 9.9 Hz, Ha). 
13C NMR 
(100 MHz, DMSO-d6): δ 194.0. 182.2, 163.7, 163.0, 157.9, 
153.2, 137.8, 122.9, 120.7, 105.7, 92.9, 51.3, 42.6, 33.2, 30.9, 
28.2, 20.10. ESI-MS: (m/z) 300.1 (M++1).  
 
7-(4-Hydroxy-6-methyl-2-oxo-2H-pyran-3-yl)-2,2-dimethyl-
1,3-dioxa-8-aza-quinoline-4-one11 
Brown solid, M.P. >300 °C. Anal. Calcd (C15H13NO6): C, 
59.40; H, 4.29; N, 4.60; Anal. Found (C15H13NO6): C, 59.53; 
H, 4.13; N, 4.72. IR (KBr, cm-1): 3283 (OH), 1735 (C=O), 
1688 (C=O).  1H NMR (400 MHz, CDCl3): δ 1.61 (6H s), 
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2.22 (3H, s), 5.89 (1H, s), 8.45 (1H, d, J = 9.0 Hz, Hb), 9.06 
(1H, d, J = 9.0 Hz, Ha).  
13C NMR (100 MHz, DMSO-d6): δ 
183.2, 164.0, 163.5, 163.1, 153.4, 151.2, 138.4, 119.4, 115.5, 
106.0, 105.7, 92.9, 27.8, 27.1, 20.1. ESI-MS: (m/z) 
304.1(M++1). 
 
2-(4-hydroxy-6-methyl-2-oxo-2H-1-pyran-3-yl)-pyrido[2,3-
b]-chroman-5-one11 
White solid, M.P. >300 °C. Anal. Calcd (C18H11NO5): C, 
67.35; H, 3.45; N; 4.35; Anal. Found (C18H11NO5): C, 67.20; 
H, 3.56; N, 4.48. IR (KBr, cm-1): 3445 (OH), 3085 (OH), 
1707 (C=O), 1670 (C=O). 1H NMR (400 MHz, CDCl3): δ 
2.22 (3H, s), 5.94 (1H, s), 7.41-8.10 (4H, m, Ar-H), 8.57 (1H, 
d, J = 9.6 Hz, Hb), 8.92 (1H, d, J = 9.0 Hz, Ha). 
13C NMR 
(100 MHz, DMSO-d6): δ 180.2, 172.7, 164.5, 162.7, 162.1, 
154.4, 152.5, 139.9, 138.7, 137.7, 129.8, 127.5, 120.1, 118.4, 
117.8, 105.9, 94.9, 19.4. ESI-MS: (m/z) 322.3 (M++1). 
 
7-(4-Hydroxy-6-methyl-2-oxo-2H-1-pyran-3-yl)-1H,3H-
pyrido[2,3-d]pyrimidine-2,4-dione11  
Orange solid, M.P. >300 °C. Anal. Calcd (C13H9N3O5): C, 
54.40; H, 3.16; N, 14.64; Anal. Found (C13H9N3O5): C, 
54.26.; H, 3.08, N, 14.51. IR (KBr, cm-1):  3396 (OH), 3225 
(NH), 3038 (NH), 1684 (C=O). 1H NMR (400 MHz, CDCl3): 
δ 2.12 (3H, s), 5.83 (1H, s), 8.07 (1H, d, J = 10.9 Hz, Hb), 
8.48 (1H, d, J = 10.9 Hz, Ha), 9.97 (1H, s, NH), 10.10 (1H, s, 
NH). 13C NMR (100 MHz, DMSO-d6): δ 184.4, 164.6, 163.6, 
161.7, 155.5, 153.8, 151.1, 147.6, 125.6, 119.6, 104.6, 96.1, 
19.5. ESI-MS: (m/z) 288.1 (M++1). 
 
1,3-Dimethyl-7-(4-hydroxy-6-methyl-2-oxo-2H-1-pyran-3-yl)-
1H,3H-pyrido[2,3-d] pyrimidine-2,4-dione11 
Orange solid, M.P. 241 °C. Anal. Calcd (C15H13N3O5): C, 
57.19; H, 4.16; N, 3.31; Anal. Found (C15H13N3O5): C, 
57.08; H, 4.04; N, 3.18. IR (KBr, cm-1): 3169 (OH), 1700 
(C=O), 1672 (C=O). 1H NMR (400 MHz, CDCl3): δ 2.13 
(3H, s, CH3), 3.14 (6H, s), 5.86 (1H, s), 8.20 (1H, d, J = 9.6 
Hz, Hb), 8.57 (1H, d, J = 9.6 Hz, Ha). 
13C NMR (100 MHz, 
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DMSO-d6): δ 182.4, 164.9, 164.8, 163.9, 160.9, 154.6, 151.9, 
148.3, 125.2, 124.4, 105.0, 95.9, 27.0, 19.6. ESI-MS: (m/z) 
316.1 (M++1). 
 
2-Thioxo-7-(4-hydroxy-6-methyl-2-oxo-2H-1-pyran-3-yl)-
1H,3H-pyrido[2,3 d]pyrimidine-4-one11  
Orange solid, M.P. >300 °C. Anal. Calcd (C13H9N3O4S): C, 
51.53; H, 2.99; N, 14.82; Anal. Found (C13H9N3O4S):  C, 
51.39; H, 3.14; N, 14.65. IR (KBr, cm-1): 3392 (OH), 3201 
(NH), 3026 (NH), 1707 (C=O), 1651 (C=O). 1H NMR (400 
MHz, CDCl3): δ 2.15 (3H, s), 5.90 (1H, s), 8.20 (1H, d, J = 
9.9 Hz, Hb), 8.46 (1H, d, J = 9.4 Hz, Ha), 10.20 (1H, s), 10.92 
(1H, s). 13C NMR (100 MHz, DMSO-d6): δ 184.4, 175.6, 
164.6, 162.0, 161.3, 154.2, 151.6, 146.4, 123.2, 121.1, 104.1, 
97.0, 19.6. ESI-MS: (m/z) 304.1 (M++1). 
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SULPHATED SILICA TUNGSTIC ACID: AN EFFICIENT 
AND RECYCLABLE HETEROGENEOUS CATALYST 
FOR THE SYNTHESIS OF 
TETRAHYDROPYRIMIDINES AND 
DIHYDROPYRIMIDINES 
 
CHAPTER 3 
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SULPHATED SILICA TUNGSTIC ACID: AN EFFICIENT AND 
RECYCLABLE HETEROGENEOUS CATALYST FOR THE SYNTHESIS OF 
TETRAHYDROPYRIMIDINES AND DIHYDROPYRIMIDINES* 
3.1. INTRODUCTION 
Tetrahydropyrimidines (THPMs)/ Dihydropyrimidines (DHPMs) represent an 
important group of highly valuable heterocyclic motifs in the field of medicinal 
chemistry. Dihydropyrimidines display a wide range of biological activities such as 
calcium channel modulators, adrenergic receptor antagonist, mitotic kinesin inhibitor, 
antiviral, antibacterial, etc.1 Enastron, monastrol and piperastrol2 are well known 
dihydropyrimidine derivatives which have already been marketed as drugs. THPMs 
have been reported to possess pharmacological profiles like HIV protease inhibiting 
activity,3 antineoplastic activity4 antiproleferative,5 herbicidal activity,6 muscarinic 
agonist activity,7 anti-inflammatory8 and antiviral properties.9 The examples of 
approved therapeutic agents incorporating tetra- and di-hydropyrimidine molecular 
frameworks are given in Figure 22. DHPMs are commonly synthesised via Biginelli 
reaction and THPMs are usually synthesised via Biginelli-like transformation10 or 
alternatively, using the two-step reaction involving Knoevenagel condensation 
followed by urea annulation.11 The protocols for the synthesis of DHPMs are well 
documented in the literature but, multicomponent protocols for the synthesis of 
THPMs tolerating heteroaldehydes under heterogeneous conditions are unfortunately 
very rare. It is therefore highly desirable to develop new methods for the efficient 
synthesis of THPMs. 
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Fig. 22. Representative therapeutic agents based on tetra- and di-hydropyrimidines 
 
                                                          
* Nayeem Ahmed, Zeba N. Siddiqui, Journal of Molecular Catalysis A: Chemical, 387 (2014) 45. 
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3.2. REVIEW OF LITERATURE 
Some recent examples of the synthesis of tetrahydropyrimidine derivatives. 
3.2.1. Microwave-assisted synthesis of 1,2,3,4-tetrahydropyrimidine-5-
carbonitrile derivatives12 
A multicomponent reaction involving one-pot reaction of ethyl cyanoacetate, 
urea/thiourea and arylaldehydes in presence of ethanolic K2CO3 has been reported by 
S. B. Mohan et al. The synthesised compounds showed promising antitubercular 
activity. 
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3.2.2. One pot synthesis of thioxopyrimidine derivatives in ethanol13 
S. Kambe et al. synthesised thioxopyrimidine derivatives via reaction of aldehydes, 
thiourea and ethyl cyanoacetate in refluxing ethanol using K2CO3 as a catalyst.  
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3.2.3. Synthesis of pyrimidine derivatives as anti-cancer agents14 
M. M. M. Ramiz et al. synthesised 1,2,3,4-tetrahydropyrimidine-5-carbonitrile 
derivatives using ethanolic K2CO3 and AcOH as a reaction medium. These derivatives 
were then successively functionalised by glycosides and were found to display good 
anti-cancer potential. 
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3.2.4. Synthesis of tetrahydropyrimidine analogs as anti-inflammatory agents15 
D. K. Lokwani et al. synthesised a series of 1,2,3,4-tetrahydropyrimidine derivatives 
and evaluated them for their anti-inflammatory potential. The synthesised compounds 
showed promising anti-inflammatory activity. 
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Some recent examples of the synthesis of dihydropyrimidine derivatives. 
3.2.5. Titanium dioxide supported on multi-walled carbon nanotubes (TiO2–
MWCNTs) catalysed Biginelli reaction16 
J. Safari and S. G. Ravande reported an efficient synthesis of 3,4-dihydropyrimidin-2-
(1H)-ones using TiO2–MWCNTs as catalyst under microwave irradiation. Reusable 
catalyst, solvent-free conditions, high yield and short reaction time are highlights of 
this protocol. 
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3.2.6. Fe3O4@mesoporous SBA-15: A magnetically recoverable catalyst for 
Biginelli reaction17 
A magnetically separable Fe3O4@mesoporous SBA-15 was used for highly efficient 
synthesis of 3,4-dihydropyrimidin-2(1H)-ones via Biginelli reaction under mild 
reaction conditions. The simple separation and reuse of the Fe3O4@mesoporous SBA-
15 along with high turnover frequencies and good yield of the products are merits of 
this protocol.  
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3.2.7. Catalytic performance of bismuth vanadate (Bi2V2O7) nanocatalyst for 
Biginelli reaction18 
S. Khademinia et al. synthesised bismuth vanadate nanocatalyst and evaluated its 
catalytic activity for the synthesis of 3,4-dihydropyrimidin-2(1H)-ones. The catalyst 
was synthesised by solid state method and showed excellent catalytic efficiency by 
giving high yields in 60 min under solvent-free conditions. 
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3.2.8. Biginelli reaction catalysed by zeolite supported on heteropolyacid19 
An eco-friendly protocol for the synthesis of 3,4-dihydropyrimidin-2(1H)-ones using 
molybdophosphoric acid (HPA) supported  on Y zeolite was reported by M. 
Moghaddas et al. The catalyst was recyclable and the products were obtained in 
excellent yields. 
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3.2.9. Nano–γ–Fe2O3–SO3H catalysed synthesis of 3,4-dihydropyrimidin-2(1H)-
ones20 
A simple, efficient, magnetically separable and recyclable nano–γ–Fe2O3–SO3H 
catalysed process for the synthesis of 3,4-dihydropyrimidin-2-(1H)-ones  under 
solvent-free thermal or microwave conditions has been reported by E. Kolvari et al. 
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3.2.10 Bis[(L)prolinato-N,O]Zn catalysed synthesis of 3,4-dihydropyrimidin-
2(1H)-ones in water21 
Z. N. Siddiqui described an efficient synthesis of 3,4-dihydropyrimidin-2(1H)-one 
derivatives using bis[(L)prolinato-N,O]Zn as an inexpensive and mild Lewis acid 
catalyst in water.  Short reaction time, high yields, clean process and low loading of 
catalyst are merits of this protocol. 
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3.2.11 MCM-41 supported perchloric acid catalysed synthesis of 3,4-
dihydropyrimidin-2(1H)-ones/thiones22 
K. Khan and Z. N. Siddiqui reported mesoporous silica (MCM-41) supported 
perchloric acid catalysed synthesis of dihydropyrimidinones under solvent-free 
conditions.  
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3.2.12 Synthesis of dihydropyrimidine derivatives using sulfonic acid 
functionalized polypropylene fiber (PPF-SO3H) as a catalyst23 
X. Shi et al. reported one-pot three-component synthesis of 3,4-dihydropyrimidin-2-
(1H)-ones/thiones using sulfonic acid-functionalized polypropylene fiber as a 
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heterogeneous catalyst. Advantages of this protocol are good yield, low catalyst 
loading, simple work-up procedure and catalyst recyclability. 
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3.2.13 ZnO catalysed synthesis of dihydropyrimidinones under solvent-free 
conditions24 
F. Tamaddon and S. Moradi reported controllable synthesis of dihydropyrimidinones 
using ZnO or nano ZnO as a catalyst under solvent-free synthesis. 
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3.2.14 Synthesis of dihydropyrimidinones using silica-bonded N–propyl sulfamic 
acid as a recyclable catalyst25 
S. R. Jetti et al. reported a simple and efficient silica-bonded N–propyl sulfamic acid 
(SBNPSA) catalysed synthesis of dihydropyrimidinones/thiones by condensation of 
different aromatic aldehydes with ethyl acetoacetate and urea/thiourea. 
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3.3. PRESENT WORK 
The development of environmentally benign organic reactions has become a crucial 
and demanding area of research in modern organic chemistry. Therefore, preparation 
of new heterogeneous catalysts with improved efficiency has been the subject of 
immense interest and the best trend is to transform a successful homogeneous catalyst 
into a heterogeneous catalyst. Immobilization of catalysts on solid support is an ideal 
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method for combining the advantages of homogeneous catalysts like high activity and 
selectivity with the advantages of heterogeneous catalysts like availability of active 
sites, easy catalyst separation, long catalytic life, thermal stability, low hygroscopic 
properties, easy handling and reusability.26-29 Among various solid supports, silica is 
usually a preferred support due to its many advantageous properties like excellent 
chemical and thermal stability, high surface area and good accessibility.  Due to 
encouraging chemical and physical properties of silica surfaces it is possible to 
functionalize the surface by any functional group (e.g., sulfonic, amine, carboxyl, 
thiol, epoxy, and so forth) that one requires on a silica.30-33 As a result, numerous 
modifications can be made for specific applications with the use of a combination of 
inorganic materials and functional groups. In the present work, taking advantage of 
the above mentioned properties of silica, we have synthesized sulphated silica 
immobilized tungstic acid (SSTA) and used it for the preparation of THPMs and 
DHPMs under solvent-free conditions. 
3.4. RESULTS AND DISCUSSION 
Scheme 6 demonstrates the concise route for the preparation of SSTA catalyst. 
Sodium tungstate (Na2WO4) reacted with silica chloride to produce silica tungstic 
acid (STA) which on reaction with chlorosulfonic acid gave sulphated silica tungstic 
acid (SSTA). The optimum concentration of H+ was determined by titration of the 
aqueous suspension of the weighed amount of thoroughly washed catalyst with 
standard NaOH solution. The strength of NaOH solution was kept very low (0.01 N) 
in order to minimise errors caused by reaction of NaOH with Lewis acid groups and 
to avoid the consumption of the base in the hydrolysis of the silica frameworks. The 
optimum concentration of H+ of SSTA was found to be 0.40 meq/gram of the support. 
The concentrations of the residual H+ on the recovered catalyst were measured 
(provided in recycling study) after successive experiments. The studies showed very 
small or marginal loss of H+, which signified that SO3H moiety was tightly anchored 
with STA, probably through a covalent linkage. The reaction of aldehyde (6b) (6-
methyl-3-formyl chromone) with urea and ethyl cyanoacetate (7a) in the presence of 
SSTA (preheated at 120 °C for 3h) occurred with high efficiency giving 94% product 
(THPM) yield. The same reaction in the presence of SSTA after keeping it at an 
ambient atmosphere for 5 days produced similar observation which confirmed that 
there was no deteriorating effect of atmospheric oxygen or moisture towards the 
activity of the catalyst. The catalyst thus, exhibited significant stability towards heat 
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and moisture which provided further evidence for covalent linkage and the potential 
of efficient recycling.  
SiO2
O O
O
Si
OH
SiO2
O O
O
Si
Cl
SiO2
O O
O
Si
O
W OO
OH
SiO2
O O
O
Si
O
W OO
O
S OO
OH
SOCl2
 Dry
 
CH2Cl2
Room Temp.
1
 h
(1)
 
Na2WO4
Dry
 n-Hexane
Reflux, 6
 h
(2)
 
0.1
 
N
 HCl,
 
1h
Dry
 
CH2Cl2
ClSO3H
Room Temp.
2
 h
Conc.
 of
 
H+
0.40
 mequiv/g
Conc.
 of
 
H+
0.34
 mequiv/g
STA SSTA
Scheme 6: Schematic representation of the synthesis of the catalyst. 
3.4.1. Characterization of the catalyst 
3.4.1a. FT-IR spectral analysis of the catalyst 
The incorporation of sulfonic groups and tungsten moieties on silica surface was 
analysed by FT-IR spectra of sodium tungstate, STA and SSTA respectively (Figure 
23). In the FT-IR spectrum of sodium tungstate (Figure 23a), the WO42- stretching 
frequency was observed at 1683 cm-1. In the spectra of STA (Figure 23b), WO42- 
stretching frequency appeared at 1650 cm-1 along with peaks corresponding to SiO2 
stretching band. Due to bonding with silica, a decrease in the intensity of WO42- 
stretching band of STA was observed. The introduction of SO32- groups in STA led to 
further decrease in the intensity of the WO42- stretching band which appeared at 1642 
cm-1. In the spectrum of SSTA (Figure 23c), OH stretching frequency was obtained at 
3448 cm-1. The asymmetric and symmetric stretching vibrations of SO32- group 
obtained around 1300 and 1200 cm-1 merged with the broad absorption peak between 
1000 and 1500 cm-1, which showed some increase in intensity and little increase in 
broadening as compared to broad peak of STA. The peaks corresponding to SiO2-Cl 
and SiO2 stretching were also observed in SSTA. The IR spectrum thus, confirms the 
successful sulfonation of STA. 
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Fig. 23. FT-IR spectra of (a) sodium tungstate (b) silica tungstic acid and (c) SSTA. 
3.4.1b. XRD spectral analysis  
The XRD patterns of the catalyst (Figure 24b) were similar to that of the support 
(Figure 24a). The WO3 group exhibits a broad peak around 2θ = 22° which merges 
with the broad peak shown by SiO2 at around 2θ = 20-25°.34,35  
 
Fig. 24. (a) Powder XRD pattern of SiO2 (b) XRD pattern of fresh SSTA (c) 
XRD pattern of the catalyst after six catalytic cycles. 
3.4.1c. SEM/EDX Analysis of the catalyst 
The surface morphologies of silica and functionalised silica analysed by SEM 
analysis (Figure 25a,b&c), revealed the change in surface morphology of silica gel 
upon functionalization. Furthermore, the formation of expected sulphated catalytic 
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system was also confirmed by EDX analysis (Figure 25d) which showed the presence 
of sulphur in addition to silicon and tungsten elements. 
 
Fig. 25. SEM images (a) of SiO2 support (b) of freshly synthesised SSTA (c) of 
recycled SSTA and (d) EDX analysis of SSTA. 
3.4.1d. TG analysis of the catalyst 
TG analysis (Figure 26) was done in order to evaluate the thermal stability of the 
catalyst. The first weight loss of 19% at ~100 °C was due to the loss of solvent 
molecules present in silica gel framework. The second weight loss of ~7% at 550 °C 
can be attributed to the decomposition of sulphate and tungstate groups from the 
surface of silica. The TG analysis thus, confirmed that the catalyst is stable up to 550 
°C.  
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Fig. 26. TG analysis of SSTA catalyst. 
3.4.2. Optimization of reaction conditions 
3.4.2a. Effect of different reaction media 
Our initial study was focused on the development of the optimal reaction conditions 
for this transformation and included screening of different catalysts and solvents 
(Table 10). The reaction of 6-methyl-3-formyl chromone (6b), urea and ethyl 
cyanoacetate (7a) was chosen as a model reaction. When the reaction was carried out 
in the presence of sulphuric acid in ethanol at reflux temperature, product 8b was 
obtained in 56% yield after 8 hours (entry 1). When sulphuric acid was used under 
solvent-free condition at 70 °C, 67% product yield was obtained in 4.2 h (entry 3). As 
the solvent-free approach produced same yield in less time, this approach was further 
explored for optimization of reaction conditions. As sulphuric acid failed to give 
satisfactory results, we then examined the effect of the differently supported sulphuric 
acids under solvent-free condition. Cellulose, xanthan, PEG and camphor (organic 
polymers) supported sulphuric acid gave unsatisfactory yields (entries 6-9). Among 
silica and zirconia supported sulphuric acids, the use of H2SO4-SiO2 showed better 
results (entry 4). In order to further improve our protocol we then turned our attention 
towards recently synthesised catalyst Silica Tungstic acid (STA) and the results 
obtained were better than different organic polymers supported acid, but were 
unsatisfactory than H2SO4-SiO2. As a simplistic means to improve it, we then 
introduced SO3H groups in STA. This strategy was found to be very effective as 
excellent product yield (94%) was obtained in only 15 min (entry 13). The catalyst 
was then further compared with different Lewis acids i.e., FeCl3, ZnCl2, ZnO and 
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MgO under solvent-free condition and the results were unsatisfactory (entries 20-23). 
Different solvents were used in order to further optimize the reaction conditions. The 
results obtained by the use of solvents like ethanol, methanol and isopropanol, hexane 
and toluene (entries 14-19) revealed that the solvent-free approach is the best 
approach for obtaining maximum yield in less time. 
Table 10: Effect of catalysts/solvents in different reaction conditions on the model 
reaction. 
H2N NH2
O
+ NH
NH
NC
O
O
O
O CH3
N
Different
 conditions
O
O
H3C H
O
O
O
H3C
(6b) (7
a) (8b)  
Entry Catalyst Condition Time Yield% 
1 H2SO4 (10 mol%) Ethanol/reflux 8 h 56 
2 H2SO4 (10 mol%) Iso-propanol/reflux 8.5 h 53 
3 H2SO4 (10 mol%) Solvent-free/70 °C 4.2 h 67 
4 H2SO4-SiO2 (200mg) Solvent-free/70 °C 40 min 82 
5 H2SO4-ZrO2 (200mg) Solvent-free/70 °C 2 h 62 
6 H2SO4-Cellulose (200mg) Solvent-free/70 °C 65 min 65 
7 H2SO4-Xanthan (200mg) Solvent-free/70 °C 60 min 68 
8 H2SO4-PEG (200mg) Solvent-free/70 °C 90 min 58 
9 CSA (200mg) Solvent-free/70 °C 2.5 h 45 
10 NH2SO3H-SiO2 (200mg) Solvent-free/70 °C 55 min 71 
11 Na2WO3 (10 mol%) Solvent-free/70 °C 3.2 h 67 
12 STA (200mg) Solvent-free/70 °C 90 min 78 
13 STA-OSO3H (200mg) Solvent-free/70 °C 15 min 94 
14 STA-OSO3H (200mg) Ethanol/reflux 2 h 73 
15 STA-OSO3H (200mg) Iso-propanol/reflux 2.5 h 65 
16 STA-OSO3H (200mg) Methanol/reflux 3.1 h 59 
17 STA-OSO3H (200mg) CH2Cl2/reflux 3.5 h 46 
18 STA-OSO3H (200mg) Hexane/reflux 4.2 h 23 
19 STA-OSO3H (200mg) Toluene/reflux 4.5 h 25 
20 FeCl3 (10 mol%) Solvent-free/70 °C 6 h 36 
21 ZnCl2 (10 mol%) Solvent-free/70 °C 5.4 h 41 
22 ZnO (10 mol%) Solvent-free/70 °C 6h No 
reaction 
23 MgO (10 mol%) Solvent-free/70 °C 6h No 
reaction 
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3.4.2b. Effect of catalyst loading 
After optimizing the catalyst and solvent, we next investigated the optimum amount 
of catalyst for the reaction.  Carrying out the reaction with more than 200 mg of 
catalyst produced no significant effect on yield. Decreasing the amount of the catalyst 
to 100 mg reduced the yield to 43% (Table 11). Therefore, 200 mg of SSTA was 
chosen as the optimum amount of the catalyst. 
Table 11: Effect of catalyst loading on the model reaction. 
H2N NH2
O
+ NH
NH
NC
O
O
O
O CH3
N
O
O
H3C H
O
O
O
H3C
	Solvent-free/70
 °C
STA-OSO3H
(6b) (7a) (8b)  
Entry Amount of catalyst Time(min) Yield (%) 
1 250 mg 15 92 
2 200 mg 15 94 
3 150 mg 30 68 
4 100 mg 45 43 
 
3.4.2c. Effect of temperature 
The effect of temperature was examined in the range from RT to 100 °C using SSTA 
as catalyst under solvent-free condition. The reaction was not successful at RT and 
with further increase in temperature the results also improved (Table 12). At 70 °C 
and 80 °C the reaction completed in 15 min with almost same yield. Further increase 
in the temperature could not show any profound effect on the reaction. So, 70 °C was 
chosen as the optimum temperature for performing the reaction. 
Table 12: Effect of different temperatures on the model reaction. 
H2N NH2
O
+ NH
NH
NC
O
O
O
O CH3
N
O
O
H3C H
O
O
O
H3C
	Solvent-free
STA-OSO3H
 
(200mg)
(6b) (7
a) (8b)  
Entry Temp. (°C) Time Yield (%) 
1 RT 8h No reaction 
2 40 7h 45 
3 70 15min 94 
4 80 15 min 92 
5 100 15 min 87 
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3.4.3. Catalytic reaction 
3.4.3a. Synthesis of tetrahydropyrimidines 
After optimizing the conditions, we then explored the scope of the reaction by using 
different heterocyclic aldehydes, ethyl cyanoacetate or phenylacetic acid and urea as 
substrates under these conditions (Scheme 7). It was observed that the reaction 
successfully tolerated aldehydes with different heterocyclic substituents to furnish the 
final products in good yields. When ethylcyano acetate was replaced by phenylacetic 
acid, the desired compounds were again obtained in good yields albeit with little 
longer reaction time (Table 13).  
R1 H
O
H2N NH2
O
+
R1 NH
NHNC
O
O
R1 NH
NH
O
O
N
H
HN
O
R1
CH3
R
O O
H3C
O
R
O
OH
O
O CH3
N
Solvent-free
SSTASolvent-free
SSTA
(2a
-b,
 
2d-g)
(6a
-f)
7a
7b
4a-b
8a-d
8e-l
8m-w
Scheme 7: Synthesis of different tetrahydropyrimidines (8a-l) and 
dihydropyrimidinone derivatives (8m-w). 
The structures of the final products were characterized by using IR, 1H, 13C NMR, 
ESI-MS and elemental analyses techniques. The I.R. spectrum of 8b (Figure 27) 
showed two NH stretching frequencies at 3444 and 3281 cm-1, respectively. The CN 
stretching band was present at 2224 cm-1. The peak at 1730 cm-1 was assigned to two 
C=O groups of tetrahydropyrimidine moiety. The chromone C=O group showed 
absorption band at 1654 cm-1. The 1H-NMR spectrum (Figure 28) showed two 
distinctive singlets of NH protons at δ 11.21 and 8.77. A singlet at δ 7.37 was 
assigned to H-2’ proton of chromone moiety. Three aromatic protons of chromone 
moiety appeared as multiplet in the range of δ 7.4-7.8. The methyl singlet was present 
at δ 3.36. In the 13C-NMR spectra (Figure 29), peaks for C=O group of chromone 
moiety and C=O groups of tetrahydropyrimidine ring were obtained at 180.22, 168.21 
and 162.44, respectively. Further structural confirmation was provided by ESI-Mass 
spectrum (Figure 30) which showed the molecular ion peak as the base peak at m/z 
296.1 (M++1). 
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Fig. 27. FT-IR spectrum of 8b 
 
 
Fig. 28. 1H-NMR spectrum of 8b 
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Fig. 29. 13C-NMR spectrum of 8b 
 
 
Fig. 30. ESI-Mass spectrum of 8b 
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3.4.3b. Synthesis of dihydropyrimidines 
The catalytic system was also evaluated for the synthesis of dihydropyrimidinones via 
biginelli condensation. Several aromatic and heterocyclic aldehydes reacted with 1,3-
dicarbonyl compounds and urea under similar reaction conditions and gave excellent 
results. Both β-ketoesters and β-diketones gave excellent results within short reaction 
time (Table 13, entries 13-23). Aldehydes containing both electron releasing and 
withdrawing groups reacted efficiently to furnish the products in excellent yield.  In 
order to show the superiority of our catalytic system, a comparison with other 
reported catalysts in the literature was made, and the study showed the superiority of 
our catalytic system in terms of reaction conditions, time and product yield (Table 
14). 
Table 13: Synthesis of tetrahydropyrimidines and dihydropyrimidinones using SSTA 
catalyst under solvent free conditions at 70 °C. 
Entry Aldehydes 4a,b & 7a,b Product (8a-w) Time (min) 
Yield 
(%) 
 
1 O
CHO
O
6a  
O
O CH3
N
7a
 O
N
H
NHNC
O
O
O
8a  
 
16 
 
91 
 
2 
O
CHO
O
H3C
6b
 
O
O CH3
N
7a
 O
N
H
NH
NC
O
O
O
H3C
8b
H
 
 
15 
 
94 
 
3 O
CHO
O
Cl
6c  
O
O CH3
N
7a
 O
N
H
NH
NC
O
O
O
Cl
8c  
 
15 
 
90 
 
4 
N
H
CHO
6d  
O
O CH3
N
7a
 NH
N
H
NHNC
O
O
8d  
 
20 
 
88 
78 
 
 
5 O
CHO
O
6a  
O
OH
7b
 
O
HN NH
O
O
O
8e  
 
21 
 
87 
 
6 
O
CHO
O
H3C
6b
 
O
OH
7b
 
O
HN NH
O
O
O
H3C
8f  
 
20 
 
90 
 
7 O
CHO
O
Cl
6c  
O
OH
7b
 
O
HN NH
O
O
O
Cl
8g  
 
20 
 
86 
 
8 
N
CHO
Cl
6e  
O
OH
7b
 
N
N
H
NH
O
O
Cl
8h  
 
25 
 
85 
 
9 O
CHO
O
Cl
6f  
O
OH
7b
 O
N
H
NH
O
O
O
Cl
8i  
 
31 
 
82 
 
10 
N
H
CHO
6d  
O
OH
7b
 NH
N
H
NH
O
O
8j  
 
22 
 
84 
 
11 
CHO
2f  
O
OH
7b
 
N
H
NH
O
O
8k  
 
23 
 
83 
 
12 
 
H3C CHO
2g  
O
OH
7b
 
N
H
NH
O
O
H3C
8l  
 
27 
 
82 
79 
 
 
13 
O
CHO
O
H3C
6b
 
O
H3C
O
O CH3
4b
 O
H3C
O NH
N
H O
CH3
OEt
O
8m
 
 
10 
 
94 
 
14 
N
H
CHO
6d  
H3C
O O
CH3
4a
 
8n
NH
N
H
O
CH3CH3
O
N
H
 
 
12 
 
92 
 
15  
H O
2a  
O
H3C
O
O CH3
4b
 N
H
NH
OH3C
C2H5O
O
8o  
 
10 
 
96 
 
16  
H O
2a  
H3C
O O
CH3
4a
 NH
NH
OH3C
H3C
O
8p  
 
12 
 
95 
 
17  
H O
NO2
2e  
O
H3C
O
O CH3
4b
 N
H
NH
OH3C
C2H5O
O
NO2
8q  
 
08 
 
95 
 
18  
H O
NO2
2e  
H3C
O O
CH3
4a
 NH
NH
OH3C
H3C
O
NO2
8r  
 
10 
 
94 
 
19 
H O
OH
2d  
O
H3C
O
O CH3
4b
 N
H
NH
OH3C
C2H5O
O
OH
8s  
 
09 
 
94 
80 
 
 
20  
H O
OH
2d  
H3C
O O
CH3
4a
 N
H
NH
OH3C
H3C
O
OH
8t  
 
12 
 
95 
 
21 
H O
2h
Cl
 
O
H3C
O
O CH3
4b
 N
H
NH
OH3C
C2H5O
O Cl
8u  
 
08 
 
93 
 
22 
H O
2h
Cl
 
H3C
O O
CH3
4a
 NH
NH
OH3C
H3C
O Cl
8v  
 
10 
 
93 
 
23 
H O
Cl
2b  
O
H3C
O
O CH3
4b
 
N
H
NH
OH3C
C2H5O
O
Cl
8w  
 
10 
 
94 
 
Table 14: Effect of different reported catalysts for formation of dihydropyrimidines. 
Entry Catalyst  Reaction 
conditions 
Yield 
(%) 
Time No. of 
recycles. 
Ref. 
1 SSTA 70 °C /Solvent-
free 
96 10 
min 
06 Present 
work. 
2 Sulfated tungstate 80 °C/solvent 
free 
92 60 
min 
04 36 
3 PS–PEG–SO3H 80 °C /Dioxane: 
2-propanol (4:3) 
80 10 h 06 37 
4 Silica sulfuric 
acid 
Reflux/Ethanol 91 6h 05 38 
5 β-cyclodextrin 100°C /Solvent-
free 
85 3h 05 39 
6 [Al(H2O)6](BF4)3 Reflux/CH3CN 85 20h 04 40 
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7 Fe3O4/PAA-SO3H RT/Solvent-free 90 2h 06 41 
8 Cellulose –SO3H 100°C/Water 85 4.5h 04 42 
9 Cu(OTf)2 100°C/Ethanol 65 60 
min 
Nil 43 
10 Tetra-butyl 
ammonium 
bromide 
100°C/KOH 96 40 
min 
Nil 44 
 
3.4.4. Reaction mechanism 
A plausible mechanism for the formation of tetrahydropyrimidines (8a-l) is depicted 
in Scheme 8. Protonation of aldehyde (6a-f, 2f-g) by SSTA activates the substrate, 
which then undergoes Knoevenagel condensation with ethyl cyanoacetate (7a) to 
form alkene derivative (L).  Addition of urea to L, followed by elimination of ethoxy 
group leads to another intermediate (M). Intramolecular Michael addition followed by 
dehydrogenation then affords the product (8a-l). The catalyst is regenerated and can 
be subsequently reused for six catalytic cycles.13,14 
C
OH
R H
CN-CH2
-COOEt
R CN
C
O
OEt
NH2
-C-NH2
O
R CN
C
NH
OEt
O
H2N
O
R CN
C
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O
H CN
C
NH
OHN
O
R
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C
NH
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O
R
CAT OH
EtOH
-H
CAT OH
SiO2
O
O
O Si O W
O
O
O S
O
O
OH
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-l)
(6a
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2f-g)
H2O
CAT O
CAT O
H
H2
H
L
M
7a
Scheme 8: plausible mechanism for the formation of tetrahydropyrimidines. 
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3.4.5. Recyclability of the catalyst 
Recyclability of the catalyst was evaluated by the reaction of 6-methyl-3-
formylchromone, ethyl cyanoacetate and urea in the presence of SSTA under solvent-
free conditions. After completion of the reaction the product was recovered by 
extracting the mixture with ethanol and the remaining catalyst was then filtered, 
washed with ethanol (3x15 mL), ethyl acetate (2x10 mL), dried at 100 °C for 1 hour 
and reused for subsequent cycles. It was found that the catalyst exhibited good 
catalytic activity for six cycles (Table 15). The XRD (Figure 24c) and SEM images 
(figure 25c) of the catalyst after six catalytic cycles showed that the morphology of 
the catalyst does not alter during recycling. 
Table 15: Recycling data of SSTA for the model reaction showing concentrations of 
residual H+ on the used support after successive experiments. 
Catalyst recycles Time (min) Yield (%) Conc. of residual H+ 
1 15 94 0.40 meq/gram 
2 15 94 0.40 meq/gram 
3 15 94 0.35 meq/gram 
4 15 92 0.35 meq/gram 
5 15 91 0.30 meq/gram 
6 15 89 0.25 meq/gram 
 
3.5. CONCLUSION 
In conclusion, sulphated silica tungstic acid (SSTA) proved to be an efficient catalyst 
for eco-friendly synthesis of various tetrahydropyrimidines and dihydropyrimidines 
by one pot reaction of aldehydes, urea and active methylene compounds. The catalyst 
is easy to prepare, highly efficient, and easily recoverable by simple filtration. The 
catalyst could be reused for six cycles without any significant loss of activity. 
3.6. EXPERIMENTAL 
3.6.1. Preparation of silica chloride 
SOCl2 (20 g) was added drop wise to the silica gel (20 g) in dry CH2Cl2 (50 mL) at 
room temperature under stirring. Evolution of copious amounts of HCl and SO2 
occurred instantaneously. After stirring for another 1h, the solvent was removed under 
reduced pressure. The silica chloride thus obtained was used in the following 
experiments.45 
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3.6.2. Preparation of silica tungstic acid 
A mixture of silica chloride (6.00 g) and sodium tungstate (7.03 g) in dry n-hexane 
(10 mL) was stirred under refluxing conditions for 6 h. After completion of the 
reaction, the reaction mixture was filtered, washed with distilled water, dried and then 
stirred in the presence of 0.1 N HCl (40 mL) for an hour. Finally, the mixture was 
filtered, washed thoroughly with distilled water, and dried to afford STA.46 
3.6.3. Preparation of sulphated silica tungstic acid (SSTA) 
A 0.5 L suction flask was equipped with a constant pressure dropping funnel. The gas 
outlet was connected to a vacuum system through an adsorbing solution of alkali trap. 
STA (2.5 g) was added into the flask and stirred for 10 min in dry CH2Cl2 (0.075 L). 
Chlorosulfonic acid (1.75 g) was added drop wise over a period of 30 min at room 
temperature. After completion of the addition, the mixture was stirred for 90 min, 
while the residual HCl was eliminated by suction. Then the SSTA was separated from 
the reaction mixture and washed several times with dried CH2Cl2. Finally SSTA was 
dried at 120 °C for three hours. 
3.6.4. General procedure for synthesis of tetrahydropyrimidines 
Aldehyde (3 mmol), ethyl cyanoacetate or phenyl acetic acid (3 mmol), urea (4.5 
mmol) and SSTA (200 mg) were mixed by stirring in a 25 mL round bottom flask for 
specified time (Table 13) at a temperature of 70 °C. The reaction mixture was cooled 
and ethanol was added to solubilize the product. The remaining solid catalyst was 
filtered, washed with ethanol (3x15 mL) and ethyl acetate (2x10 mL) and reused for 
further catalytic cycles. The filtrate was evaporated under reduced pressure to obtain 
the product. The crude product was further purified by recrystallization from suitable 
solvent (Ethanol or DMSO). 
3.6.5. General procedure for synthesis of dihydropyrimidines 
Aldehyde (3 mmol), ethyl acetoacetate or acetyl acetone (3.5 mmol), urea (4.5 mmol) 
and SSTA (200 mg) were mixed in a 25 mL round bottom flask for specified time 
(Table 13) at a temperature of 70 °C. The reaction mixture was cooled and added 
ethanol to solubilize the product. Catalyst was recovered by above mentioned 
procedure. The filtrate was evaporated under reduced pressure to obtain the product. 
The compounds were recrystallized from ethanol. 
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3.6.6. Spectral data of Synthesized compounds 
O
N
H
NHNC
O
O
O
8a
1
2
34
5
6
1'
2'
3'
4'
5'
6'
7'
8'
9'
10'
 
6-(4-oxo-4H-[1]benzopyran-3-yl)-2,4-dioxo-1,2,3,4-
tetrahydropyrimidine-5-carbonitrile. 
White solid, M.p. 210-215 °C. Anal. Calcd (C14H7N3O4): C, 
59.79; H, 2.51; N, 14.94. Anal. Found (C14H7N3O4): C, 59.75; 
H, 2.54; N, 14.95. IR (KBr, cm-1):1647 (C=O), 1732 
(2xC=O), 2218 (CN), 3262 (NH), 3442 (NH). 1H NMR (400 
MHz, DMSO-d6): δ 10.86 (s, 1H, NH), 8.18 (s, 1H, NH), 6.67 
(s, 1H, H-2’), 7.1-7.9 (m, 4H, Ar-H). 13C NMR (100 MHz, 
DMSO-d6): δ 179.14, 169.24, 167.52, 161.32, 156.86, 150.29, 
135.27, 133.21, 127.44, 124.18, 121.51, 113.94, 109.11, 
91.21. ESI-MS m/z 282.1 (M+ +1). 
O
N
H
NH
NC
O
O
O
H3C
8b
1
2
34
5
6
1'
2'
3'4
'5'6'
7'
8'
H
9'
10'
 
6-(6-methyl-4-oxo-4H-[1]benzopyran-3-yl)-2,4-dioxo-1,2,3,4-
tetrahydropyrimidine-5-carbonitrile. 
White solid, M.p. 225-230 °C. Anal. Calcd (C15H9N3O4): C, 
61.02; H, 3.07; N, 14.23. Anal. Found (C15H9N3O4): C, 61.05; 
H, 3.03; N, 14.26. IR (KBr, cm-1):1654 (C=O), 1730 
(2xC=O), 2224(CN), 3281 (NH), 3444 (NH).1H NMR (400 
MHz, DMSO-d6): δ 11.21 (s, 1H, NH), 8.74 (s, 1H, NH), 7.37 
(s, 1H, H-2’), 7.4-7.8 (m, 3H, Ar-H), 3.36 (s, 3H, CH3). 13C 
NMR (100 MHz, DMSO-d6): δ 180.22, 172.94, 168.21, 
162.44, 158.07, 152.11, 138.78, 133.36, 127.12, 123.34, 
120.11, 115.81, 107.31, 86.14, 27.02. ESI-MS m/z 296.1 (M+ 
+1). 
O
N
H
NH
NC
O
O
O
Cl
8c
1
2
34
5
6
1'
2'
3'4
'5'6'
7'
8'
 
6-(6-chloro-4-oxo-4H-[1]benzopyran-3-yl)-2,4-dioxo-
tetrahydropyrimidine-5-carbonitrile. 
White solid, M.p. 220-225 °C. Anal. Calcd (C14H6ClN3O4): 
C, 53.27; H, 1.92; N, 13.31. Anal. Found (C14H6ClN3O4): C, 
53.25; H, 1.95; N, 13.27. IR (KBr, cm-1):1694 (C=O), 1738 
(2xC=O), 2233 (CN), 3297(NH), 3396 (NH). 1H NMR (400 
MHz, DMSO-d6): δ 10.86 (s, 1H, NH), 8.25 (s, 1H, NH), 
7.01(s, 1H, H-2’), 7.2-7.8 (m, 3H, Ar-H). 13C NMR (100 
MHz, DMSO-d6): δ 181.02, 171.23, 168.47, 163.72, 154.24, 
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149.89, 136.76, 135.21, 132.70, 130.49, 124.09, 119.76, 
113.28, 88.76. ESI-MS m/z 316.2 (M+ +1). 
N
H
N
H
NHNC
O
O
8d  
6-(indol-3-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-
carbonitrile. 
Orange solid, M.p. 203-208 °C. Anal. Calcd (C13H8N4O2): C, 
61.90; H, 3.20; N, 22.21. Anal. Found (C13H8N4O2): C, 61.86; 
H, 3.25; N, 22.23. IR (KBr, cm-1): 1736 (2xC=O), 2218 (CN),  
3166 (NH), 3241 (NH), 3389 (NH). 1H NMR (400 MHz, 
DMSO-d6): δ 11.06 (s, 1H, NH), 9.82 (s, 1H, NH-Indole), 8.31 
(s, 1H, NH), 8.23 (s, 1H), 7.2-8.0 (m, 4H, Ar-H). 13C NMR 
(100 MHz, DMSO-d6): δ 174.56, 168.24, 154.51, 141.09, 
131.24, 129.82, 127.29, 126.87, 124.17, 121.75, 119.05, 
115.12, 92.43. ESI-MS m/z 253.2 (M+ +1). 
O
HN NH
O
O
O
8e
1 2 3
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1'
2'
3'4'
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6-(4-oxo-4H-[1]benzopyran-3-yl)-5-phenyl-1,2,3,4-
tetrahydropyrimidine-2,4-dione. 
White solid, M.p. 240-245 °C. Anal. Calcd (C19H12N2O4): C, 
68.67; H, 3.64; N, 8.43. Anal. Found (C19H12N2O4): C, 68.62; 
H, 3.67; N, 8.41. IR (KBr, cm-1):1664 (C=O), 1743 (2xC=O), 
3257(NH), 3389 (NH). 1H NMR (400 MHz, DMSO-d6): δ 
10.13 (s, 1H, NH), 8.94 (s, 1H, NH), 6.63 (s, 1H, H-2’), 7.4-
7.8 (m, 9H, Ar-H). 13C NMR (100 MHz, DMSO-d6): δ 
182.72, 172.53, 165.24, 161.56, 157.54, 149.11, 134.62, 
132.35, 129.21, 128.79, 127.54, 125.57, 122.72, 121.90, 
119.81, 112.46, 102.63. ESI-MS m/z 333.1(M+ +1). 
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HN NH
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O
O
H3C
8f
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6-(6-methyl-4-oxo-4H-[1]benzopyran-3-yl)-5-phenyl-1,2,3,4-
tetrahydropyrimidine-2,4-dione.  
White solid, M.p. 260-265 °C. Anal. Calcd (C20H14N2O4): C, 
69.36; H, 4.07; N, 8.09. Anal. Found (C20H14N2O4): C, 69.32; 
H, 4.02; N, 8.11. IR (KBr, cm-1):1652 (C=O), 1735 (2xC=O), 
3270(NH), 3447 (NH). 1H NMR (400 MHz, DMSO-d6): δ 
10.73 (s, 1H, NH), 8.52 (s, 1H, NH), 6.44 (s, 1H, H-2’), 7.1-
8.2 (m, 8H, Ar-H), 3.35 (s, 3H, CH3). 13C NMR (100 MHz, 
DMSO-d6): δ 181.54, 170.21, 166.18, 159.38, 157.72, 151.02, 
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134.52, 133.11, 128.92, 127.09, 126.76, 124.61, 123.17, 
121.34, 118.87, 111.76, 102.77, 28.55. ESI-MS m/z 347.1 
(M+ +1). 
O
HN NH
O
O
O
Cl
8g
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'
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6-(6-chloro-4-oxo-4H-[1]benzopyran-3-yl)-5-phenyl-1,2,3,4-
tetrahydropyrimidine-2,4-dione. 
White solid, M.p. 265-270 °C. Anal. Calcd (C19H11ClN2O4): 
C, 62.22; H, 3.02; N, 7.64. Anal. Found (C19H11ClN2O4): C, 
62.18; H, 3.05; N, 7.59. IR (KBr, cm-1):1695 (C=O), 1739 
(2xC=O), 3292(NH), 3400(NH). 1H NMR (400 MHz, DMSO-
d6): δ 10.63 (s, 1H, NH), 8.24 (s, 1H, NH), 6.69 (s, 1H, H-2’), 
7.0-7.7 (m, 8H, Ar-H). 13C NMR (100 MHz, DMSO-d6): δ 
180.22, 169.83, 164.76, 156.92, 154.24, 149.82, 135.19, 
132.79, 131.27, 130.97, 129.51, 127.16, 126.48, 124.06, 
122.84, 120.41, 104.73. ESI-MS m/z 367.2 (M+ +1). 
N
N
H
NH
O
O
Cl
8h  
6-(2-chloro-4quinolinyl)-5-phenyl-1,2,3,4-
tetrahydropyrimidine-2,4-dione. 
Yellow solid, M.p. 262-267 °C. Anal. Calcd. 
(C19H12ClN3O2): C, 65.24; H, 3.46; N, 12.01. Anal. Found 
(C19H12ClN3O2): C, 65.19; H, 3.42; N, 12.04. IR (KBr, cm-1): 
1738 (2xC=O), 3281(NH), 3393 (NH). 1H NMR (400 MHz, 
DMSO-d6): δ 11.24 (s, 1H, NH), 8.32 (s, 1H, NH), 8.01(s, 
1H), 7.1-7.9 (m, 9H, Ar-H). 13C NMR (100 MHz, DMSO-d6): 
δ 176.81, 162.25, 155.88, 151.17, 148.62, 142.51, 138.36, 
134.44, 133.92, 131.02, 129.87, 128.19, 127.23, 126.38, 
124.79, 124.05, 108.62. ESI-MS m/z 350.1 (M+ +1). 
O
N
H
NH
O
O
O
Cl
8i  
6-(4-chloro-2-oxo-2H-[1]benzopyran-3-yl)-5-phenyl-1,2,3,4-
tetrahydropyrimidine-2,4-dione. 
Yellow solid, M.p. 220-225 °C.  Anal. Calcd. 
(C19H11ClN2O4): C, 62.22; H, 3.02; N, 7.64. Anal. Found 
(C19H11ClN2O4): C, 62.26; H, 3.19; N, 7.67. IR (KBr, cm-
1):1635 (C=O), 1727 (2xC=O), 3219(NH), 3378 (NH). 1H 
NMR (400 MHz, DMSO-d6): δ 11.21 (s, 1H, NH), 8.77 (s, 
1H, NH), 7.31-8.09 (m, 9H, Ar-H). 13C NMR (100 MHz, 
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DMSO-d6): δ 174.67, 167.24, 158.34, 156.22, 149.07, 141.18, 
139.63, 135.80, 132.23, 131.40, 129.57, 127.81, 126.09, 
124.28, 123.77, 120.11, 109.29. ESI-MS m/z 367.1 (M+ +1). 
N
H
N
H
NH
O
O
8j  
6-(indol-3-yl)-5-phenyl-1,2,3,4-tetrahydropyrimidine-2,4-
dione. 
Orange solid, M.p. 230-235 °C. Anal. Calcd. (C18H13N3O2): 
C, 71.28; H, 4.32; N, 13.85. Anal. Found (C18H13N3O2): C, 
71.32; H, 4.28; N, 13.81. IR (KBr, cm-1): 1733 (2xC=O), 
3157(NH), 3284 (NH), 3421(NH). 1H NMR (400 MHz, 
DMSO-d6): δ 10.54 (s, 1H, NH), 9.24 (s, 1H, NH-indole), 8.18 
(s, 1H, NH), 7.82 (s, 1H), 6.84-7.23 (m, 9H, Ar-H). 13C NMR 
(100 MHz, DMSO-d6): δ 175.24, 162.39, 151.08, 144.76, 
141.87, 136.48, 132.77, 130.93, 129.16, 127.51, 126.92, 
123.41, 122.83, 118.79, 112.27, 109.33. ESI-MS m/z 
304.1(M+ +1). 
N
H
NH
O
O
8k  
6-(Phenyl methyl)-5-phenyl-1,2,3,4-tetrahydropyrimidine-2,4-
dione. 
White solid, M.p. 210-215 °C. Anal. Calcd. (C17H14N2O2): C, 
73.37; H, 5.07; N, 10.07. Anal. Found (C17H14N2O2): C, 
73.39; H, 5.04; N, 10.11. IR (KBr, cm-1): 1723 (2xC=O), 3285 
(NH), 3401 (NH). 1H NMR (400 MHz, DMSO-d6): δ 10.92 (s, 
1H, NH), 8.87 (s, 1H, NH), 7.14-7.53 (m, 10H, Ar-H), 4.35 (s, 
2H, CH2). 13C NMR (100 MHz, DMSO-d6): δ 171.24, 158.39, 
148.08, 140.76, 137.48, 132.47, 129.96, 129.23, 128.11, 
127.03, 124.88, 105.51, 38.82. ESI-MS m/z 279.1 (M+ +1). 
N
H
NH
O
O
H3C
8l  
6-(Ethyl)-5-phenyl-1,2,3,4-tetrahydropyrimidine-2,4-dione. 
White solid, M.p. 160-165 °C. Anal. Calcd. (C12H12N2O2): C, 
66.65; H, 5.59; N, 12.96. Anal. Found (C12H12N2O2): C, 
66.61; H, 5.63; N, 12.93. IR (KBr, cm-1): 1731 (2xC=O), 3291 
(NH), 3414 (NH). 1H NMR (400 MHz, DMSO-d6): δ 10.32 (s, 
1H, NH), 8.27 (s, 1H, NH), 7.01-7.33 (m, 5H, Ar-H), 2.95 (q, 
2H, CH2), 1.34 (t, 3H, CH3). 13C NMR (100 MHz, DMSO-d6): 
δ 168.41, 156.13, 149.87, 135.22, 129.07, 128.51, 127.92, 
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101.25, 27.02, 18.71. ESI-MS m/z 217.1 (M+ +1). 
O
H3C
O NH
N
H O
CH3
OEt
O
8m
1
234
5
6
1'
2'
3'4
'5'
6'
7'
8'
 
5-Ethoxycarbonyl-6-methyl-4-(6-methyl-4-oxo-4H-
[1]benzopyran-3-yl)-3,4 dihydropyrimidin-2 (1H)-one. 
White solid, M.p. 297-300 °C. Anal. calcd. (C18H18N2O5): C, 
63.15; H, 5.29; N, 8.18, Anal. Found. (C18H18N2O5): C, 
63.21; H, 5.37; N, 8.14. IR (KBr, cm-1):1646 (C=O), 1706 
(C=O), 3122 (NH), 3242 (NH). 1H NMR (400 MHz, DMSO-
d6): δ 1.09 (t, J = 7.2 Hz, 3H, CH3), 2.25 (s, 3H, CH3), 2.42 (s, 
3H, CH3), 3.98 (q, J = 6.9 Hz,  2H, OCH2), 5.24 (s, 1H, H-4), 
7.62-7.22 (m, 3H, Ar-H), 7.85 (br s, 1H, NH), 8.11 (s, 1H, H-
2’), 9.22 (s, 1H, NH). 13C NMR (100 MHz, DMSO-d6): δ 
176.22, 166.18, 152.83, 149.76, 147.61, 143.32, 134.89, 
131.25, 128.72, 126.11, 125.66, 114.84, 101.28, 72.14, 51.48, 
28.62, 21.22, 18.17. ESI-MS m/z 343.1 (M+ +1). 
8n
NH
N
H
O
CH3CH3
O
N
H
 
5-Acetyl-6-methyl-4-(indol-3-yl)-3,4-dihydropyrimidin-2(1H)-
one. 
Orange solid, M.p. 208-210 °C. Anal. calcd. (C15H15N3O2): 
C, 66.87; H, 5.61; N, 15.61. Anal. Found. (C15H15N3O2): C, 
66.83; H, 5.57; N, 15.57. IR (KBr, cm-1):1668 (C=O), 3167 
(NH). 1H NMR (400 MHz, DMSO-d6): δ 2.38 (s, 3H, CH3), 
2.49 (s, 3H, COCH3), 5.29 (s, 1H, H-4), 7.13 (s, 1H), 8.01-
7.30 (m, 4H, Ar-H), 8.15 (br s, 1H, NH), 8.53 (s, 1H, NH), 
12.5 (s, 1H, NH).13C NMR (100 MHz, DMSO-d6): δ 181.76, 
156.28, 138.91, 134.25, 128.42, 125.36, 120.11, 118.46, 
116.08, 110.19, 102.56, 101.21, 58.89, 32.57, 21.06. ESI-MS 
m/z 270.1 (M+ +1). 
N
H
NH
OH3C
C2H5O
O
8o  
5-Ethoxycarbonyl-6-methyl-4-phenyl-3,4-dihydropyrimidin-
2(1H)-one.22 
 White solid, M.p. 202-204 oC; Anal. calcd. (C14H16N2O3): C, 
64.60; H, 6.19; N, 10.76. Anal. Found. (C14H16N2O3): C, 
64.47; H, 6.24; N, 10.71. IR (KBr, cm-1): 1650 (C=O), 1729 
(C=O), 3122 (NH), 3245 (NH). 1H NMR (400 MHz, DMSO-
d6): δ 1.11 (t, J = 7.2 Hz, 3H, CH3), 2.24 (s, 3H, CH3), 4.01 (q, 
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J = 7.2 Hz, 2H, OCH2), 5.17 (s, 1H), 7.48-7.22 (m, 5H, Ar-H), 
7.74 (br s, 1H, NH), 9.20 (br s, 1H, NH). ESI-MS m/z 261.1 
(M+ +1).  
N
H
NH
OH3C
H3C
O
8p  
5-Acetyl-6-methyl-4-phenyl-3,4-dihydropyrimidin-2(1H)-one. 
21 
White solid, M.p. 232-235 oC. Anal. calcd. (C13H14N2O2): C, 
67.81; H, 6.12; N, 12.16. Anal. Found. (C13H14N2O2): C, 
67.73; H, 6.22; N, 12.11. IR (KBr, cm-1): 1650 (C=O), 1706 
(C=O), 3267 (NH); 1H NMR: (400 MHz, DMSO-d6) δ 2.10 
(s, 3H, CH3), 2.28 (s, 3H, COCH3), 5.25(s, 1H), 7.35-7.23 (m, 
5H, Ar-H), 7.83 (s, 1H, NH), 9.19 (s, 1H, NH). ESI-MS m/z 
231.1 (M+ +1) 
N
H
NH
OH3C
C2H5O
O
NO2
8q  
5-Ethoxycarbonyl-6-methyl-4-(3-nitrophenyl)-3,4-
dihydropyrimidin-2(1H)-one. 22 
White solid, M.p. 227-229 °C. Anal. calcd. (C14H15N3O5: C, 
55.08; H, 4.94; N, 13.76. Anal. Found. (C14H15N3O5): C, 
55.16; H, 4.97; N, 13.70. IR (KBr, cm-1): 1627 (C=O), 1706 
(C=O), 3100 (NH), 3223 (NH); 1H NMR (400 MHz, DMSO-
d6) δ 1.11 (t, J = 7.2 Hz, 3H, CH3), 2.26 (s, 3H, CH3), 4.01 (q, 
J = 6.9 Hz, 2H, OCH2), 5.30 (s, 1H), 8.14-7.62 (m, 4H, Ar-H),  
7.90 (br s, 1H, NH), 9.37 (s, 1H, NH). ESI-MS m/z 306.1 (M+ 
+1). 
N
H
NH
OH3C
H3C
O
NO2
8r  
5-Acetyl-6-methyl-4-(3-nitrophenyl)-3,4-dihydropyrimidin-
2(1H)-one. 21 
White solid, M.p. 220-225 °C. Anal. calcd. (C13H13N3O4): C, 
56.72; H, 4.76; N, 15.26. Anal. Found (C13H13N3O4):  C, 
56.63; H, 4.85; N, 15.16.; IR (KBr, cm-1): 1683 (C=O), 3275 
(NH); 1H NMR: (400 MHz, DMSO-d6) δ 2.05 (s, 3H, CH3), 
2.33 (s, 3H, COCH3), 5.67 (s, 1H), 7.45-7.27 (m, 4H, Ar-H), 
7.72 (s, 1H, NH), 9.26 (s, 1H, NH). ESI-MS m/z 276.1 (M+ 
+1). 
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N
H
NH
OH3C
C2H5O
O
OH
8s  
5-Ethoxycarbonyl-6-methyl-4-(4-hydroxyphenyl)-3,4-
dihydropyrimidin-2(1H)-one. 22 
White solid, M.p. 227-229 °C. Anal. calcd. (C14H16N2O4): C, 
60.86; H, 5.83; N, 10.13; Anal. Found (C14H16N2O4): C, 
60.72; H, 5.89; N, 10.16. IR (KBr, cm-1): 1646 (C=O), 1690 
(C=O), 3122 (NH), 3246 (NH), 3515 (OH); 1H NMR (400 
MHz, DMSO-d6): δ 1.12 (t, J = 7.2 Hz, 3H, CH3), 2.23 (s, 3H, 
CH3), 4.01 (q, J = 7.2 Hz, 2H, OCH2), 5.04 (s, 1H), 6.69 (d, 
2H, J = 8.4 Hz, Ar-H),  7.04 (d, 2H, J = 8.4 Hz, Ar-H), 7.60 
(br s, 1H, NH), 9.09 (br s, 1H, NH), 9.31 (s, 1H, OH). ESI-
MS m/z 277.1 (M+ +1). 
N
H
NH
OH3C
H3C
O
OH
8t  
5-Acetyl-6-methyl-4-(4-hydroxyphenyl)-3,4-dihydropyrimidin-
2(1H)-one. 21 
White solid, M.p. 231-234 °C. Anal. calcd. (C13H14N2O3): C, 
63.40; H, 5.73; N, 11.37. Anal. Found (C13H14N2O3): C, 
63.48; H, 5.82; N, 11.33. IR (KBr, cm-1 ): 1647 (C=O), 1687 
(C=O), 3120 (NH), 3283 (NH), 3516 (OH). 1H NMR (400 
MHz, DMSO-d6): δ 2.10 (s, 3H, CH3), 2.22 (s, 3H, CO-CH3), 
5.04 (s, 1H), 6.69 (d, 2H, J = 8.4 Hz, Ar-H), 7.04 (d, 2H, J = 
8.4 Hz, Ar-H), 7.60 (s, 1H, NH), 9.09 (s, 1H, NH), 9.31 (s, 
1H, OH). ESI-MS m/z 247.08 (M+ +1). 
N
H
NH
OH3C
C2H5O
O Cl
8u  
5-Ethoxycarbonyl-6-methyl-4-(2-chlorophenyl)-3,4-
dihydropyrimidin-2(1H)-one. 22 
White solid, M.p. 214-216 oC.; Anal. calcd. (C14H15N2O3Cl): 
C, 57.05; H, 5.12; N, 9.50. Anal. Found (C14H15N2O3Cl): C, 
57.12; H, 5.29; N 9.46. IR (KBr, cm-1): 1650 (C=O), 1700 
(C=O), 3115 (NH), 3230 (NH);  1H NMR (400 MHz, DMSO-
d6): δ 1.01 (t, J = 6.9 Hz, 3H, CH3), 2.30 (s, J = 6.9 Hz, 3H, 
CH3), 3.92 (q, 2H, OCH2), 5.63 (s, 1H), 7.25-7.41 (m, 4H, Ar-
H), 7.68 (br s, 1H, NH), 9.25 (br s, 1H, NH); ESI-MS m/z 
295.11(M+ +1). 
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N
H
NH
OH3C
H3C
O Cl
8v  
5-Acetyl-6-methyl-4-(2-chlorophenyl)-3,4-dihydropyrimidin-
2(1H)-one. 21 
White solid, M.p. 303-305 °C. Anal. calcd. (C13H13N2O2Cl): 
C, 58.98; H, 4.95; N, 10.58. Anal. Found (C13H13N2O2Cl): C, 
58.92; H, 4.97; N, 10.63. IR (KBr, cm-1):1625 (C=O), 1708 
(C=O), 3092 (NH), 3246 (NH). 1H NMR: (400 MHz, DMSO-
d6) δ 2.05 (s, 3H, CH3), 2.33 (s, 3H, COCH3), 5.67 (s, 1H), 
7.45-7.27 (m, 4H, Ar-H), 7.72 (s, 1H, NH), 9.26 (s, 1H, NH). 
ESI-MS m/z 265.09 (M++1). 
N
H
NH
OH3C
C2H5O
O
Cl
8w  
5-Ethoxycarbonyl-6-methyl-4-(4-chlorophenyl)-3,4-
dihydropyrimidin-2(1H)-one. 22 
White solid, M.p. 213-215 °C. Anal. calcd. (C14H15N2O3Cl): 
C, 57.05; H, 5.13; N, 9.50, Anal. Found (C14H15N2O3Cl): C, 
57.04; H, 5.02; N, 9.56. IR (KBr, cm-1): 1651 (C=O), 1718 
(C=O), 3120 (NH), 3243 (NH). 1H NMR (400 MHz, DMSO-
d6): δ 1.10 (t, J = 7.2 Hz, 3H, CH3), 2.24 (s, 3H, CH3), 4.01 (q, 
J = 6.9 Hz, 2H, OCH2), 5.14 (s, 1H), 7.25-7.23 (d, 2H, J = 8.4 
Hz), 7.40-7.37 (d, 2H, J = 8.1 Hz),  7.78 (br s, 1H, NH), 9.26 
(s, 1H, NH). ESI-MS m/z 295.10 (M+ +1). 
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Chitosan as a support for dispersion of 
catalytically active lanthanides 
= Ce(III), Dy(III) 
CHAPTER 4 
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4.1. INTRODUCTION 
During the last decades the use of lanthanides as efficient Lewis acids have found 
widespread use in the development of green chemistry.1 According to Pearson’s 
HSAB classification, trivalent lanthanides are considered to be hard acids and 
therefore have strong affinity toward hard bases such as oxygen donor ligands.2 This 
strong oxophilicity is one of the most important characteristic features of 
lanthanide(III) compounds making them suitable as Lewis acid catalysts.2 These 
elements display unique physical and chemical properties which differ from those of 
main group and transition elements. Low toxicity, availability at a moderate price, 
stability and activity in protic media make these elements attractive for use in organic 
synthesis.3 The trivalent lanthanides (most common oxidation state) have found 
widespread use in carbon-carbon bond forming reactions and functional group 
transformation. Some lanthanides also display stable divalent states, and are therefore 
used for the reduction of organic functional groups and reductive coupling reactions.4 
Chitosan, i.e. N-deacetylated chitin (poly(1–4)N-acetyl-β-D-glucosamine), is 
commercially the most important biocompatible polymer from an environmental or 
biomedical point of view. It is a biodegradable polysaccharide obtained by 
deacetylation of chitin (Figure 31), which is the second most abundant natural 
polymer in the world after cellulose and the process of deacetylation is carried out to 
different degrees depending upon the targeted applications.5 The physiological 
properties of chitosan, especially solubility, are determined by its molecular weight 
and degree of deacetylation. Chitosan is readily soluble in acidic solutions and 
insoluble in the majority of common solvents, and the acid solutions can be casted 
into films and fibres, or they can be precipitated into well-defined spherical particles 
by spraying into alkaline solution.6 The property of non-solubility in common organic 
solvents has generated a lot of interest for its use as support in heterogeneous 
catalysis.  The interesting chemo-physical and biological properties of chitosan like, 
hydrophilic character, biodegradability, non-toxicity and biocompatibility provide a 
wide spectrum of opportunities for the development of functional nano-, bio-, and 
hybrid materials.7 The primary functional groups present in the chitosan polymer are 
hydroxyl, amino, and acetamido groups. It also has a property of strongly adsorbing 
and chelating a range of metal ions due to the presence of these functional groups and 
is prone to chemical modification. The high density of amino and hydroxyl groups of 
chitosan enables an effective functionalization and avoids the aggregation of metallic 
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nanoparticles.8 As a result, many resulting applications of chitosan include waste 
water treatment, pharmaceutical and cosmetic preparations, heavy metal 
complexation, and heterogeneous catalysis.9 
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Fig. 31. Structures of chitin and chitosan  
SECTION A 
SUSTAINABLE SYNTHESIS OF SPIROPIPERIDINE DERIVATIVES USING 
CERIUM(III) IMMOBILISED CHITOSAN AS AN EFFICIENT AND 
RECYCLABLE HETEROGENEOUS CATALYST* 
Functionalised piperidines form the core of a large family of natural products 
particularly alkaloids and in various biologically active compounds.10 The presence of 
these motifs in drug molecules has led to huge amount of efforts being directed 
towards developing ever more efficient methodologies for their syntheses. Spiro-
substituted piperidines, due to their important pharmacological profiles like selective 
and potent σ receptor ligands which can be used in the treatment of cocaine abuse, 
depressions, epileptic disorders and 5-HT2B receptor antagonists, have received 
considerable attention during the last few decades.11-16 This privileged unit also forms 
the core of a large family of alkaloids and natural products with strong biological 
profiles and interesting structural properties.17 Therefore, because of the 
pharmacological and medicinal importance of these compounds, it is highly desirable 
to develop an efficient protocol for the synthesis of spiropiperidine derivatives which 
is highly efficient, environmental friendly, tolerates wide range of substrates and 
involves the reuse of the catalyst. 
4.2. REVIEW OF LITERATURE 
Some recent examples of the synthesis of 3,5-dispirosubstituted piperidine 
derivatives. 
 
                                                             
* Nayeem Ahmed and Zeba N. Siddiqui, ACS Sustainable Chemistry & Engineering, 3 (2015) 1701. 
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4.2.1. Three-component synthesis of 3,5-dispirosubstituted piperidines in 
ethanol.18 
N. G. Kozlov et al. reported the synthesis of 3,5-dispirosubstituted piperidines via 
three-component condensation of anilines, dimedone and formaldehyde. The 
highlights of the reaction are mild conditions, operationally simplicity and high 
yields. 
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4.2.2. Silica tungstic acid catalysed synthesis of 3,5-dispirosubstituted 
piperidines.19 
A.B. Atar et al. reported the synthesis of 3,5-dispirosubstituted piperidines via a three 
component, one-pot reaction of aromatic amines, formaldehyde and dimedone using 
silica supported tungstic acid as heterogeneous catalyst. Recyclable catalyst, short 
reaction time and good yields are the merits of the reported protocol. 
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4.2.3. Superparamagnetic iron oxide catalysed synthesis of spiro-piperidines.20 
F. Janati et al. reported the synthesis of spiropiperidines catalysed by 
superparamagnetic iron oxide nanoparticles. The catalyst was easily recovered by the 
use of an external magnet, reused several times and showed good efficiency. 
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4.2.4. FeCl3 catalysed synthesis of 3,5-dispirosubstituted piperidines.21 
C. Mukhopadhyay et al. reported the synthesis of 3,5-dispirosubstituted piperidines 
via multicomponent reaction of 1,3-dicarbonyl compound, amines and formaldehyde 
catalysed by FeCl3 in dichloromethane at room temperature.  
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4.3. PRESENT WORK 
Nanoparticles have a characteristic high surface-to-volume ratio, and as a result large 
fraction of surface atoms are exposed to reactant molecules, making them promising 
catalysts in chemical synthesis.22 However, the direct application of the ultra-fine 
nanoparticles in catalysis is often difficult as their small size increases the tendency 
towards agglomeration because of van der Waals forces. Thus, for the development of 
efficient and recyclable catalytic systems, it is very important to employ suitable 
support materials which will enable fine dispersion and prevent agglomeration of 
these nanoparticles. Among lanthanides, cerium salts have been extensively used as 
catalysts in synthetic organic chemistry.23 The extensive use of Ce salts in reduction, 
C–C, C–N and C–O bond formation reactions is ascribed to their properties like 
moderate to low toxicity, water tolerance, easy handling, availability at moderate cost 
and suitability for use without purification.24 Nonetheless, from economic and 
environmental view point their use in stoichiometric amounts is the main limitation. 
Therefore, the development of heterogenised version of Ce salts by immobilisation on 
a solid support is a very good means to overcome this limitation. In the present work, 
taking advantage of the above mentioned interesting properties of chitosan, 
cerium(III) has been supported on chitosan and used for the highly efficient and 
sustainable synthesis of spiropiperidine derivatives via multicomponent reaction of 
substituted anilines, formaldehyde and different active methylene compounds at room 
temperature. 
4.4. RESULTS AND DISCUSSION 
The synthesis of the catalyst from chitosan is illustrated in scheme 9. The chitosan 
was suspended in water maintained at pH 9 by using ammonia solution. CeCl3.7H2O 
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was added, and the mixture was stirred overnight at room temperature to obtain the 
catalyst. 
 
Scheme 9: Schematic representation of the synthesis of the catalyst. 
4.4.1. Characterization of the catalyst 
4.4.1a. FT-IR spectral analysis 
FT-IR spectra of pure chitosan and Ce(III) immobilised chitosan are shown in figure 
32. In the spectra of chitosan (Figure 32a) a broad band centred at 3419 cm−1 is 
assigned for stretching of OH and NH groups. The presence of the NH2 groups is 
confirmed by bending vibrations at 1588 cm−1. The stretching vibrations of C—O and 
C—N groups were obtained at 1076 and 1379 cm−1, respectively. The band obtained 
at 2920 cm−1 is ascribed to the C—H stretching of methylene groups.25 In the FT-IR 
spectra of Ce(III) immobilised chitosan (Figure 32b) the bands obtained in the low-
frequency region (600–500 cm-1) indicated the formation of Ce–N and Ce–O 
coordinate bonds .26,27  Moreover, decrease in the intensity of –NH band at 1596 cm−1, 
is indicative of the complexation of cerium with –NH2 groups. Similarly, shifting of 
the OH-bending band at 1071 cm-1 is accounted for the interaction of cerium species 
with the OH groups of chitosan.28  
 
Fig. 32. FT-IR spectral analysis (a) of chitosan, (b) of Ce immobilised chitosan. 
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4.4.1b. XRD and EDX analyses 
The XRD patterns of the catalyst (Figure 33a) were similar to that of support (Figure 
33b). The absence of peaks pertaining to cerium in the XRD of the catalyst may be 
due to complexation of cerium with chitosan through coordinate bonds coupled with 
its low content and small size. However, the presence of Ce in the catalyst was 
confirmed by EDX analysis (Figure 33c) which showed peaks for Ce in addition to 
C, N and O elements. Moreover, the EDX spectrum does not show presence of Cl, 
therefore, the active species, immobilised on the support, is Ce(III) in the form of 
Ce(OH)3. 
 
Fig. 33. XRD analysis (a) of Ce immobilised chitosan (b) of chitosan and (c) 
EDX spectra of Ce immobilised chitosan. 
4.4.1c. ICP-AES analysis 
ICP-AES analysis was performed in order to obtain the actual amount of Ce in the 
catalyst. The analysis showed the weight percentage of Cerium to be 7.94%, which 
corresponded to the loading amount of 0.57 mmol/gram of catalyst.  
4.4.1d. TEM analysis 
TEM images (Figure 34a & b) of the catalyst showed a very well dispersion of Ce 
nanoparticles (dark spots) in the form of Ce(OH)3, with a particle diameter of 3-8 nm, 
on the surface of chitosan. 
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Fig. 34. TEM images (a) and (b) of the synthesised catalyst at different 
magnifications. 
4.4.2. Optimization of reaction conditions 
Various control experiments using indane-1,3-dione (4j) (2 mmol), formaldehyde (3 
mmol) and aniline (9a) (1 mmol) as model substrates were carried out at room 
temperature in PEG-200 in order to make sure that Ce sites bound to chitosan are 
responsible for the catalytic activity. Reaction in the absence of any catalyst could not 
lead to any product formation, whereas using chitosan (10 mol%) as a catalyst gave 
unsatisfactory results. When the reaction was tried using CeCl3.7H2O (10 mol%) as a 
catalyst, the reaction proceeded with good results (product yield of 74% in 2.5h), 
which clearly demonstrated that the catalytic activity originated from Ce sites.  The 
CeCl3.7H2O could not be recovered or recycled because of its homogeneous nature, 
therefore, we performed the reaction using Ce(III) immobilised on chitosan (200 mg, 
0.114 mmol of Ce) as a catalyst and a remarkable increase in its catalytic activity was 
observed affording the product with high yield (92%) in shorter time period. We then 
focused our attention towards finding the right solvent and catalyst amount for this 
reaction. The optimization of reaction conditions involved indane-1,3-dione (2 mmol), 
formaldehyde (3 mmol) and aniline (1 mmol) as substrates for the model reaction. 
4.4.2a. Effect of different solvents 
The effect of different solvents on the model reaction was examined at room 
temperature. Various solvents like water, methanol, ethanol, isopropanol, PEG-200, 
PEG-400 and PEG-600 were screened to test the efficiency of our catalyst and the 
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results are summarised in table 16. When water was used as a solvent, no 
transformation of the reactants was observed. Using methanol as a solvent 
unsatisfactory result was obtained. Using ethanol and isopropanol as solvents average 
results were obtained.  We then used PEG’s as solvents and the results obtained were 
very much satisfactory (Table 16, entries 5-7). PEG-200 was found to be most 
efficient with excellent product yield in 35 min. The high viscosity of PEG-600 at 
room temperature may be the reason for its poor performance (Table 16, entry 7). 
Therefore, PEG-200 was used as a solvent of choice for this reaction. 
Table 16: Effect of different solvents on the model reaction. 
NH2
HH
O Cerium(III)/chitosan
NO
O O
O
O
O
+ +
RT
(9a) (4j) (10a)  
Entry Solvent Time (min) Yield (%) 
1 Water (5mL) 60  No reaction 
2 Methanol (5mL) 53  68 
3 Ethanol (5mL) 48  78 
4 Isopropanol (5mL) 45  81 
5 PEG-200 (5mL) 35  92 
6 PEG-400 (5mL) 42   85 
7 PEG-600 (5mL) 65  45 
 
4.4.2b. Effect of catalyst loading 
To investigate effect of catalyst loading, the model reaction was carried out in the 
presence of varying amounts of the catalyst (Table 17). It was observed that upon 
increasing the amount of catalyst from 50-200 mg the conversion of spiropiperidine 
derivative increased linearly. No further increase in product formation was observed 
when amount of the catalyst increased to 250 mg. Therefore, 200 mg of the catalyst 
was found to be the optimum amount for the model reaction (entry 4). 
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Table 17: Effect of different catalyst loading on the model reaction. 
NH2
HH
O Ceerriiuumm(IIIIII)//cchhiittoossaann
NO
O O
O
O
O
++ ++ RTPEG--2200,,
(9aa) (44j) (110aa)  
Entry Catalyst loading (mg) Time (min) Yield (%) 
1 50 85 70 
2 100 65 81 
3 150 45 87 
4 200 35 92 
5 250 35 92 
 
4.4.3. Catalytic reaction 
After optimization of reaction conditions, the substrate scope of Ce(III)/chitosan 
catalysed synthesis of spiropiperidine derivatives was examined (Scheme 10). It was 
found that the reaction efficiently tolerated amines with activating and deactivating 
groups. The reactions with alicyclic amine also gave very good results. Moreover, the 
reaction with different cyclic active methylene compounds was also investigated and 
it was found that the reaction efficiently proceeded with indane-1,3-dione as well as 
with 4-hydroxycoumarin and dimedone also, giving products in excellent yields 
(Table 18).  The results demonstrated the scope and generality of this protocol as a 
range of cyclic active methylene substrates and amines can be used for the synthesis 
of spiropiperidine derivatives.  
NH2
HH
O
NO
O O
O
O
O
+ + PEG
-200, R.T.
X
X X
O
O
O O
OH
O
O
H3C
H3C
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R
NH2 NH2
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OMe
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CH3
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4d,
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Scheme 10: General scheme for the formation of spiropiperidine derivatives 
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The structures of the final products were determined from their IR, 1H NMR, 13C 
NMR and ESI-MS spectra. I.R. spectrum of 10a (Figure 35) showed carbonyl 
stretching frequencies of four carbonyl groups at 1704 and 1731 cm-1. The 1H-NMR 
spectrum (Figure 36) showed distinctive singlet at δ 2.77 for two H-4’ hydrogens of 
piperidine ring. Two methylene protons of piperidine were discernible as singlet at δ 
3.94. Thirteen aromatic hydrogen atoms were present as multiplet in the range δ 6.94-
7.96. 13C-NMR (Figure 37) showed a distinctive peak at δ 197.5 ppm for carbonyl 
groups of indane-1,3-dione moieties and all other peaks were obtained at respective 
places and are given in the experimental section. Further, structure 10a was confirmed 
by ESI-Mass spectrum (Figure 38) which showed the molecular ion peak as base 
peak at m/z 422.1 (M++1).  
 
Fig 35. FT-IR spectrum of 10a 
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Fig 36. 1H-NMR spectrum of 10a 
 
 
Fig 37. 13C-NMR spectrum of 10a 
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Fig 38. ESI-Mass spectrum of 10a 
 
In order to further show the efficiency of our protocol, a comparison with available 
reported protocols in the literature was done (Table 19). The data showed the 
superiority of our catalytic system for the synthesis of spiropiperidines in terms of 
efficiency, environment compatibility and practical applicability in comparison to 
reported procedures. 
Table 18: Scope of different active methylene compounds and amines for the 
synthesis of spiropiperidine derivatives. 
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Table 19: Comparison of the efficiency of Ce(III)/chitosan catalyst with reported 
procedures. 
Entry Catalyst Condition Solvent Yield (%) Time Ref. 
1 
Ce(III)/ 
chitosan 
R. T. PEG-200 96 35 min 
Present 
work. 
2 STA R. T. DCM 92 4h 19 
3 FeCl3 R. T. DCM 88 6h 21 
4 Fe3O4 80 °C Solvent-free 89 3h 20 
5 - 
Reflux (5 min)/ 
overnight/R. T. 
Ethanol 84 12h 18 
108 
 
4.4.4. Reaction mechanism 
A plausible mechanism for the synthesis of spiropiperidine derivative (10a) is 
proposed in Scheme 11.18-21 In the first step the catalyst activates both indane-1,3-
dione (4j) and formaldehyde to undergo Knoevenagel condensation to give 
intermediate (N). The intermediate (N) and another activated molecule of indane-1,3-
dione (4j) then undergo Michael addition to generate (O). The intermediate O, 
formaldehyde and aniline 9a react via Mannich reaction to generate (P) which 
undergoes another Mannich reaction with formaldehyde to form final product 10a. 
The catalyst could be regenerated in the last step and reused for further catalytic 
cycles. 
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Scheme 11: Proposed reaction mechanism for the formation of 10a 
4.4.5. Leaching study of Ce(III)/chitosan catalyst 
ICP-AES analysis of the catalyst before and after five catalytic cycles was performed 
in order to carry out the leaching study. The Ce concentration before (7.94 Wt. % Ce) 
and after recycling experiments (7.90 Wt. % Ce) was found to be fairly in agreement 
(within the experimental error) which denoted that Ce is tightly bound to the support 
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and no leaching of the catalyst occurs upon its reuse. The TEM image of the catalyst 
after five cycles (Figure 39) did not show any significant change in the morphology 
of the catalyst, which indicated that the integrity of the catalyst is maintained 
throughout the recycling studies. The above studies thus, confirm that the structure of 
the catalyst is stable and cerium is tightly bound to the support. 
 
Fig. 39. TEM image of the recycled catalyst after five cycles. 
4.4.6. Catalyst Recycling  
The catalyst recycling experiment was done using the model reaction of indane-1,3-
dione, formaldehyde, aniline and 200 mg of the catalyst in PEG-200 at room 
temperature. After completion of the reaction water was added to the reaction mixture 
in order to dissolve PEG-200, a 1:10 mixture of isopropanol and ethyl acetate was 
then added to extract the product. The remaining catalyst in aqueous layer was 
filtered, washed with isopropanol/ethyl acetate (1:10) and reused.  It was found that 
the catalyst maintained good activity for a minimum of five cycles (Figure 40) 
displaying a high catalytic performance with over 83% yield of the product after fifth 
run. 
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Fig. 40. Recycling data of Ce/Chitosan catalyst 
4.5. CONCLUSION 
In summary, an efficient and heterogeneous Ce(III)/chitosan catalyst has been 
synthesised and used for the simple, efficient and environmentally benign synthesis of 
spiropiperidine derivatives at room temperature using PEG-200 as a green solvent. 
The substrate scope of the reaction was also demonstrated by the tolerance of 
aromatic and alicyclic amines in addition to various cyclic active methylene 
compounds. Low catalyst loading, clean reaction profiles, one pot multi-component 
procedure, reusability of the catalyst and operational simplicity are the important 
features of this methodology. 
4.6. EXPERIMENTAL 
4.6.1. Synthesis of Ce(III)/Chitosan catalyst 
1g of CeCl3.7H2O was added to the suspension of Chitosan (80% deacetylated) (5g) 
in 100 mL of water with continuous stirring. The pH of the solution was adjusted at 9 
using 25% ammonia solution. The mixture was then continuously stirred overnight at 
room temperature and the resulting catalyst was separated by filtration and dried 
under vacuum at 60 °C.  
4.6.2. General Procedure for the synthesis of 3,5-dispirosubstituted piperidines 
(10a-e, 10k-o) 
A mixture of amines (9a-e) (4 mmol), active methylene compounds 4c, 4j (8 mmol), 
formaldehyde (12 mmol, 37–41% aqueous solution) and a catalytic amount of 
Ce(III)/chitosan (0.8 g, 0.456 mmol of Ce) in PEG-200 (15 mL) was stirred at room 
temperature for the stipulated period of time (Table 18). The appearance of solid 
compound denoted the formation of products. After completion of the reaction 
(monitored by TLC), water (20 mL) was added in order to dissolve the PEG-200 and 
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a mixture of isopropanol/ethyl acetate (1:10) was then added to extract the products. 
Solid products were obtained by further evaporation of this organic layer under 
reduced pressure. The catalyst in the remaining aqueous phase was filtered, washed 
with isopropanol/ethyl acetate (1:10) mixture, dried and reused. The pure compounds 
were obtained by further recrystallization. 
4.6.3. General procedure for the synthesis of 3,5-dispirosubstituted piperidines (10f-j) 
A mixture of amines (9a-e)  (4 mmol), 4-hydroxycoumarin 4d (8 mmol), 
formaldehyde (12 mmol, 37–41% aqueous solution), and a catalytic amount of 
Ce(III)/chitosan (0.8 g, 0.456 mmol of Ce) in PEG-200 (15 mL) was stirred at room 
temperature for the stipulated period of time (Table 18). The appearance of solid 
compound denoted the formation of products. After completion of the reaction 
(monitored by TLC), water was added and the mixture of catalyst and solid products 
was filtered. After filtration, DMSO (10 mL) was added to dissolve the products 
leaving behind the catalyst. The catalyst was filtered, washed with DMSO, 
isopropanol/ethyl acetate (1:10) mixture, dried and reused. The solvent containing 
products was left undisturbed in order to obtain pure compounds. 
4.6.4. Spectral data of Synthesized compounds 
NO
O O
O
 
10a 
1’-phenyldispiro[indane-1,3-dione-2,3’-piperidine-5’,2”-
indane-1,3-dione]  
Yellow solid, M.p. 257-258 °C. Anal. Calcd. (C27H19NO4) C, 
76.95; H, 4.54; N, 3.32. Anal. Found (C27H19NO4) C, 76.91; 
H, 4.49; N, 3.36. IR (KBr, cm-1): 2939 (C-H), 2867(C-H), 
1731 (C=O), 1704 (C=O). 1H NMR (400 MHz, CDCl3): 2.77 
(2H, s), 3.94 (4H, s, CH2-N-CH2), 6.94-7.96 (13H, m, Ar-H).  
13C NMR (100 MHz, CDCl3): 19.2, 58.4, 67.8, 114.3, 122.9, 
125.7, 126.7, 130.7, 130.8, 133.3, 134.2, 144.2, 153.7, 197.5. 
ESI-MS m/z 422.1 (M++1). 
NO
O O
O
Cl
 
10b 
1’-(4-chlorophenyl)dispiro[indane-1,3-dione-2,3’-piperidine-
5’,2”-indane-1,3-dione] 
Yellow solid, M.p. 260-261 °C. Anal. Calcd. (C27H18ClNO4) 
C, 71.13; H, 3.98; N, 3.07. Anal. Found (C27H18ClNO4) C, 
71.19; H, 3.94; N, 3.11. IR (KBr, cm-1): 2940 (C-H), 2871(C-
H), 1729 (C=O), 1701 (C=O). 1H NMR (400 MHz, CDCl3): 
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2.71 (2H, s), 3.85 (4H, s, CH2-N-CH2), 6.71-7.87 (12H, m, 
Ar-H). 13C NMR (100 MHz, DMSO-d6): 19.5, 59.2, 66.9, 
113.4, 126.2, 126.9, 128.5, 131.1, 132.0, 134.8, 135.1, 145.9, 
154.7, 197.2. ESI-MS m/z 456.1 (M++1). 
NO
O O
O
CH3
 
10c 
1’-(4-methylphenyl)dispiro[indane-1,3-dione-2,3’-piperidine-
5’,2”-indane-1,3-dione] 
Yellow solid, M.p. 265-266 °C. Anal. Calcd. (C28H21NO4) C, 
77.23; H, 4.86; N, 3.22. Anal. Found (C28H21NO4) C, 77.19; 
H, 4.89; N, 3.27. IR (KBr, cm-1): 2932 (C-H), 2854 (C-H), 
1741 (C=O), 1704 (C=O). 1H NMR (400 MHz, CDCl3): 2.40 
(3H, s, CH3), 2.77 (2H, s), 3.90 (4H, s, CH2-N-CH2), 6.91-
7.96 (12H, m, Ar-H). 13C NMR (100 MHz, DMSO-d6): 18.9, 
23.8, 59.1, 65.4, 113.1, 125.6, 126.3, 131.8, 133.5, 135.7, 
136.0, 143.7, 152.1, 198.9. ESI-MS m/z 436.1 (M++1). 
NO
O O
O
OMe
 
10d 
1’-(4-methoxyphenyl)dispiro[indane-1,3-dione-2,3’-
piperidine-5’,2”-indane-1,3-dione]  
Yellow solid, M.p. 258-259 °C. Anal. Calcd. (C28H21NO5) C, 
74.49; H, 4.69; N, 3.10. Anal. Found (C28H21NO5) C, 74.44; 
H, 4.73; N, 3.15. IR (KBr, cm-1): 2944 (C-H), 2871 (C-H), 
1728 (C=O), 1708 (C=O). 1H NMR (400 MHz, CDCl3): 2.79 
(2H, s), 3.84 (4H, s, CH2-N-CH2), 4.02 (3H, s, OCH3), 6.72-
7.95 (12H, m, Ar-H). 13C NMR (100 MHz, CDCl3): 20.1, 
58.5, 60.2, 67.4, 116.5, 119.6, 126.1, 126.9, 127.4, 131.8, 
132.1, 134.1, 134.9, 145.1, 152.7, 155.1, 196.1. ESI-MS m/z 
452.1 (M++1). 
NO
O O
O
 
10e 
1’-benzyldispiro[indane-1,3-dione-2,3’-piperidine-5’,2”-
indane-1,3-dione] 
Yellow solid, M.p. 261-262 °C. Anal. Calcd. (C28H21NO4) C, 
77.23; H, 4.86; N, 3.22. Anal. Found (C28H21NO4) C, 77.28; 
H, 4.81; N, 3.17. IR (KBr, cm-1): 2928 (C-H), 2857 (C-H), 
1741 (C=O), 1702 (C=O). 1H NMR (400 MHz, CDCl3): 2.52 
(2H, s), 3.39 (4H, s, CH2-N-CH2), 3.68 (2H, s, Ph-CH2), 7.13-
7.93 (13H, m, Ar-H). 13C NMR (100 MHz, CDCl3): 18.5, 
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58.1, 65.7, 69.2, 125.5, 125.9, 127.2, 128.3, 131.2, 132.1, 
141.3, 149.7, 196.7. ESI-MS m/z 436.2 (M++1). 
N
OO
O
O O
O
 
10f 
1’-phenyldispiro[chroman-2,4-dione-3,3’-piperidine-5’,3”- 
chroman-2,4-dione] 
White solid, M.p. 275-276 °C. Anal. Calcd. (C27H19NO6) C, 
71.52; H, 4.22; N, 3.09. Anal. Found (C27H19NO6) C, 71.46; 
H, 4.27; N, 3.03. IR (KBr, cm-1): 2941 (C-H), 2886 (C-H), 
1748 (C=O), 1651 (C=O). 1H NMR (400 MHz, DMSO-d6): 
2.51 (2H, s), 3.51(4H, s, CH2-N-CH2), 7.31-8.16 (13H, m, Ar-
H). 13C NMR (100 MHz, DMSO-d6): 22.4, 59.1, 66.5, 116.8, 
119.0, 121.4, 127.2, 128.2, 129.5, 133.5, 137.8, 147.3, 156.8, 
176.2, 196.2. ESI-MS m/z 454.1 (M++1). 
N
OO
O
O O
O
Cl
 
10g 
1’-(4-chlorophenyl)dispiro[chroman-2,4-dione-3,3’-
piperidine-5’,3”- chroman-2,4-dione]  
White solid, M.p. 279-280 °C. Anal. Calcd. (C27H18ClNO6) 
C, 66.47; H, 3.72; N, 2.87. Anal. Found (C27H18ClNO6) C, 
66.51; H, 3.68; N, 2.82. IR (KBr, cm-1): 2940 (C-H), 2876 (C-
H), 1745 (C=O), 1669 (C=O). 1H NMR (400 MHz, DMSO-
d6): 2.79 (2H, s), 3.64 (4H, s, CH2-N-CH2), 7.14-8.09 (12H, 
m, Ar-H).13C NMR (100 MHz, DMSO-d6): 21.2, 58.7, 66.1, 
115.9, 119.4, 120.1, 127.4, 128.5, 129.5, 130.4, 133.1, 137.9, 
151.2, 170.4, 197.2. ESI-MS m/z 488.1 (M++1). 
N
OO
O
O O
O
CH3
 
10h 
1’-(4-methylphenyl)dispiro[chroman-2,4-dione-3,3’-
piperidine-5’,3”- chroman-2,4-dione]  
White solid, M.p. 280-281 °C. Anal. Calcd. (C28H21NO6) C, 
71.94; H, 4.53; N, 3.00. Anal. Found (C28H21NO6) C, 71.99; 
H, 4.48; N, 2.97. IR (KBr, cm-1): 2918 (C-H), 2852 (C-H), 
1742 (C=O), 1702 (C=O). 1H NMR (400 MHz, DMSO-d6): 
2.55 (3H, s, CH3), 2.75 (2H, s), 3.59 (4H, s, CH2-N-CH2), 
7.23-8.12 (12H, m, Ar-H). 13C NMR (100 MHz, DMSO-d6): 
21.3, 26.5, 58.1, 66.2, 118.4, 121.3, 124.7, 125.1, 128.1, 
130.5, 131.3, 134.5, 136.2, 149.2, 155.6, 171.2, 197.5. ESI-
MS m/z 468.1 (M++1). 
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N
OO
O
O O
O
OMe
 
10i 
1’-(4-methoxyphenyl)dispiro[chroman-2,4-dione-3,3’-
piperidine-5’,3”-chroman-2,4-dione] 
White solid, M.p. 286-287 °C. Anal. Calcd. (C28H21NO7) C, 
69.56; H, 4.38; N, 2.90. Anal. Found (C28H21NO7) C, 69.51; 
H, 4.43; N, 2.95.  IR (KBr, cm-1): 2931 (C-H), 2868 (C-H), 
1741 (C=O), 1683 (C=O). 1H NMR (400 MHz, DMSO-d6): 
2.62 (2H, s), 3.89 (4H, s, CH2-N-CH2), 4.15 (3H, s, OCH3), 
7.33-8.12 (12H, m, Ar-H). 13C NMR (100 MHz, DMSO-d6): 
22.5, 54.2, 58.8, 65.4, 117.1, 120.4, 121.2, 123.5, 124.1, 
128.3, 129.0, 130.4, 137.2, 148.2, 154.7, 171.6, 196.4. ESI-
MS m/z 484.1 (M++1). 
N
OO
O
O O
O
 
10j 
1’-benzyldispiro[chroman-2,4-dione-3,3’-piperidine-5’,3”- 
chroman-2,4-dione]  
White solid, M.p. 280-281 °C.  Anal. Calcd. (C28H21NO6) C, 
71.94; H, 4.53; N, 3.00. Anal. Found (C28H21NO6) C, 71.89; 
H, 4.48; N, 3.05. IR (KBr, cm-1): 2927 (C-H), 2869 (C-H), 
1745 (C=O), 1651 (C=O). 1H NMR (400 MHz, DMSO-d6): 
2.61 (2H, s), 3.73 (4H, s, CH2-N-CH2), 3.97 (2H, s, Ph-CH2), 
7.11-8.03 (13H, m, Ar-H). 13C NMR (100 MHz, DMSO-d6): 
21.5, 57.9, 64.3, 73.6, 118.5, 122.3, 123.1, 127.3, 128.1, 
129.3, 131.5, 134.8, 135.3, 139.2, 144.6, 152.1, 172.1, 197.2. 
ESI-MS m/z 468.1 (M++1). 
O
OH3C
H3C
N
O
O
CH3
CH3  
10k 
Melting point: 192 °C  
Melting point (literature)18-21:191-193 °C 
 
O
OH3C
H3C
N
O
O
CH3
CH3
Cl
 
10l 
Melting point: 199 °C 
Melting point (literature)18-21: 198-200 °C 
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O
OH3C
H3C
N
O
O
CH3
CH3
CH3
 
10m 
Melting point: 201 °C 
Melting point (literature)18-21: 199-201 °C 
O
OH3C
H3C
N
O
O
CH3
CH3
OMe
 
10n 
Melting point: 187 °C 
Melting point (literature)18-21: 186-188 °C 
O
OH3C
H3C
N
O
O
CH3
CH3  
10o 
3,3,11,11-Tetramethyl-15-(benzyl)-15 azadispiro [5.1.5.3] 
hexadecane-1,5,9,13-tetrone  
Light yellow crystals, M.p. 201-202 °C. Anal. Calcd. 
(C26H33NO4) C, 73.73; H, 7.85; N, 3.31. Anal. Found 
(C26H33NO4) C, 73.68; H, 7.79; N, 3.36. IR (KBr, cm-1): 2953 
(C-H), 2901 (C-H), 1724 (C=O), 1698 (C=O). 1H NMR (400 
MHz, CDCl3): 0.85 (6H, s), 0.94 (6H, s), 2.32 (2H,s), 2.67 
(4H, d, J=13.6Hz), 2.76 (4H, d, J=13.6Hz), 3.52 (4H, s, CH2-
N-CH2), 3.86 (2H, s, Ph-CH2), 7.25-7.32 (5H, m, Ar-H). 13C 
NMR (100 MHz, CDCl3): 27.2, 31.5, 34.0, 54.7, 67.3, 71.8, 
119.7, 123.5, 128.9, 154.7, 198.0. ESI-MS m/z 424.1 (M++1). 
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SECTION B 
DYSPROSIUM(III) ON CHITOSAN:  A RECYCLABLE HETEROGENEOUS 
CATALYST FOR THE SYNTHESIS OF HEXAHYDROPYRIMIDINES IN 
WATER* 
In the field of medicinal chemistry, hexahydropyrimidine derivatives are one of the 
most important class of compounds with diverse range of biological activities.1 These 
scaffolds exhibit interesting biological profiles such as antibacterial,2 antiviral, 
analgesic and anti-inflammatory activities.3 Anti-inflammatory and analgesic 
activities of some hexahydropyrimidine derivatives were found to be comparable with 
diclofenac sodium gel and aspirin.4 A number of alkaloids such as verbamethine and 
verbametrine5 also contain this skeleton. Hexetidine, which shows promising 
anesthetic, deodorant and antiplaque effects,6 also contains this structural unit. Several 
hexahydropyrimidine derivatives have also shown promising anti-HIV-1 activity.7 
Some hexahydropyrimidine derivatives were found to be important transport 
molecules for tumor inhibition and antineoplastic activity.8 N-Substituted 
hexahydropyrimidines serve as key synthetic intermediates for spermidine-
nitroimidazole drugs which are used for the treatment of A549 lung carcinoma.9 
Recently, appropriately substituted hexahydropyrimidines were found to be potent 
hepatitis C virus inhibitors.10 Therefore, in view of the very important biological 
profiles of these derivatives it is highly desirable to develop a method which is 
efficient, environmentally benign and tolerates a range of substrates. 
4.7. REVIEW OF LITERATURE 
Some recent examples of the synthesis of hexahydropyrimidines and their spiro 
analogues. 
4.7.1. FeCl3 catalysed synthesis of hexahydropyrimidines and spiro derivatives.11 
C. Mukhopadhyay et al. reported an FeCl3 catalysed synthesis of 1,3-diaryl-
hexahydropyrimidines via reaction of 1,3-dicarbonyl compounds, amines and 
formaldehyde in dichloromethane at room temperature. 
                                                             
* Nayeem Ahmed, Saima Tarannum, Zeba N. Siddiqui, RSC Advances, 5 (2015) 50691. 
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4.7.2. (S)-Proline catalysed synthesis of 1,3-diaryl-5-
spirohexahydropyrimidines.12 
H. L. Wei et al. reported an efficient synthesis of 1,3-diaryl-5-spirohexahydro 
pyrimidines via one-pot condensation of anilines, formaldehyde, and cyclohexanones 
catalysed by (S)-proline in DMSO. 
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4.7.3. Synthesis of spiropyrimidine derivatives catalysed by magnetically 
recoverable CuFe2O4 nanoparticles.13 
A. Dandia et al. reported an efficient protocol for the synthesis of medicinally 
important fluorinated spiropyrimidine derivatives using a magnetically separable and 
reusable heterogeneous copper ferrite nano-catalyst under mild reaction conditions 
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, O O
 
4.7.4. Indium triflate catalysed one-pot synthesis of spiro-
hexahydropyrimidines.14 
A. Dandia et al. reported an efficient synthesis of spiro-hexahydropyrimidine                      
derivatives via a three-component, one-pot cyclocondensation reaction of aromatic 
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amines, formaldehyde, and cyclic ketones using In(OTf)3 as Lewis acid catalyst under 
mild conditions. 
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4.7.5. Synthesis of 1,3-diaryl-5-spirohexahydropyrimidines catalysed by 
supported preyssler nanoparticles.15 
M. M. Heravi et al. reported the preparation of 1,3-diaryl-5-spirohexahydro 
pyrimidines via a one-pot condensation of anilines, formaldehyde, and cyclohexanone 
using silica-supported Preyssler nanoparticles (H14[NaP5W30O110])/SiO2 as a 
recyclable catalyst. 
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N
NOO
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4-CH3
, 4-Br
R1 R1
R1
= H,
 
CH3  
4.8. PRESENT WORK 
Based on the principles of green chemistry, the development of practical methods, 
reaction conditions, and the use of appropriate materials is a very challenging task. 
During last few decades the use of lanthanides as catalysts in organic synthesis has 
amplified very rapidly due to their unique physical and chemical properties.16 
Dysprosium, which exhibits similar Lewis acidity, oxophilicity, ease of handling and 
stability towards air and water as compared to other lanthanides, has not received 
much attention in the field of synthetic organic chemistry. Analogous to other 
lanthanides, +III state of dysprosium is the most stable oxidation state, due to which it 
behaves as an extremely mild and efficient Lewis acid catalyst having the ability to 
promote various types of carbon-carbon bond forming reactions like Mannich type, 
Diels-Alder, Povarov, Friedel-Crafts alkylation, electrocyclizations and cycloaddition 
reactions.17 It is also used in a variety of transformations with unprotected amines 
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because of  its unique ability to retain its catalytic activity in presence of Lewis basic 
nitrogen groups.17 
Organic synthesis in water has received considerable attention due to the 
environmental impact of using volatile organic solvents (VOCs). Recent research has 
shown that water as a solvent produces beneficial effects which speed up the reaction 
and the separation process also becomes easier because of the insolubility of organic 
compounds in water.18 
In this section, Dy(III) has been supported on chitosan and used as a catalyst for the 
eco-friendly synthesis of hexahydropyrimidines and their spiro analogues in water. 
4.9. RESULTS AND DISCUSSION 
The synthesis of the catalyst is illustrated in Scheme-12. To a weighed amount of pre-
suspended chitosan in water, was added Dy(NO3)3.6H2O with continuous stirring. The 
catalyst was then obtained by simple filtration of the mixture after overnight stirring. 
 
Scheme 12: Schematic representation for the synthesis of Dy(III)/chitosan catalyst. 
4.9.1. Characterization of the catalyst 
4.9.1a. FT-IR spectral analysis 
FT-IR spectrum (Figure 41a) of pure chitosan showed a broad OH and NH stretching 
band at 3419 cm−1. Whereas N–H bending band was present at 1588 cm−1. The 
absorption bands present at 1076 and 1379 cm−1 correspond to the stretching 
vibrations of C−O and C−N groups, respectively. The band for C−H stretching mode 
of methylene group was present at 2920 cm−1.19 In the FT-IR spectrum of Dy(III) 
supported chitosan (Figure 41b), a different fingerprint region (600-500 cm−1), as 
compared to that of pure chitosan, was obtained due to the formation of Dy−N and 
Dy−O coordinate bonds.20 The decrease in the intensity of N–H bending vibration 
band of NH2 group obtained at 1561 cm−1 after modification, indicated the 
coordination of Dy(III) by NH2 groups. Moreover, increase in the sharpness of the 
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OH stretching band at 3417 cm−1 indicated the coordination of Dy(III) by OH groups 
of chitosan.21 
 
Fig. 41. FT-IR spectra (a) of chitosan and (b) of Dy(III)/chitosan catalyst 
4.9.1b. XRD and EDX analyses 
The XRD analysis revealed that the diffraction patterns of the support (Figure 42a) 
and the catalyst (Figure 42b) were similar. Absence of the peaks pertaining to Dy(III) 
may be because of its low content and small size of the Dy(III) nanoparticles. 
However, the presence of Dy in the catalyst was established by EDX analysis which 
showed peaks for Dy in addition to C, N and O elements (Figure 43).  
 
Fig. 42. XRD spectra (a) of chitosan and (b) of Dy(III)/chitosan catalyst. 
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Fig. 43. EDX spectra of Dy(III)/chitosan catalyst. 
4.9.1c. ICP-AES, TEM and Elemental Mapping analyses 
ICP-AES analysis was performed in order to determine the actual concentration of Dy 
in the catalyst. The analysis showed the weight percentage of Dysprosium to be 
1.38%. The TEM images of the catalyst (Figure 44) displayed the spherical shape of 
the Dy(III) nanoparticles with average diameter in the range of 5-12 nm. The 
elemental mapping analysis showed that the Dy(III) nanoparticles were uniformly 
distributed on the surface of chitosan (Figure 45).  
 
 
Fig. 44. TEM image of Dy(III)/chitosan catalyst 
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Fig. 45. Elemental mapping analysis of the catalyst showing uniformly distributed Dy 
4.9.1d. TG analysis 
Thermal behaviour and stability of the catalyst at elevated temperatures was evaluated 
by TG analysis. In the TG curve of chitosan, a two stage weight loss of 12.7% at 60 
°C and 52.2% at 280 °C (Figure 46a) was observed. The first weight loss attributed to 
removal of adsorbed water molecules from polymer matrix and the second weight loss 
corresponded to the decomposition of the polysaccharide chain. The TG curve of 
Dy(III)/chitosan catalyst showed a decrease in thermal stability (weight loss of 52.4 % 
at 260 °C) (Figure 46b) with respect to chitosan, which is in agreement with the 
reported trend. It is reported that chemical modifications as well as metal 
complexations generally lead to decrease in the thermal stability of chitosan.22  This 
observation further supports the formation of Dy(III)/chitosan catalyst. 
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Fig. 46. TG analysis (a) of pure chitosan and (b) of Dy(III)/chitosan catalyst. 
4.9.2. Optimization of reaction conditions 
4.9.2a. Effect of different catalysts and solvents:  
In order to find the optimized conditions for the synthesis of hexahydropyrimidines, 
various experiments were carried out using aniline (9a), formaldehyde and ethylcyano 
acetate (7a) as model substrates. When the reaction was performed without any 
catalyst (Table 20, entry 1), no product formation was observed. Using chitosan as a 
catalyst could not show satisfactory results (Table 20, entry 7). We then used various 
Lewis acids such as Dy(NO3)3.6H2O,  CuCl2, Fe(NO3)3, Zn(OAc)2 and CeCl3.7H2O as 
catalysts in water at room temperature (Table 20) and found Dy(NO3)3.6H2O  to be 
most efficient for this reaction. As Dy(NO3)3.6H2O could not be recovered and 
recycled, we explored the use of chitosan supported Dy(III) as a catalyst  and the 
results obtained were very satisfactory as the product in excellent yield (91%) was 
obtained in short time period (Table 20, entry 8). After obtaining the right catalyst 
for this transformation, we then focused our attention towards finding the right 
solvent for this transformation. 
Taking Dy(III)/chitosan  as a catalyst for this reaction, the model reaction was 
conducted in H2O, as well as other organic solvents like EtOH, MeOH, isopropanol, 
CH3CN and ethylene glycol (Table 20, entries 9-13). In comparison to H2O, other 
solvents gave low to moderate yields of the product and took long time period (5-6.5 
h) for completion of the reaction. H2O showed significant improvement over other 
solvents in terms of yield and reaction time (Table 20, entry 8). This rate 
enhancement of the reaction can be attributed to the unique properties of water like 
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hydrogen bonding to stabilize the intermediate transition states and hydrophobic 
effects to decrease the hydrocarbon–water interfacial area.18 
Table 20: Effect of different reaction media on model reaction. 
N N
NC O
O
CH3
O
O CH3
NC
NH2
HH
O+ +
Stirring
RT
(9a) (7a) (11a)  
Entry Catalyst Solvent Time Yield (%) 
1 Nil H2O (5mL) 12 h No reaction 
2 CuCl2 (10 mol%) H2O (5mL) 3.1 h 58 
3 Fe(NO3)3 (10 mol%) H2O (5mL) 2.8 h 62 
4 Zn(OAc)2 (10 mol%) H2O (5mL) 2.5 h 60 
5 CeCl3 (10 mol%) H2O (5mL) 2.1 h 69 
6 Dy(NO3)3.6H2O (10 mol%) H2O (5mL) 1.6 h 78 
7 Chitosan (100 mg) H2O (5mL) 9.5 h 23 
8 Dy(III)/chitosan (100 mg) H2O (5mL) 45 min 91 
9 Dy(III)/chitosan (100 mg) EtOH (5mL) 6 h 61 
10 Dy(III)/chitosan (100 mg) MeOH (5mL) 6.1 h 64 
11 Dy(III)/chitosan (100 mg) Isopropanol (5mL) 6.5 62 
12 Dy(III)/chitosan (100 mg) CH3CN (5mL) 5 h 57 
13 Dy(III)/chitosan (100 mg) Ethylene glycol (5mL) 5.4 h 39 
 
4.9.2b. Effect of catalyst loading 
In order to find the effect of the catalyst loading, the model reaction was carried out 
by varying the amount of the catalyst (Table 21). It was observed that, with the 
increase in the catalyst amount from 50-100 mg, the formation of 
hexahydropyrimidine derivative increased linearly. Further increasing the amount of 
catalyst to 125 mg did not produce any profound effect on the reaction. Therefore, 
100 mg of Dy(III)/chitosan was found to be the optimum amount of the catalyst for 
the synthesis of hexahydropyrimidines. 
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Table 21: Effect of catalyst loading 
N N
NC O
O
CH3
O
O CH3
NC
NH2
HH
O+ Water
Dy(III)/chitosan
Room
 
Temp.
Stirring
+
(9a) (7a) (11a)  
Entry Catalyst loading (mg) Time (min) Yield (%) 
1 50 125 69 
2 75 65 76 
3 100 45 91 
4 125 45 91 
 
4.9.3. Catalytic reaction  
After optimizing the reaction conditions, the substrate scope and generality of 
Dy(III)/chitosan catalysed synthesis of hexahydropyrimidine derivatives (11a-l) using 
different amines (9a-d ,9f), formaldehyde and active methylene compounds 
(4b,4c,7a) in water was examined (Scheme-13). It was observed that the designed 
reaction tolerated both acyclic and cyclic active methylene compounds very 
efficiently as well as amines with both activating and deactivating groups (Table 22). 
N
N
R1
O
O
CH3
N
NO
R1 = CN
      = COCH3
O
O CH3
R1
O
NH2
HH
O
+
Water
Dy(III)/chitosan
Room
 
Temp.
Stirring
R
R
R
(9a
-d,
 
9f)
(7a)
(4e)
(11a
-h)
(11i
-l)
R
R
(4b)
 
Scheme 13: General scheme for the synthesis of hexahydropyrimidine derivatives 
The structures of the final products were elucidated by using spectral (IR, 1H, 13C 
NMR and ESI-MS) and elemental analysis data. The I.R. spectrum (Figure 47) of 11a 
showed CN stretching peak at 2251 cm-1.  The absorption band at 1738 cm-1 was 
assigned to carbonyl group of ethyl ester. In the 1H-NMR spectrum (Figure 48), four 
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hydrogens of 2xN–CH2 moieties exhibited two distinctive doublets at δ 3.63 and δ 
3.77, respectively.  The two hydrogen atoms of N–CH2–N moiety exhibited 
distinctive doublets at δ 4.24 and δ 4.74, respectively. The aromatic protons appeared 
as multiplet in the range δ 6.91-7.10. 13C-NMR spectrum (Figure 49) showed a 
distinctive peak at δ 164.39 ppm for carbonyl group of ethyl ester. All other peaks 
were obtained at respective places and are given in the experimental section. Further, 
structure 11a was confirmed by ESI-Mass spectrum (Figure 50) which showed the 
molecular ion peak as base peak at m/z 336.1 (M++1).  
 
Fig. 47. FT-IR spectrum of 11a 
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Fig. 48. 1H-NMR spectrum of 11a 
 
Fig. 49. 13C-NMR spectrum of 11a 
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Fig. 50. ESI-Mass spectrum of 11a 
It is pertinent to mention that no product formation was observed when aliphatic 
amines (ethyl amine) or active methylene compounds like (Meldrum’s acid, 4-
hydroxycoumarin, 1,3-dimethylbarbituric acid)  were used as substrates. In order to 
further show the superiority of our protocol, a comparison with reported methods 
revealed our catalytic system to be more efficient in terms of time period (40-58 min) 
and product yield (85-94%) (Table 23). 
Table 22: Synthesis of hexahydropyrimidines and spiro analogues. 
 
 
 
132 
 
3 
NH2
Cl  
9b 
O
O CH3
N
 
7a 
N
N
CN
O
O
Cl
Cl
CH3
 
11c 
45 90 
4 
NH2
OCH3  
9d 
O
O CH3
N
 
7a 
N
N
CN
O
O
H3CO
OCH3
CH3
 
11d 
43 93 
5 
NH2
NO2  
9f 
O
O CH3
N
 
7a 
N
N
CN
O
O
O2N
NO2
CH3
 
11e 
48 89 
6 
NH2
 
9a 
O
H3C
O
O CH3  
4b 
N
N
H3C O
O
O
CH3
 
11f 
58 93 
7 
NH2
CH3  
9c 
O
H3C
O
O CH3  
4b 
N
N
H3C O
O
O
CH3
H3C
CH3  
11g 
55 94 
8 
NH2
OCH3  
9d 
O
H3C
O
O CH3  
4b 
N
N
H3C O
O
O
CH3
H3CO
OCH3  
11h 
54 93 
9 
NH2
 
9a 
O
 
4e 
N
NO
 
11i 
50 87 
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10 
NH2
CH3  
9c 
O
 
4e 
N
NO
CH3
CH3  
11j 
45 89 
11 
NH2
Cl  
9b 
O
 
4e 
N
NO
Cl
Cl  
11k 
51 87 
12 
NH2
NO2  
9f 
O
 
4e 
N
NO
NO2
NO2  
11l 
53 85 
 
Table 23: Comparison of efficiency of Dy(III)/chitosan catalyst with reported 
procedures. 
Entry Catalyst Condition Solvent Yield (%) Time Ref. 
1 Dy(III)/chitosan RT stirring Water 91 
45 
min 
Present 
work. 
2 In(OTf)3 RT stirring DCM 78 4h 14 
3 CuFe2O4 RT stirring Ethanol 74 4h 13 
4 S-Proline RT stirring DMSO 73 30h 12 
5 
(H14[NaP5W30O110])/
SiO2 
Reflux DMSO 60 30h 15 
 
4.9.4. Reaction mechanism: 
The mechanism of the reaction is outlined in scheme-14 and was proposed on the 
basis of reported literature.11-14 In the first step, activated active methylene compound 
(7a) and imine Q undergo Michael addition to form R. In the next step, the 
intermediate R is activated by the catalyst which then undergoes Michael addition 
with second molecule of imine Q, to form propane-1,3-diamine intermediate S. The 
final product (11a) is obtained via condensation of intermediate S with formaldehyde 
and the catalyst is freed for subsequent recycles. 
134 
 
NH2
H
H
O
N
H2C
OEt
O
N
NH
OEt
O
N
N
OEt
O
N
OEt
O
N
NH
OEt
O
N
N
CH2
OEt
O
HNNH
N
OEtO
N
N
N
H
H
O
H2O
H
H
(7a)
(Q)
(R)
(Q)
(S)
(11a)
(7
a )
(1a)
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Scheme 14: Plausible reaction mechanism for the formation of hexahydropyrimidine 
derivative 11a. 
4.9.5. Leaching study of Dy(III)/chitosan catalyst: 
The metal leaching of the catalyst before and after six catalytic cycles was evaluated 
by ICP-AES analyses in order to understand the heterogeneous nature of the catalyst. 
The analysis revealed that the metal concentration before (1.38Wt.% Dy) and after 
recycling experiments (1.36Wt.% Dy) remained unchanged with a very marginal 
reduction (within the experimental error of ICP-AES analysis), indicating that the 
metal is tightly bound to the support and no leaching of the Dy(III) occurs upon reuse 
of the catalyst. 
4.9.6. Catalyst recycling 
In order to explore the extent of recyclability of our catalytic system, the reaction 
between aniline, formaldehyde (37–41% aqueous solution) and ethyl cyanoacetate in 
water at room temperature using Dy(III)/chitosan as a catalyst was chosen as model 
reaction. After completion of the reaction, the catalyst was recovered by extracting the 
mixture with ethyl acetate followed by filtration. The catalyst was then washed with 
ethyl acetate, reused, and was found to retain its activity for a minimum of six 
reaction cycles in water (Table 24). The TEM images of the catalyst after six cycles 
(Figure 51) also did not show any significant change in the morphology of the 
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catalyst indicating that the structural integrity of the catalyst is maintained throughout 
the recycling processes. 
Table 24: Recycling potential of Dy(III)/chitosan catalyst. 
No. of cycles Fresh Run 1 Run 2 Run 3 Run 4 Run 5 
Yield (%) 91 91 89 86 85 83 
Time (min) 45 45 45 45 45 45 
 
 
Fig. 51. TEM image of recycled catalyst after six cycles. 
 
4.9.7. CONCLUSION 
In summary, Dy(III) supported chitosan was found to be highly efficient catalyst for 
the green and energy sustainable synthesis of hexahydropyrimidine derivatives in 
aqueous media. The catalyst was able to maintain good efficiency for six catalytic 
cycles. The use of a recyclable catalyst, water, substrate tolerance, and ambient 
conditions are the advantages of this energy sustainable protocol. 
4.9.8. EXPERIMENTAL 
4.9.8a. Synthesis of Dy(III)/chitosan catalyst 
Chitosan (3g) was suspended in 100 mL of distilled water in a round bottomed flask 
and stirred for 30 min. Dy(NO3)3.6H2O (0.2g) was then added to the suspension with 
continuous stirring. The mixture was then continuously stirred overnight and the solid 
catalyst was separated by filtration, washed with water and dried at 80 °C for 6 h. 
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4.9.8b. General procedure for the synthesis of hexahydropyrimidine derivatives 
A mixture of amine (2 mmol), active methylene compound (1 mmol), formaldehyde 
(3 mmol, 37–41% aqueous solution) and catalyst (100 mg) in 5 mL water was stirred 
at room temperature for appropriate period of time (table 22). After completion of 
reaction (monitored by TLC), the reaction mixture was allowed to cool, extracted by 
ethyl acetate, washed with water (3 × 10 mL), dried over anhydrous Na2SO4 and 
evaporated under reduced pressure to obtain the products. The remaining solid 
catalyst in aqueous phase was separated by filtration, washed with ethyl acetate (3 x 
10 mL) and reused for further catalytic cycles. The crude products were recrystallized 
to afford the pure products. Compounds (11f-h) were separated by column 
chromatography using (60–120 mesh) column chromatography with 5% ethyl acetate 
in petroleum ether as eluent. 
4.9.8c. Spectral data of synthesised compounds 
N
N
CN
O
O
CH3
 
11a 
5-cyano-1,3-diphenyl-hexahydro-pyrimidine-5-carboxylic acid ethyl 
ester 
White crystals, M.p. 120-125 °C; Anal. Calcd. (C20H21N3O2): C, 
71.62; H, 6.31; N, 12.53; Anal. Found (C20H21N3O2): C, 71.66; H, 
6.28; N, 12.57. IR (KBr, cm-1): 2251 (CN), 1738 (C=O). 1H NMR 
(400 MHz, CDCl3): δ 1.16 (s, 3H), 3.63 (d, 2H, N–CH2), 3.77 (d, 
2H, N–CH2), 4.09 (q, 2H), 4.24 (d, 1H, N–CH–N), 4.74 (d, 1H, N–
CH–N), 6.91-7.14 (m, 10H, Ar-H). 13C NMR (100 MHz, 
CDCl3):164.39, 149.27, 131.54, 127.29, 121.22, 117.13, 70.25, 
64.81, 62.18, 52.23, 14.18. ESI-MS m/z 336.1 (M++1). 
N
N
CN
O
O
H3C
CH3
CH3
11b 
5-cyano-1,3-di-(4-methylphenyl)-hexahydro-pyrimidine-5-
carboxylic acid ethyl ester 
White crystals, M.p. 115-120 °C; Anal. Calcd. (C22H25N3O2): C, 
72.70; H, 6.93; N, 11.56; Anal. Found (C22H25N3O2): C, 72.75; H, 
6.89; N, 11.52. IR (KBr, cm-1): 2244 (CN), 1729 (C=O). 1H NMR 
(400 MHz, CDCl3): δ 1.22 (s, 3H), 2.29 (s, 6H), 3.71 (d, 2H, N–
CH2), 3.90 (d, 2H, N–CH2), 4.12 (q, 2H), 4.27 (d, 1H, N–CH–N), 
4.72 (d, 1H, N–CH–N), 6.97-7.12 (m, 8H, Ar-H). 13C NMR (100 
MHz, CDCl3): 166.14, 148.10, 131.27, 127.01, 122.75, 118.52, 
69.07, 64.22, 61.59, 51.88, 21.35, 14.86. ESI-MS m/z 364.1(M++1). 
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N
N
CN
O
O
Cl
Cl
CH3
11c 
5-cyano-1,3-di-(4-chlorophenyl)-hexahydro-pyrimidine-5-
carboxylic acid ethyl ester 
White crystals, M.p. 110-115 °C; Anal. Calcd. (C20H19Cl2N3O2): 
C, 59.42; H, 4.74; N, 10.39; Anal. Found (C20H19Cl2N3O2): C, 
59.46; H, 4.78; N, 10.36. IR (KBr, cm-1): 2241 (CN), 1725 (C=O).  
1H NMR (400 MHz, CDCl3): δ 1.24 (s, 3H), 3.72 (d, 2H, N–CH2), 
3.93 (d, 2H, N–CH2), 4.15 (q, 2H), 4.31 (d, 1H, N–CH–N), 4.68 (d, 
1H, N–CH–N), 6.89-7.21 (m, 8H, Ar-H). 13C NMR (100 MHz, 
CDCl3): 165.11, 149.19, 132.87, 129.27, 124.81, 117.95, 71.03, 
64.44, 61.94, 51.76, 14.43. ESI-MS m/z 405.1 (M++1). 
N
N
CN
O
O
H3CO
OCH3
CH3
11d 
5-cyano-1,3-di-(4-methoxyphenyl)-hexahydro-pyrimidine-5-
carboxylic acid ethyl ester 
White crystals, M.p. 120-125 °C; Anal. Calcd. (C22H25N3O4): C, 
66.82; H, 6.37; N, 10.63; Anal. Found (C22H25N3O4): C, 66.78; H, 
6.34; N, 10.68. IR (KBr, cm-1): 2249 (CN), 1731 (C=O). 1H NMR 
(400 MHz, CDCl3): δ 1.25 (s, 3H), 3.69 (d, 2H, N–CH2), 3.75 (s, 
6H, 2xOCH3), 3.87 (d, 2H, N–CH2), 4.11 (q, 2H), 4.40 (d, 1H, N–
CH–N), 4.74 (d, 1H, N–CH–N), 6.88-7.25 (m, 8H, Ar-H). 13C 
NMR (100 MHz, CDCl3): 168.07, 148.23, 134.42, 129.08, 124.27, 
119.18, 71.13, 63.18, 62.54, 55.81, 51.88, 15.11. ESI-MS m/z 396.1 
(M++1). 
N
N
CN
O
O
O2N
NO2
CH3
11e 
5-cyano-1,3-di-(4-nitrophenyl)-hexahydro-pyrimidine-5-carboxylic 
acid ethyl ester 
White crystals, M.p. 125-130 °C; Anal. Calcd. (C20H19N5O6): C, 
56.47; H, 4.50; N, 16.46; Anal. Found (C20H19N5O6): C, 56.43; H, 
4.53; N, 16.49. IR (KBr, cm-1): 2238 (CN), 1724 (C=O). 1H NMR 
(400 MHz, CDCl3): δ 1.27 (s, 3H), 3.76 (d, 2H, N–CH2), 3.92 (d, 
2H, N–CH2), 4.14 (q, 2H), 4.28 (d, 1H, N–CH–N), 4.78 (d, 1H, N–
CH–N), 7.14-8.26 (m, 8H, Ar-H). 13C NMR (100 MHz, CDCl3): 
167.12, 149.22, 135.82, 131.21, 125.03, 117.73, 72.02, 64.11, 
63.58, 51.97, 15.77. ESI-MS m/z 426.1 (M++1). 
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N
N
H3C O
O
O
CH3
11f 
5-acetyl-1,3-diphenyl-hexahydro-pyrimidine-5-carboxylic acid ethyl 
ester11 
Viscous liquid, 1H NMR (400 MHz, CDCl3): δ 1.19 (t, 3H), 2.27 (s, 
3H), 3.88 (d, 2H, N–CH2), 3.97 (d, 2H, N–CH2), 4.02 (q, 2H), 4.29 
(d, 1H, N–CH–N),4.38 (d, 1H, N–CH–N), 6.79-7.31 (m, 10H, Ar-
H). 13C NMR (100 MHz, CDCl3): 195.64, 164.39, 147.38, 129.52, 
121.41, 117.13, 67.91, 61.39, 60.23, 50.31, 26.43, 13.24. ESI-MS 
m/z 353.1 (M++1). 
N
N
H3C O
O
O
CH3
H3C
CH3
11g 
5-acetyl-1,3-di-(4-methylphenyl)-hexahydro-pyrimidine-5-
carboxylic acid ethyl ester11 
Viscous liquid, 1H NMR (400 MHz, CDCl3): δ 1.13 (t, 3H), 2.25 (s, 
3H), 2.64 (s, 6H), 3.79 (d, 2H, N–CH2), 3.88 (d, 2H, N–CH2), 4.06 
(q, 2H), 4.31 (d, 1H, N–CH–N), 4.51 (d, 1H, N–CH–N), 6.73-7.24 
(m, 8H, Ar-H). 13C NMR (100 MHz, CDCl3): 194.70, 166.23, 
148.15, 130.07, 129.17, 117.49, 68.65, 61.23, 59.15, 54.37, 26.18, 
20.43, 14.36. ESI-MS m/z 381.1 (M++1). 
N
N
H3C O
O
O
CH3
H3CO
OCH3
11h 
5-acetyl-1,3-di-(4methoxyphenyl)-hexahydro-pyrimidine-5-
carboxylic acid ethyl ester11 
Viscous liquid, 1H NMR (400 MHz, CDCl3): δ 1.11 (t, 3H), 2.28 (s, 
3H), 3.71 (s, 6H), 3.84 (d, 2H, N–CH2), 3.96 (d, 2H, N–CH2), 4.13 
(q, 2H), 4.33 (d, 1H, N–CH–N), 4.59 (d, 1H, N–CH–N), 7.13-7.92 
(m, 8H, Ar-H). 13C NMR (100 MHz, CDCl3): 195.82, 165.30, 
148.00, 130.78, 129.27, 120.22, 68.94, 62.08, 58.23, 55.91, 54.18, 
26.68, 20.37, 13.78.  ESI-MS m/z 413.1 (M++1). 
N
NO
 
11i 
2,4-Bis-phenyl-2,4-diazaspiro[5.5]undecan-7-one12,14 
Viscous liquid, 1H NMR (400 MHz, CDCl3): δ 1.58-1.63 (m, 2H), 
1.83-1.95 (m, 4H), 2.45 (t, 2H), 3.46 (d, 2H), 3.63 (d, 2H), 4.09 (d, 
1H), 4.66 (d, 1H), 6.79-7.23 (m, 10H, Ar-H). 13C NMR (100 MHz, 
CDCl3): 198.13, 149.65, 129.33, 120.21, 118.49, 68.21, 55.11, 
50.73, 39.78, 34.36, 27.73, 20.33. ESI-MS m/z 321.1 (M++1). 
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N
NO
CH3
CH3
 
11j 
2,4-Bis-(4-methylphenyl)-2,4-diazaspiro[5.5]undecan-7-one12,14 
White solid, M.p 127 ºC; 1H NMR (400 MHz, CDCl3): δ 1.61-1.67 
(m, 2H), 1.81-1.92 (m, 4H), 2.35 (s, 6H), 2.51 (t, 2H), 3.42 (d, 2H), 
3.61(d, 2H), 4.12 (d, 1H), 4.74 (d, 1H), 6.67-7.38 (m, 8H, Ar-H). 
13C NMR (100 MHz, CDCl3): 198.68, 148.51, 129.95, 121.52, 
118.11, 69.53, 55.11, 50.28, 39.16, 34.98, 27.10, 22.44, 20.13. ESI-
MS m/z 349.1 (M++1). 
N
NO
Cl
Cl  
11k 
2,4-Bis-(4-chlorophenyl)-2,4-diazaspiro[5.5]undecan-7-one12,14 
White solid, M.p 161 ºC; 1H NMR (400 MHz, CDCl3): δ 1.64-1.69 
(m, 2H), 1.81-1.90 (m, 4H), 2.42 (t, 2H), 3.44 (d, 2H), 3.64 (d, 2H), 
4.17 (d, 1H), 4.63 (d, 1H), 6.79-7.13 (m, 8H, Ar-H). 13C NMR (100 
MHz, CDCl3): 199.57, 148.87, 128.38, 125.61, 118.51, 67.30, 
56.25, 49.21, 39.37, 34.96, 27.32, 20.08. ESI-MS m/z 390.1 
(M++1). 
N
NO
NO2
NO2
 
11l 
2,4-Bis-(4-nitrophenyl)-2,4-diazaspiro[5.5]undecan-7-one12,14 
White solid, M.p 170-175 ºC; 1H NMR (400 MHz, CDCl3): δ 1.68-
1.72 (m, 2H), 1.88-1.95 (m, 4H), 2.45 (t, 2H), 3.41 (d, 2H), 3.62 (d, 
2H), 4.10 (d, 1H), 4.58 (d, 1H), 7.09-8.11(m, 8H, Ar-H). 13C NMR 
(100 MHz, CDCl3): 199.52, 147.73, 138.87, 124.34, 117.62, 68.01, 
56.44, 49.93, 38.89, 34.54, 27.11, 20.52. ESI-MS m/z 411.1 
(M++1). 
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SILICA MOLYBDIC ACID (SMA) CATALYSED MULTICOMPONENT 
SYNTHESIS OF TETRAZOLE DERIVATIVES UNDER MICROWAVE 
IRRADIATION IN AQUEOUS MEDIA*  
 
5.1. INTRODUCTION 
Tetrazoles and their derivatives represent an important class of N-containing 
heterocycles with wide range of applications. These derivatives are not found in 
nature and possess a unique property of being resistant to biological degradation. This 
property makes it possible to use tetrazoles as isosteric substitutes for various 
functional groups in order to develop them as potential medicinal agents.1 The 
tetrazole group has been used as a successful bioisosteric replacement for carboxylic 
acid groups2 which has led to the development of  drug compounds like Lasortan, 
Irbesartan, Tomelukast, and PTZ(2) (Figure 52). 5-Substituted tetrazoles are reported 
to possess important biological profiles like potential drugs against schizophrenia and 
cerebral ischemia,3 antidiabetic,4 antiviral,5 antibacterial6 and antihypertensive 
activities.7 These compounds are also regarded as important synthetic intermediates in 
synthetic organic chemistry.8 They also show good coordination properties and are 
used as ligands in coordination chemistry. These derivatives also find use in the fields 
of propellants, explosives and material chemistry.9-10 
 
Fig. 52: Representative drugs based on tetrazoles. 
Many available methods for the synthesis of tetrazoles include [3 + 2] cycloaddition 
of azide to nitriles,11 reaction of primary amines with NaN3 and triethyl 
                                                          
* Nayeem Ahmed, Zeba N. Siddiqui, RSC Advances, 5 (2015) 16707. 
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orthoformate,12 nucleophilic substitution by an azide anion13 and addition of NaNO2 
to aminoguanidine.14 But [3+2] cycloaddition still remains the most employed method 
for the synthesis of 5-substituted tetrazoles. Few efforts were devoted to develop 
multicomponent protocols for the synthesis of 5-substituted tetrazoles, but long 
reaction times and limited substrate tolerance hampers their practical applicability. 
5.2. REVIEW OF LITERATURE 
Some recent examples of the synthesis of tetrazole derivatives via three 
component reaction of aldehydes, malononitrile and sodium azide 
5.2.1. Multicomponent diastereoselective synthesis of new 5-substituted 1H-
tetrazoles.15 
Z. N. Tisseh et al. reported multicomponent synthesis of new 5-substituted-tetrazoles 
via domino Knoevenagel condensation/1,3 dipolar cycloaddition reaction of carbonyl 
compounds, malononitrile and sodium azide in water. 
CHO
X
CN
CN 50
 °C
NaN3
, H2O+
X
H
CN
N
N
NHN
X=
 
H,
 
Br,
 
OH
 
5.2.2. Synthesis and characterization of new 5-substituted 1H-tetrazoles in 
water.16 
M. Mahkam et al. reported a catalyst-free protocol for the synthesis of tetrazoles. The 
merits of the presented protocol were catalyst-free conditions, water as a solvent and 
good yields. 
CN
CN 50
 °C
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, H2O+
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N N
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5.2.3. Multicomponent synthesis of 3-(1H-tetrazol-5-yl)coumarins.17 
Z. N. Tisseh et al. reported a straightforward synthesis of 3-(1H-tetrazol-5-yl) 
coumarins via domino Knoevenagel condensation, Pinner reaction, and 1,3-dipolar 
cycloaddition of substituted salicylaldehydes, malononitrile, and sodium azide in 
water. 
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5.2.4. Synthesis of N-rich heterocycles via multi-component reactions.18 
Z. N. Tisseh et al. reported the synthesis of 1H-tetrazoles via multicomponent 
reaction of α-dicarbonyl compounds, 2,3-diaminomaleonitrile and sodium azide 
without any catalyst using DMSO as a solvent. 
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5.3. PRESENT WORK 
Meeting the challenges of sustainability and global energy requirements are currently 
the major concerns of the scientists throughout the world. Catalysis is an important 
tool which can assist in meeting those challenges via the development of sustainable 
pathways for the production of industrially important organic chemicals. With the 
advent of green chemistry, catalysis has taken the centre stage by leading to efficient 
and eco-friendly synthetic protocols that avoid the use of volatile organic solvents, 
toxic reagents, and harsh reaction conditions.19 Heterogenisation of a successful 
homogeneous catalyst is a very good way to design a sustainable catalyst. Among 
many techniques available for heterogenisation, covalent binding is considered to be 
the best, because the catalyst becomes sufficiently robust to survive the harsh reaction 
conditions and simultaneously minimizes leaching, which in turn allows the catalyst 
to be recycled and reused.20 
The important aspect of reducing the environmental impact of a synthetic process is 
the optimization of energy consumption and in this context, the use of microwave 
(MW) irradiations as a heat source represents a good alternative to conventional 
heating.21 The use of MW irradiations in conventional solvents has developed very 
rapidly, and now the main focus has shifted towards the use of greener solvents such 
as water, for the development of environmentally benign processes. As water is 
abundantly available in nature and devoid of any toxic properties, it is advantageous 
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to carry out reactions in aqueous media. Moreover, it is a well-established fact that the 
combination of heterogeneous catalysts and microwaves has led to the development 
of effective, rapid and environmentally benign synthetic methods.22 Keeping in view 
the environmental concerns, we describe, in this chapter, the synthesis of silica 
molybdic acid (SMA), its characterization, and its application for the synthesis of 
functionalized tetrazoles via three component addition of aldehydes, malononitrile 
and sodium azide in water using microwaves. 
5.4. RESULTS AND DISCUSSION 
Scheme 15 illustrates the concise route for the preparation of the catalyst. The 
reaction of silica with SOCl2 gives silica chloride, which further undergoes 
nucleophilic substitution by sodium molybdate followed by stirring in 0.1N HCl 
solution to afford silica molybdic acid (SMA). The amount of H+ is determined by 
back titration analysis using standard 0.01N NaOH solution and is found to be equal 
to 0.23 meq/gm of the catalyst. 
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Scheme 15: Schematic representation of the synthesis of silica molybdic acid (SMA) 
5.4.1. Characterization of the catalyst 
5.4.1a. FT-IR spectral analysis 
The FT-IR spectra of sodium molybdate and SMA were studied in order to confirm 
the presence of molybdate moieties on silica surface. In FT-IR spectrum of sodium 
molybdate (Figure 53a) characteristic Mo ̶ O stretching frequencies were obtained at 
865 and 912 cm-1.23 In the FT-IR spectrum of SMA (Figure 53b) characteristic 
frequencies corresponding to silica and molybdate groups were observed. The Mo ̶ O 
stretching vibrations in [MoO4]2- species were obtained at 873 and 975 cm-1 and the 
broad peak in the range 1000-1200 cm-1 was attributed to antisymmetric Si ̶ O ̶ Si 
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stretching. The Si ̶ O ̶ Si symmetric stretching was obtained at 803 cm-1. The FT-IR 
spectra, thus, shows successful functionalization of molybdate groups on the surface 
of silica. 
 
Fig. 53: FT-IR spectrum (a) of sodium molybdate, (b) of silica molybdic acid and (c) 
of recycled silica molybdic acid. 
5.4.1b. XRF analysis 
XRF analysis was performed in order to determine the actual composition of the 
catalyst (Table 25). The analysis confirmed the presence of molybdate groups in the 
silica matrix. The actual composition of the catalyst was found as 84.60 (%W/W) 
SiO2 (entry 1) and 1.58 (%W/W) MoO4 (entry 2). 
Table 25: XRF data of Silica Molybdic acid 
Entry Compound Concentration 
1 SiO2 84.60% 
2 MoO4 1.58% 
3 V2O5 0.34% 
4 Cl 0.04% 
5 SO3 0.04% 
6 CaO 0.03% 
7 Al2O3 0.02% 
8 Fe2O3 0.02% 
9 TiO2 0.02% 
10 Others + LOI* 13.25% 
*LOI= Loss on ignition 
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5.4.1c. XRD analysis 
The XRD analysis showed that the diffraction pattern of the catalyst (Figure 54a) was 
similar to that of support (Figure 54b). The peaks of MoO4 group obtained in the 
range of 2θ 20-35° merged with the broad peak of SiO2, at 2θ 20-30°.24 The presence 
of MoO4 groups was further confirmed by comparing the data with PDF#852405. The 
peaks obtained at 24.086, 25.921, 27.672 and 29.558 confirmed the presence of 
molybdate groups on the silica surface. 
 
Fig. 54: XRD analysis (a) of fresh SMA and (b) of silica. 
5.4.1d. Thermogravimetric (TG) analysis 
TG analysis was performed in order to determine the stability and the amount of 
molybdate groups on the surface of silica (Figure 55). The TG curve showed a first 
weight loss of 15.09% up to 200 °C which can be attributed to loss of physisorbed 
water molecules. The second weight loss of 5.12% in the range 301 °C - 579 °C, 
shown by TG curve, was due to the loss of molybdate groups covalently bound to 
silica surface. Thus, it can be concluded that the catalyst is stable up to 300 °C.  
The amount of molybdate groups bound to silica surface was also calculated by TG 
analysis. The weight loss of 5.12 % corresponded to 0.051gm of molybdate in 1 gm of 
catalyst, which, therefore, amounted to loading of 0.21mmol/gm of the catalyst, as 
also confirmed by back titration analysis. 
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Fig. 55: TG analysis of SMA. 
5.4.1e. SEM-EDX and Elemental mapping analyses 
The SEM analysis was performed in order to observe the changes in the surface 
morphology of silica after functionalization. The images showed the change in surface 
morphology of the silica (Figure 56a) after functionalization with molybdate groups 
(Figure 56b). The EDX analysis confirmed the successful incorporation of molybdate 
groups on the silica surface (figure 57), by showing the presence of Mo in addition to 
O and Si elements. The elemental mapping analysis (Figure 58) showed a uniform 
distribution of molybdate groups on the surface of the silica. 
 
Fig. 56: SEM images (a) of silica and (b) of silica molybdic acid (SMA). 
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Fig. 57: EDX analysis of SMA showing presence of Mo in addition to Si and O. 
 
Fig. 58: Elemental mapping showing distribution of Mo on the surface of 
silica. 
5.4.2. Optimization of reaction conditions 
5.4.2a. Effect of different catalysts and solvents 
The optimization studies were initiated by carrying out model reaction between 
thiophene-2-carboxaldehyde (6h), malononitrile (7c) and sodium azide. The reaction 
was tested under a variety of reaction conditions, which included screening of 
different catalysts, solvents and influence of the catalyst amount. The reaction without 
any catalyst afforded the product with moderate yield in 24h (Table 26, entry 1). 
Unsatisfactory results were obtained by using silica gel and silica chloride as catalysts 
(Table 26, entries 2&3). Moderate yield of the product was obtained in longer 
reaction time period when FeCl3 and AlCl3 were used as catalysts (entries 4&5). 
AcOH as a catalyst also couldn’t show promising result (entry 6).  Reaction catalysed 
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by H2MoO4 gave good yield of the product in 6.1h (entry 7). However, best result, 
(product yield of 85% in 4.5h) was obtained when SMA was used as a catalyst (entry 
8). After obtaining the right catalyst for this reaction, the reaction conditions were 
further optimized by the screening of different solvents. Solvents like ethanol, 
methanol, toluene, benzene, ethylene glycol, PEG-200 and water were screened to test 
the efficiency of the catalyst and the results are summarized in Table 26 (entries 8-
14). The results clearly indicated the superiority of water over the other solvents 
(entry 8). The increased reactivity in water can be attributed to the development of 
hydrogen bonding between water and azide ion, which stabilizes the intermediate 
structures during the formation of products. The hydrophobic effects generated by 
water also help in increasing the rate of reaction by decreasing the hydrocarbon–water 
interfacial area. In order to further improve the protocol to make it energy sustainable, 
the reaction mixture was irradiated with microwaves. As visualized a remarkable 
improvement in the yield of the product was observed in very short time period 
(Table 26, entry 15). The rate enhancement of reaction is due to the efficient 
interaction of molecules in reaction mixture with microwaves. Further water being a 
polar solvent has a good potential to absorb microwaves and convert them into heat 
energy, consequently accelerating the rate of reactions in aqueous medium as 
compared to results obtained using conventional heating (Table 26, entries 8 & 15). 
Table 26: Effect of different catalysts and solvents on model reaction 
H
O CN
CN
NaN3+ +
N
N
H
N
N
NC
HSS
(6h) (7c) (12g)  
Entry Solvent Reaction condition Time Yield (%) 
1 Water (5mL) 
50 °C, Heat, without 
catalyst 
24 h 76 
2 Water (5mL) 
50 °C, Heat, 
Silica gel (100 mg) 
19h 72 
3 Water (5mL) 
50 °C, Heat, 
Silica Chloride         
(100 mg) 
22h 69 
4 Water (5mL) 
50 °C, Heat, FeCl3     
(10 mol%) 
6.4h 77 
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5 Water (5mL) 
50 °C, Heat, AlCl3     
(10 mol%) 
6.2h 73 
6 Water (5mL) 
50 °C, Heat, AcOH    
(10 mol%) 
7.6h 69 
7 Water (5mL) 
50 °C, Heat, H2MoO4 
(100 mg) 
6.1h 77 
8 Water (5mL) 
50 °C, Heat, SMA   
(100 mg) 
4.5 h 85 
9 Ethanol (5mL) 
50 °C, Heat , SMA  
(100 mg) 
6 h 65 
10 Methanol (5mL) 
50 °C, Heat, SMA   
(100 mg) 
6.5 h 61 
11 Toluene (5mL) 
50 °C, Heat, SMA   
(100 mg) 
9 h 25 
12 Benzene (5mL) 
50 °C, Heat, SMA   
(100 mg) 
9 h 23 
13 
Ethylene glycol 
(5mL) 
50 °C, Heat, SMA   
(100 mg) 
10 h 33 
14 PEG-200 (5mL) 
50 °C, Heat, SMA   
(100 mg) 
8.5 h 35 
15 Water (5mL) 
50 °C, Microwaves, 
SMA (100 mg) 
15 min 93 
 
5.4.2b. Effect of catalyst loading 
The effect of the catalyst loading on the model reaction (Table 27) revealed that 0.1 g 
of the catalyst was sufficient to get the maximum yield of the product (Table 27, 
entry 3). Decreasing the amount of catalyst to 0.03 g decreased the yields with 
increase in time period for completion of the reaction (entries 1,2). Increasing the 
catalyst amount did not have any effect on the reaction (entries 4,5). Therefore, 0.1 g 
SMA was found to be the optimum amount of catalyst. 
Table 27: Effect of catalyst loading 
H
O CN
CN
NaN3+ +
N
N
H
N
N
NC
HSS
SMA
Water
 
(5mL)
M icrowaves, 50
 °C
(6h) (7c) (12g)  
Entry Catalyst loading (g) Time(min) Yield (%) 
1 0.03 35 71 
2 0.05 20 87 
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3 0.10 15 93 
4 0.15 15 93 
5 0.20 15 91 
5.4.2c. Effect of temperature 
The effect of temperature on the model reaction was studied and it was found that 
reaction was influenced by the change in temperature (Table 28). At room 
temperature the reaction completed in 75 min with poor yield of the product (Table 
28, entry 1). When the temperature was increased to 40 °C, improved product yield 
was obtained in 35 min (entry 2). When the temperature was increased to 50 °C, best 
result of 93 % product yield in 15 min was obtained (entry 3). Further increase in 
temperature to 70 °C resulted in decrease in the product yield (entry 4). 
Table 28: Effect of reaction temperature 
H
O CN
CN
NaN3+ +
N
N
H
N
N
NC
HSS
SMA
 
(0
.1g)
Water
 
(5mL)
M icrowaves
(6h) (7c) (12g)  
Entry Temperature (°C) Time (min) Yield (%) 
1 Room Temp. 75 25 
2 40 35 66 
3 50 15 93 
4 70 15 90 
 
5.4.2d. Effect of the amount of NaN3 
The effect of the amount of the NaN3 on the product formation (Table 29) was also 
evaluated and it was observed that under the optimum thermal reaction conditions, 
without any catalyst, 2 mmols of NaN3 were required for the satisfactory product 
formation (Table 29, entry 2). With the use of 0.1g of SMA as a catalyst, 1.5 mmol 
NaN3 was required to obtain good yield of the product (entry 4). By irradiating the 
reaction mixture under the optimized reaction conditions, it was observed that 1 mmol 
of NaN3 was enough to give maximum product yield (entry 5). Thus, the use of 
microwaves further added to greenness of the procedure by making the reaction atom 
economical. 
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Table 29: Effect of the amount of NaN3 
H
O CN
CN
NaN3+ +
N
N
H
N
N
NC
HSS
(6h) (7c) (12g)  
Entry Condition NaN3 (mmol) Yield (%) 
1 50 °C, Stirring 1 57 
2 50 °C, Stirring 2 79 
3 50 °C, Stirring, SMA (0.1g) 1 73 
4 50 °C, Stirring, SMA (0.1g) 1.5 85 
5 50 °C, Microwaves, SMA (0.1g) 1 93 
 
5.4.2e. Catalytic reaction 
With the optimal conditions in hand, the substrate scope of SMA catalysed synthesis 
of tetrazole derivatives was examined under both conventional and microwave 
heating (scheme 16). The results indicated that aldehydes containing both activating 
and deactivating groups reacted efficiently with malononitrile and sodium azide to 
afford the corresponding tetrazoles in excellent yields (Table 30). The heterocyclic 
aldehydes bearing substituents like chromone, quinoline and thiophene also reacted 
effortlessly giving the expected products in good to excellent yields. Under 
conventional heating, the catalyst showed good efficiency giving the products in 3.5-
5.5 h, whereas excellent efficiency of 89-95% product yield in 15 min was observed 
under microwave irradiation. The results thus, demonstrated SMA to be an efficient 
catalyst for the preparation of large spectrum of substituted tetrazoles in very high 
yields under aqueous conditions.  
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Scheme 16: General scheme for the synthesis of tetrazole deriatives. 
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The structural assignment of all the compounds was done by elemental and 
spectroscopic data (IR, NMR and mass). The IR spectrum of 12h (Figure 59) showed 
NH strtetching frequency at 3439 cm-1 and CN stretching band at 2220 cm-1. The C=C 
stretchig frequency was obtained at 1575 cm-1. The 1H-NMR spectrum (Figure 60) 
showed a singlet for olefinic proton at δ 8.45. The two hydrogen atoms of thiophene 
ring gave characteristic doublets at δ 7.75 and 7.04, respectively. The NH proton was 
discernible at δ 3.33. The 13C-NMR spectrum (Figure 61) showed peaks for all the 
carbon atoms and are provided in spectral data section. Further structural confirmation 
was provided by ESI-Mass spectrum (Figure 62) which showed the molecular ion 
peak as the base peak at m/z 218.1 (M++1). 
 
Fig. 59: FT-IR spectrum of 12h 
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Fig. 60: 1H-NMR spectrum of 12h 
 
 
Fig. 61: 13C-NMR spectrum of 12h 
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Fig. 62: ESI-Mass spectrum of 12h 
Table 30: Synthesis of tetrazole derivatives 
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5.4.3. Reaction mechanism 
The plausible reaction mechanism is presented in Scheme 17. Protonation of aldehyde 
6 by the catalyst initiates the reaction by generating the active species T, which 
undergoes knoevenagel condensation reaction to form 
aryl/heteroarylidenemalononitrile U. The activation of the nitrile group of the 
intermediate U by protonation stimulates the attack of the azide ion, which leads to 
the formation of an open imidoyl azide intermediate V.  This intermediate V 
subsequently cyclises to intermediate W via [3+2] cycloaddition reaction and upon 
further addition of HCl, finally generates the product 12.25 
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Scheme 17: Plausible reaction mechanism for the formation of tetrazoles. 
5.4.4. Recyclability of the catalyst 
The potential of recyclability of SMA was evaluated using model reaction. After 
completion of the reaction, the reaction mixture was extracted with ethyl acetate 
followed by filtration of the catalyst. The catalyst was then reused for subsequent 
cycles and was found to maintain good activity for a minimum of seven reaction 
cycles in water with over 83 % product yield (Figure 63). The FT-IR spectra of the 
catalyst after seven runs (Figure 53c) displayed the same vibrational fingerprint of the 
freshly prepared catalyst indicating the stability of the catalyst throughout the 
recycling study. 
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Fig. 63: Recycling data of SMA 
5.5. CONCLUSION 
In conclusion we successfully synthesised silica molybdic acid and used it for the 
synthesis of tetrazole derivatives in water under both conventional and microwave 
irradiation. The protocol tolerated aldehydes with diverse structural motifs giving 
corresponding tetrazoles in excellent yields. Use of water as a green solvent coupled 
with microwaves, low reaction times, recyclable catalyst and excellent yields of the 
products are advantages of the presented protocol. 
5.6. EXPERIMENTAL 
5.6.1. Synthesis of silica chloride 26 
A mixture of silica–gel (10 g) and thionyl chloride (40 mL) was refluxed for 48 h in a 
round bottomed flask (250 mL) equipped with a condenser and a drying tube (CaCl2 
as a drying agent). The resulting white-greyish powder was filtered and stored in a 
tightly capped bottle. 
5.6.2. Synthesis of silica molybdic acid (SMA) 
A mixture of silica chloride and sodium molybdate in n-hexane (10 mL) was stirred 
under refluxing conditions for 5 h. The reaction mixture was then filtered, washed 
with distilled water and dried at 120 °C in an oven for 6h. The resulting mixture was 
then further stirred in 0.1N HCl solution (40 mL) for 1 h, filtered, washed with 
distilled water and dried in an oven at 120 °C for 6h to finally obtain the catalyst. 
5.6.3. General procedure for the synthesis of tetrazoles under thermal condition 
A mixture of aldehyde (2 mmol), malononitrile (2 mmol), sodium azide (3 mmol) and 
catalyst (SMA, 200 mg) in 10 mL water was stirred at 50 °C for appropriate period of 
time (Table 30). After completion of reaction (monitored by TLC), the reaction 
mixture was allowed to cool and added 10 mL of 2N HCl solution with vigorous 
93 93 90 90 87 85 83 
1 2 3 4 5 6 7 
Yi
el
d(
%
) 
No. of cycles 
Time = 15 min 
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stirring. The precipitate obtained was extracted by ethyl acetate, washed with water (3 
× 10 mL), dried over anhydrous Na2SO4 and evaporated under reduced pressure to 
obtain the product. The remaining solid catalyst was separated by filtration, washed 
with ethyl acetate (3 x 10 mL) and reused for further catalytic cycles. The crude 
product was recrystallized from ethanol to afford the pure product. 
5.6.4. General procedure for the synthesis of tetrazoles under microwave irradiation 
A mixture of aldehyde (2 mmol), malononitrile (2 mmol), sodium azide (2 mmol) and 
catalyst (SMA, 200 mg) in 10 mL water was taken in a G30 vial and irradiated with 
microwaves with continuous stirring at 50 °C for 15 min (Table 30). After 
completion of reaction (monitored by TLC), the reaction mixture was allowed to cool 
and added 10 mL of 2N HCl solution with vigorous stirring. The precipitate as 
obtained was extracted by ethyl acetate, washed with water (3 × 10 mL), dried over 
anhydrous Na2SO4 and evaporated under reduced pressure to obtain the product. The 
remaining insoluble solid catalyst in aqueous phase was separated by filtration, 
washed with ethyl acetate (3 x 10 mL) and reused for further catalytic cycles. The 
crude product was recrystallized from ethanol to afford the pure product. 
5.6.5. Spectral data of synthesised compounds 
N
N
H
N
N
NC
H
N
N
H3C
Cl
12a
 
3-(5-chloro-3-methyl-1-phenylpyrazol-4-yl)-2-(1H-tetrazol-5-yl) 
acrylonitrile  
Cream coloured solid, M.p. 125-130 °C. Anal. Calcd. 
(C14H10ClN7) C, 53.94; H, 3.23; N, 31.45. Anal. Found 
(C14H10ClN7) C, 53.88; H, 3.28; N, 31.51. IR (KBr, cm-1): 3435 
(NH), 2227 (CN), 1676 (C=C). 1H NMR (400 MHz, CDCl3) δ 
8.30 (s, 1H), 7.51-7.59 (m, Ar-H, 5H), 3.34 (s, 1H, NH), 2.52 (s, 
3H, CH3). 13C NMR (100 MHz, CDCl3):159.71, 155.48, 149.29, 
137.53, 134.32, 129.17, 127.62, 123.98, 118.13, 116.49, 114.21, 
15.14. ESI-MS m/z 312.1 (M++1). 
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N
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N
N
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12b
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3-(4-oxo-4H-[1]benzopyran-3-yl)-2-(1H-tetrazol-5-yl) 
acrylonitrile  
Cream coloured solid, M.p. 255-260 °C. Anal. Calcd. 
(C13H7N5O2) C, 58.87; H, 2.66; N, 26.41. Anal. Found. 
(C13H7N5O2) C, 58.81; H, 2.70; N, 26.45. IR (KBr, cm-1): 3462 
(NH), 2228 (CN), 1653 (C=O), 1605 (C=C). 1H NMR (400 
MHz, DMSO-d6) δ 8.27 (s, 1H), 7.18-8.11 (m, Ar-H, 4H), 6.79 
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(s,1H, H2”), 4.08 (s, NH, overlap with solvent). 13C NMR (100 
MHz, DMSO-d6): 185.64, 164.39, 150.38, 147.12, 146.49, 
135.77, 129.52, 128.51, 127.28, 119.02, 117.13, 114.57, 112.28. 
ESI-MS m/z 266.2 (M++1).  
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O
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N
H
N
N
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3-(6-Methyl-4-oxo-4H-[1]benzopyran-3-yl)-2-(1H-tetrazol-5-yl) 
acrylonitrile  
Cream coloured solid, M.p. 260-265 °C. Anal. Calcd. 
(C14H9N5O2) C, 60.21; H, 3.25; N, 25.08. Anal. Found 
(C14H9N5O2) C, 60.25; H, 3.31; N, 25.03. IR (KBr, cm-1): 3414 
(NH), 2229 (CN), 1659 (C=O), 1598 (C=C). 1H NMR (400 
MHz, DMSO-d6) δ 8.23 (s, 1H), 7.26-8.15 (m, Ar-H, 3H), 6.88 
(s, 1H, H2”), 4.10 (s, NH, overlap with solvent), 2.27 (s, 3H, 
CH3). 13C NMR (100 MHz, DMSO-d6): 188.21, 162.54, 151.22, 
147.36, 145.91, 137.44, 135.18, 129.11, 128.34, 121.09, 118.22, 
113.63, 111.79, 25.38. ESI-MS m/z 280.1 (M++1). 
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3-(6-chloro-4-oxo-4H-[1]benzopyran-3-yl)-2-(1H-tetrazol-5-yl) 
acrylonitrile 
Cream coloured solid, M.p. 263-268 °C. Anal. Calcd. 
(C13H6ClN5O2) C, 52.10; H, 2.02; N, 23.37. Anal. Found 
(C13H6ClN5O2) C, 52.16; H, 1.95; N, 23.42. IR (KBr, cm-1): 3423 
(NH), 2225 (CN), 1665 (C=O), 1585 (C=C). 1H NMR (400 
MHz, DMSO-d6) δ 8.31 (s, 1H), 7.25-8.23 (m, Ar-H, 3H), 6.73 
(s, 1H, H2”), 3.90 (s, NH, overlap with solvent). 13C NMR (100 
MHz, DMSO-d6): 183.51, 163.22, 150.57, 146.88, 144.91, 
136.22, 131.27, 130.17, 126.22, 120.55, 119.86, 114.18, 112.54. 
ESI-MS m/z 300.1 (M++1). 
O O
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12e  
3-(4-chloro-2-oxo-2H-[1]benzopyran-3-yl)-2-(1H-tetrazol-5-yl) 
acrylonitrile  
Light yellow solid, M.p. 230-235 °C. Anal. Calcd. 
(C13H6ClN5O2) C, 52.10; H, 2.02; N, 23.37. Anal. Found 
(C13H6ClN5O2) C, 52.07; H, 2.07; N, 23.41. IR (KBr, cm-1): 3441 
(NH), 2219 (CN), 1642 (C=O), 1591 (C=C). 1H NMR (400 
MHz, DMSO-d6) δ 8.72 (s, 1H), 7.38-7.77 (m, Ar-H, 4H), 3.28 
(s, NH, overlap with solvent). 13C NMR (100 MHz, DMSO-d6): 
167.23, 158.56, 151.18, 148.54, 142.71, 138.44, 131.52, 129.76, 
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127.94, 126.33, 121.41, 119.92, 110.55. ESI-MS m/z 300.1 
(M++1). 
N Cl
N
N
H
N
N
NC
H
12f  
3-(2-chloro-4quinolinyl)-2-(1H-tetrazol-5-yl) acrylonitrile  
Light yellow solid, M.p. 240-245 °C. Anal. Calcd. (C13H7ClN6) 
C, 55.23; H, 2.50; N, 29.73. Anal. Found (C13H7ClN6) C, 55.19; 
H, 2.55; N, 29.77. IR (KBr, cm-1): 3432 (NH), 2220(CN), 
1588(C=C). 1H NMR (400 MHz, DMSO-d6) δ 8.74 (s, 1H), 
7.24-7.80 (m, Ar-H, 5H), 3.30 (s, NH, overlap with solvent). 13C 
NMR (100 MHz, DMSO-d6): 157.56, 154.05, 149.33, 146.68, 
136.88, 130.07, 129.17, 128.62, 127.58, 126.96, 117.49, 115.29. 
ESI-MS m/z 283.1 (M++1). 
N
N
H
N
N
NC
HS
12g  
3-(thiophen-2-yl)-2-(1H-tetrazol-5-yl) acrylonitrile 
White solid, M.p. 132-137 °C. Anal. Calcd. (C8H5N5S) C, 
47.28; H, 2.48; N, 34.46. Anal. Found (C8H5N5S) C, 47.33; H, 
2.43; N, 34.50. IR (KBr, cm-1): 3456 (NH), 2223(CN), 
1571(C=C). 1H NMR (400 MHz, CDCl3) δ 8.41 (s, 1H), 7.72 (d, 
1H, CH, J=3.74), 6.97 (d, 1H, CH, J=3.11), 3.34 (s, 1H, NH). 
13C NMR (100 MHz, CDCl3): 151.22, 145.67, 142.51, 133.76, 
132.41, 127.87, 118.58, 112.09. ESI-MS m/z 204.1 (M++1). 
N
N
H
N
N
NC
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3-(5-methyl-thiophen-2-yl)-2-(1H-tetrazol-5-yl) acrylonitrile 
White solid, M.p. 135-140 °C. Anal. Calcd. (C9H7N5S) C, 
49.76; H, 3.25; N, 32.24. Anal. Found (C9H7N5S) C, 49.82; H, 
3.21; N, 32.27. IR (KBr, cm-1): 3439 (NH), 2220 (CN), 1575 
(C=C). 1H NMR (400 MHz, CDCl3) δ 8.45 (s, 1H), 7.75 (d, 1H, 
CH, J=3.84), 7.04 (d, 1H, CH, J=3.04), 3.33 (s, 1H, NH), 2.63 (s, 
3H, CH3). 13C NMR (100 MHz, CDCl3): 151.72, 146.45, 142.12, 
134.71, 132.13, 125.53, 119.18, 114.23, 15.27. ESI-MS m/z 
218.1 (M++1). 
N
N
H
N
N
NC
H
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3-(4-methoxyphenyl)-2-(1H-tetrazol-5-yl) acrylonitrile 
White solid, M.p. 156-160 °C. Anal. Calcd. (C11H9N5O) C, 
58.14; H, 3.99; N, 30.82. Anal. Found (C11H9N5O) C, 58.19; H, 
3.94; N, 30.87. IR (KBr, cm-1): 3433 (NH), 2219 (CN), 1566 
(C=C). 1H NMR (400 MHz, CDCl3) δ 8.28 (s, 1H), 7.10-8.00 
(m, Ar-H, 4H), 3.90 (s, 3H, OCH3), 3.33 (s, 1H, NH). 13C NMR 
(100 MHz, CDCl3): 163.04, 151.52, 141.97, 132.25, 126.18, 
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120.11, 119.44, 100.37. 59.88. ESI-MS m/z 228.1 (M++1). 
N
N
H
N
N
NC
H
Cl 12j  
3-(4-chlorophenyl)-2-(1H-tetrazol-5-yl) acrylonitrile 
White solid, M.p. 165-168 °C. Anal. Calcd. (C10H6ClN5) C, 
51.85; H, 2.61; N, 30.23. Anal. Found (C10H6ClN5) C, 51.79; H, 
2.66; N, 30.27. IR (KBr, cm-1): 3434 (NH), 2224 (CN), 1580 
(C=C). 1H NMR (400 MHz, CDCl3) δ8.32(s, 1H), 7.15-8.21 (m, 
Ar-H, 4H), 3.35 (s, 1H, NH). 13C NMR (100 MHz, CDCl3): 
165.18, 152.26, 143.71, 134.21, 125.07, 121.81, 119.13, 101.56. 
ESI-MS m/z 232.1 (M++1). 
N
N
H
N
N
NC
H
HO
O
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3-(4-hydroxy-3-methoxyphenyl)-2-(1H-tetrazol-5-yl) acrylonitrile 
White solid, M.p. 164-169 °C. Anal. Calcd. (C11H9N5O2) C, 
54.32; H, 3.73; N, 28.79. Anal. Found (C11H9N5O2) C, 54.36; H, 
3.68; N, 28.81. IR (KBr, cm-1): 3441 (NH), 3122(OH), 2220 
(CN), 1588 (C=C). 1H NMR (400 MHz, CDCl3) δ 8.18 (s, 1H), 
6.79-7.52 (m, Ar-H, 3H), 10.21 (s, 1H, OH), 3.98 (s, 3H, OCH3), 
3.31 (s, 1H, NH). 13C NMR (100 MHz, CDCl3): 168.05, 154.22, 
140.54, 131.31, 130.89, 130.17, 129.58, 127.19, 119.55, 102.28, 
54.25. ESI-MS m/z 244.1 (M++1). 
N
N
H
N
N
NC
H
NO2
12l
 
3-(3-nitrophenyl)-2-(1H-tetrazol-5-yl) acrylonitrile 
White solid, M.p. 159-163 °C. Anal. Calcd. (C10H6N6O2) C, 
49.59; H, 2.50; N, 34.70. Anal. Found. (C10H6N6O2) C, 49.63; 
H, 2.56; N, 34.67. IR (KBr, cm-1): 3430 (NH), 2219 (CN), 1575 
(C=C). 1H NMR (400 MHz, CDCl3) δ 8.25 (s, 1H), 7.86-8.18 
(m, Ar-H, 4H), 3.34 (s, 1H, NH). 13C NMR (100 MHz, CDCl3): 
157.23, 149.17, 146.38, 140.27, 136.71, 130.88, 127.27, 125.35, 
119.88, 102.72. ESI-MS m/z 243.1 (M++1). 
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Highly efﬁcient ZnO nanoparticle catalyzed one-pot solvent-free synthesis of novel pyridine derivatives
by three-component reaction of b-enaminones, different active methylene compounds, and ammonium
acetate via Michael addition, cyclodehydration, and elimination sequence is reported. The catalyst was
recyclable up to six catalytic cycles without a signiﬁcant loss in the catalytic activity. This new protocol
has the advantages of environmental friendliness, higher yields, solvent-free, low loading of catalyst,
shorter reaction times, and convenient operation procedure. ZnO nanoparticles were characterized by
XRD, SEM, and TEM analyses.
 2013 Elsevier Ltd. All rights reserved.
The greenest solvent, in terms of reducing waste, is no solvent.
Due to the toxic, ﬂammable, and expensive nature of organic sol-
vents,1 special emphasis has been placed toward solvent-free reac-
tions. Overall the advantages of solvent-free organic synthesis are
shorter reaction times, cleaner reaction products, and environmen-
tally more benign conditions compared with the classical
reactions.2 The use of nano-sized inorganic solid oxides as hetero-
geneous catalysts has received much attention because of their
high level of chemoselectivity, environmental compatibility, sim-
plicity of operation, and their availability at low cost.3 Catalytic
efﬁciency depends on the surface area of the catalyst. As nanopar-
ticles provide a very large surface area because of their high surface
to volume ratio and low-coordinated sites, their use as catalysts is
quite encouraging.4
Among the nitrogen-containing heterocycles, pyridine deriva-
tives constitute one of the most important classes of compounds
as they widely occur as key structural subunits in numerous natu-
ral products that exhibit many interesting biological activities.5–7
These derivatives possess a large spectrum of biological activities
like anti-prion,8 anti-hepatitis B virus,9 anti-bacterial,10 and anti-
cancer.11 Recently, some of these compounds have been recog-
nized as potential targets for the development of new drugs for
the treatment of Parkinson’s disease, hypoxia, asthma, kidney dis-
ease, epilepsy, cancer, and Creutzfeldt–Jakob disease.12–14
b-Enaminones turned out to be simple synthetic intermediates
for the subject of the present synthesis due to the presence of amb-
ident nucleophilic character of enamine moiety and the ambident
electrophilic character of enone moiety. Taking advantage of their
electronic properties we used heteroaryl b-enaminones for the
synthesis of these substituted pyridines. Synthesis of these substi-
tuted pyridines is reported by the reaction of b-enaminones with
b-dicarbonyls in the presence of ammonium acetate in reﬂuxing
acetic acid,15 using Montmorillonite K10 in 2-propanol,16
K5CoW12O403H2O,17 and CeCl3/NaI.18 However, these methods
exhibit limited substrate tolerance and reactivity, suffer from low
yields, and use of toxic solvents. Owing to numerous advantages
due to its eco-friendly nature, ZnO NPs have been explored as a
powerful catalyst for several organic transformations.19–21 On the
basis of our progressive endeavors in exploring novel one-pot reac-
tions22,23 we, herein, report an efﬁcient ZnO nanoparticle cata-
lyzed, solvent-free, regioselective synthesis of novel substituted
pyridines through Michael addition, cyclodehydration, and elimi-
nation sequence.24
To recognize the optimization of the reaction conditions, the
reaction was studied by employing a series of catalysts in solvents
and solvent-free conditions with the expectation to maximize the
product yield in short reaction time (Table 1). Initially, b-enami-
none 1a, ethyl acetoacetate 3b, and ammonium acetate were
reﬂuxed in AcOH as the solvent without any catalyst. The reaction
took a longer time period of 24 h to complete and afforded product
in less yield (Table 1, entry 1), demonstrating the need of a catalyst.
The reaction was then studied in the presence of catalysts such as
sulfamic acid, P2O5, P2O5–silica, NaHSO4–SiO2, ZnO, MgO, and ZnO
NPs under solvents EtOH and AcOH, and solvent-free reaction con-
ditions (Table 1). Among all the catalysts and solvents, ZnO NPs un-
der solvent-free condition proved to be most efﬁcient in terms of
reaction time and product yield.
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a  b  s  t  r  a  c  t
A  simple,  efﬁcient  and  environmentally  benign  on-water  protocol  for the synthesis  of  novel  1,4-
dihydropyridine  derivatives  via  pseudo  four component  addition  and  cyclization  sequence  using
mesoporous  alumina  sulphuric  acid  as  a recyclable  and heterogeneous  catalyst,  has  been  described.  The
catalyst  showed  excellent  catalytic  activity  giving  products  in high  yields  and  could  be reused  for  seven
successive  catalytic  cycles.  The  catalyst  was  characterized  by FT-IR,  XRD,  FE-SEM,  EDX  and  TG  analyses.
The  mesoporosity  of  alumina  was determined  by  BET  and  TEM  analyses.
© 2014  Elsevier  B.V.  All  rights  reserved.
1. Introduction
In the light of green chemistry water is uniquely advanta-
geous as a solvent. It is environmentally benign, non-ﬂammable,
possesses a high heat capacity, and tolerates a wide range of tem-
perature, making it inherently safe. It also possesses the remarkable
ability to catalyze chemical transformations between some insolu-
ble organic reactants and this phenomenon, termed as “on-water”
catalysis by Sharpless and co-workers, was ﬁrst observed in the
late 1930s but is only now being widely adopted [1–8]. Subsequent
mechanistic studies have established that this behaviour results
from enforced hydrophobic interactions [9] and stabilization of the
activated complex by hydrogen-bond formation [10]. Sharpless’s
group has shown that several uni- and bimolecular reactions are
greatly accelerated when carried out in vigorously stirred aqueous
suspensions. These reactions include the important classes such as
cycloadditions, ene reactions, Claisen rearrangements and nucleo-
philic substitutions [1].
Multicomponent reactions (MCRs) have become powerful
tools of synthetic organic chemistry in recent years owing to
exceptional synthetic efﬁciency, intrinsic atom economy, high
selectivity, and procedural simplicity [11]. These reactions enable
∗ Corresponding author. Tel.: +91 9412653054.
E-mail  addresses: siddiqui zeba@yahoo.co.in,  zns.siddiqui@gmail.com
(Z.N. Siddiqui).
straightforward access to large libraries of structurally related,
drug-like compounds and thereby facilitating lead generation and
lead optimization in drug discovery [12]. In a true sense, these rep-
resent environmentally friendly processes by reducing the number
of steps, energy consumption and waste production [13].
Nitrogen  containing heterocycles are subunits found in numer-
ous natural products and many biologically active pharmaceuticals.
Among these 1,4-dihydropyridine substructures are among the
most prevalent, the most famous ones certainly being the cal-
cium agonists Felodipine, Nicardipine, Nimodipine, Nifedipine
(Fig. 1) and NADPH. In addition, these compounds show other
versatile biological proﬁles such as anticonvulsant activity, selec-
tive adenosine-A3 receptor antagonism, radioprotective activity,
sirtuin activation and inhibition, antitumor, antidiabetic, or pho-
tosensitizing activities [14–16]. Conventionally, 1,4-DHPs can be
synthesized via the Hantzsch reaction, reduction of pyridines, addi-
tion to pyridines or cycloadditions, etc. but the Hantzsch reaction
still remains a frequently employed tactic for the synthesis of
these compounds [17]. New efforts to develop structurally diverse
1,4-DHPs led to the utilization of enaminones as substrates and
few reports available in literature employing l-proline/MeOH,
TMSCl, TsOH/DCE, NaAuCl4 and AcOH [17,18] as catalytic systems.
However, these methods exhibit limited substrate tolerance and
reactivity, suffer from low yields, and use of toxic solvents. Hence
it is highly desirable to develop a new protocol for the synthesis
of 1,4-DHPs using enaminones, which is highly efﬁcient, environ-
mentally benign and tolerates wide range of substrates.
http://dx.doi.org/10.1016/j.molcata.2014.07.015
1381-1169/© 2014 Elsevier B.V. All rights reserved.
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Sulphated  silica  tungstic  acid  as  a  highly  efﬁcient  and  recyclable  solid
acid  catalyst  for  the  synthesis  of  tetrahydropyrimidines  and
dihydropyrimidines
Nayeem  Ahmed,  Zeba  N.  Siddiqui ∗
Department of Chemistry, Aligarh Muslim University, Aligarh 202 002, India
a  r  t  i  c  l  e  i  n  f  o
Article history:
Received 9 December 2013
Received  in revised form 16 February 2014
Accepted 18 February 2014
Available online 4 March 2014
Keywords:
SSTA
Tetrahydropyrimidines
Heterogeneous
Solvent-free
Recyclability
a  b  s  t  r  a  c  t
For  the  ﬁrst  time  sulphated  silica  tungstic  acid  (SSTA)  has  been  synthesized  and  used  as  an  acidic  catalyst
in  organic  synthesis.  The  catalyst  was  prepared  by a simple  method  based  on the  reaction  of  silica  with
SOCl2 followed  by addition  of  sodium  tungstate  and  then  functionalization  with  chlorosulfonic  acid.  The
three-component  Biginelli-like  condensation  of  different  heteroaldehydes,  urea  and  ethyl  cyanoacetate
or  phenyl  acetic  acid catalyzed  by SSTA  under  solvent-free  conditions  afforded  novel  tetrahydropyrim-
idines  in high  yields.  The  catalyst  tolerated  different  heteroaldehydes  and  also  catalyzed  the  synthesis
of  Biginelli  compounds  efﬁciently  giving  excellent  yield  of products.  The  catalyst  was characterized  by
FT-IR,  XRD  and  SEM-EDX  analyses.  The  stability  of  the catalyst  was  evaluated  by  DSC  and  TG  analyses.
The  major  advantages  of  the  present  method  are  high  yields,  short  reaction  times,  and  solvent-free  reac-
tion  conditions.  The  activity  and  simple  recyclability  without  losing  catalytic  activity  make  this  catalyst
a  good  replacement  to literature  methods.
©  2014  Elsevier  B.V.  All rights  reserved.
1. Introduction
The catalysts which make the organic reactions environmen-
tally benign and economically feasible are extremely demanded by
the chemical industries. In recent years, preparation of new hetero-
geneous catalysts with improved efﬁciency has been the subject of
immense interest [1]. The ideal method for combining the advan-
tages of homogeneous catalysts (high activity and selectivity, etc.)
with the advantages of heterogeneous catalysts (available active
sites, easy catalyst separation, long catalytic life, thermal stabil-
ity, low hygroscopic properties, easy handling and reusability) is
by immobilization of catalysts on solid support, which leads to
clean chemical synthesis from both environmental and commercial
point of view [2–5]. In modern material science, silica is the ubiq-
uitous inorganic platform used in systems designed for catalysis,
separation, ﬁltration, sensing, optoelectronics and environmental
technology. Due to the favourable chemical and physical proper-
ties of silica surfaces, it is possible to impart nearly any reactive
functional group that one requires on a silica surface (e.g., sulfonic,
amine, carboxyl, thiol, epoxy, and so forth) through well-known
silane chemistry [6–8]. As a result, numerous variations can be
∗ Corresponding author. Tel.: +91 9412653054.
E-mail  address: zns.siddiqui@gmail.com (Z.N. Siddiqui).
made for speciﬁc applications with the use of a combination of
inorganic materials and functional groups which often result in syn-
ergetic effects that lead to increased physical stability and enhanced
chemical functionality [9,10].
The Biginelli multicomponent reaction is a very elegant
methodology to obtain 3,4-dihydropyrimidin-2(1H)-one (DHPMs)
derivatives in a one-step procedure [11]. DHPMs usually display
various biological activities such as calcium channel modula-
tors, adrenergic receptor antagonists, mitotic kinesin inhibitors,
antivirals, antibacterials [12] and compounds such as enastron,
monastrol, piperastrol and other derivatives [13] are well known
biologically active compounds which have already been developed
into drugs.
Moreover tetrahydropyrimidine ring is found in both natural
as well as synthetic organic compounds. Many tetrahydropyrim-
idines containing an amino acid show interesting and diverse
pharmacological activities like HIV protease inhibiting activity
[14], antineoplastic activity [15], antiproliferative [16], herbicidal
activity [17], muscarinic agonist activity [18], anti-inﬂammatory
[19] and antiviral properties [20]. The presently known MCR
protocols for the synthesis of THPMs are via Biginelli-like trans-
formation [21] or alternatively, using the two-step operation of
Knoevenagel condensation and urea annulation [22]. To the best of
our knowledge, not a single multicomponent protocol for the syn-
thesis of THPMs tolerating heteroaldehydes under heterogeneous
http://dx.doi.org/10.1016/j.molcata.2014.02.019
1381-1169/© 2014 Elsevier B.V. All rights reserved.
Cerium Supported Chitosan as an Eﬃcient and Recyclable
Heterogeneous Catalyst for Sustainable Synthesis of Spiropiperidine
Derivatives
Nayeem Ahmed and Zeba N. Siddiqui*
Department of Chemistry, Aligarh Muslim University, Aligarh 202 002, India
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ABSTRACT: A new Ce/chitosan catalyst has been prepared
and used for the highly eﬃcient synthesis of diverse range of
spiropiperidine derivatives via multicomponent reaction of
substituted anilines, formaldehyde and diﬀerent cyclic active
methylene compounds at room temperature in PEG-200. The
catalyst could be reused for ﬁve consecutive cycles without
appreciable loss in catalytic activity. The structure of the catalyst
was determined by IR, XRD, EDX, TEM and ICP-AES
techniques. The present green protocol has advantages such
as novel products, energy sustainability, short reaction times,
high yield of products, economic viability and recyclability of
the catalyst.
KEYWORDS: Heterogeneous, Multicomponent, Spiropiperidine, PEG-200, Green
■ INTRODUCTION
In the last decades, the use of lanthanides as Lewis acids in
organic synthesis has increased enormously1,2 and among them
Ce salts, being the most abundant, have been extensively used
in reduction, C−C, C−N and C−O bond formation reactions.3
This extensive use of Ce salts is attributed to moderate to low
toxicity, water tolerance, easy to handle, availability at moderate
cost and suitability for use without puriﬁcation. However, the
main limitation from economic and environmental point of
views is their use in stoichiometric amounts. Therefore, the
development of heterogenized version of Ce salts remains a
major objective of modern organic chemistry, and the simplest
strategy to perform this task is by immobilization on a solid
support. In recent years, biopolymers have gained lot of
attention for their use as supporting materials.4 Chitosan is a
natural, abundant and low-cost polymer that exhibits interesting
properties like nontoxicity, easy chemical modiﬁcation due to
presence of both amino and hydroxyl groups, inertness toward
air and moisture, biocompatibility and biodegradability, and
thus, make it a versatile supporting material.5−8
The piperidine ring unit forms the core of a large family of
alkaloids and natural products with strong medicinal and
interesting structural properties. The presence of piperidine
motifs in drug molecules has generated a lot of interest in
development of eﬃcient protocols for the synthesis of these
compounds.9−14 Recently, spiro-substituted piperidines have
received considerable attention due to their important
pharmacological proﬁles like selective and potent σ receptor
ligands that can be used in the treatment of cocaine abuse,
depression and epileptic disorders and 5-HT2B receptor
antagonists.15−20 Owing to the importance of these compounds
in the ﬁeld of medicine, unexpectedly, there are only few
protocols available in the literature documenting the synthesis
of these spiro compounds.21−24 However, many shortcomings
associated with these protocols include the use of homoge-
neous catalysts, toxic solvents, long reaction times and very
limited substrate tolerance. Therefore, it is highly desirable to
develop an eﬃcient protocol for the synthesis of spiropiperidine
adducts that is highly eﬃcient, environmental friendly, tolerates
a wide range of substrates and involves the reuse of the catalyst.
In the present work, taking advantage of the above-
mentioned properties of chitosan, we have synthesized a new,
eﬀective, inexpensive and recyclable chitosan supported cerium
catalyst and used it for the synthesis of novel spiropiperidine
derivatives via multicomponent reaction of substituted anilines,
formaldehyde and diﬀerent active methylene compounds at
room temperature using PEG-200 as a green solvent. It is
worthy to mention that polyethylene glycols (PEGs) are
inexpensive, nontoxic, nonvolatile and thermally stable
compounds that serve as suitable media for environmentally
sustainable organic transformations.25 Their solubility in water
leads to easy separation and recovery of products from the
reaction medium.
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Dy/chitosan: a highly eﬃcient and recyclable
heterogeneous nano catalyst for the synthesis of
hexahydropyrimidines in aqueous media†
Nayeem Ahmed, Saima Tarannum and Zeba N. Siddiqui*
A chitosan supported Dy(III) nanocatalyst was synthesised by a simple procedure. It was used as a catalyst for
one pot, three component synthesis of hexahydropyrimidine derivatives. All the reactions were completed
in a short time period at room temperature and the products were obtained in high to excellent yields. The
catalyst was characterized by FT-IR, XRD, SEM-EDX, TEM and ICP-AES analyses. The stability of the catalyst
was evaluated by TG analysis. Use of water, ambient conditions, recyclability and high TOF of the catalyst
make this protocol a sustainable alternative to existing protocols.
Introduction
Hexahydropyrimidines are an important class of compounds
with a diverse range of biological activities.1 These scaﬀolds are
one of the most commonly encountered heterocycles in
medicinal chemistry with various proles such as antibacterial,2
antiviral, antitumor and anti-inammatory activities.3 This
skeleton is also found in a number of alkaloids such as verba-
methine4 and verbametrine.5 Hexetidine, which is a hexahy-
dropyrimidine based drug molecule, has promising anesthetic,
deodorant and antiplaque eﬀects.6 N-substituted hexahy-
dropyrimidines serve as key synthetic intermediates for sper-
midine–nitroimidazole drugs which are used for the treatment
of A549 lung carcinoma.7 New trypanothione reductase inhib-
iting ligands used for the regulation of oxidative stress in
parasite cells also contain this structural unit.8 Recently,
appropriately substituted hexahydropyrimidines were found to
be potent hepatitis C virus inhibitors.9
Recently, lanthanides have found widespread use in the
development of green chemistry as mild and eﬃcient Lewis
acids.10 A prominent feature of lanthanides is their stability and
activity in protic media, making them ideal for use as stable
Lewis acids in water. Dysprosium(III) is an extremely mild and
eﬃcient Lewis acid catalyst having the ability to promote
various types of carbon–carbon bond-forming reactions, elec-
trocyclizations and cycloaddition reactions.11 Compared to
other lanthanides, dysprosium has not received much attention
from the synthetic community even though it exhibits similar
stability towards air and water, ease of handling, Lewis acidity
and oxophilicity. It also has the unique ability to retain its
catalytic activity in presence of Lewis basic nitrogen groups,
which allows its use in a variety of transformations with
unprotected amines.11
Chitosan is a naturally occurring and versatile hydrophilic
polysaccharide derived from chitin. The high density of amino
and hydroxyl groups of chitosan enables an eﬀective function-
alization and avoids the aggregation of metallic nano-
particles.12–16 Therefore, its use as a biodegradable supporting
material for various catalysts is quite promising.
With the emphasis on the use of cleaner processes and
concerns over the environmental impact of using volatile
organic solvents (VOCs), increasing attention has been focused
towards the use of water as reaction medium in organic
syntheses. Recent research has shown that the speed of
heterogeneous mixture of reactants and water is dramatically
faster than for aqueous solutions. Under these heterogeneous
conditions the water plays the role of a medium and not of
solvent, and hence are termed as on-water reactions.17
Therefore, in continuation of our interest in developing water
compatible processes,18 we herein, report the synthesis of novel
Dy(III)/chitosan and its application as catalyst for the synthesis of
hexahydropyrimidines and their spiro analogues in water.
Results and discussion
Scheme 1 illustrates the synthesis of the catalyst. Weighed
amount of chitosan was rst suspended in water and stirred for
30 min. Dy(NO3)3$6H2O was then added to the suspension with
continuous stirring. The mixture was then continuously stirred
overnight and the catalyst was obtained by simple ltration.
Catalyst characterization
FT-IR spectra (Fig. 1a) of chitosan showed broad stretching
band for OH and NH groups at 3419 cm1. The band at
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Silica molybdic acid catalysed eco-friendly three
component synthesis of functionalised tetrazole
derivatives under microwave irradiation in water
Nayeem Ahmed and Zeba N. Siddiqui*
The catalytic multicomponent reaction between diﬀerent aldehydes, malononitrile and sodium azide, for
the synthesis of functionalised tetrazoles in pure water was performed using silica molybdic acid as an
acidic catalyst under microwave irradiation at ambient temperature. The catalyst showed remarkable
activity by decreasing the time period of the reaction from 24 h (without catalyst) to 15 min under
microwave irradiation. The catalyst successfully tolerated diﬀerent aromatic and heterocyclic aldehydes
furnishing the desired products in excellent yields. The major advantages of this protocol are recyclable
catalyst, water as a green solvent, excellent yields, very short reaction times, use of microwaves and high
TOF of the catalyst.
Introduction
Application of clean technologies in chemical synthesis has
currently been the major area of focus in green chemistry. The
eco-friendly and reusable heterogeneous catalysts have till now
been the leaders in providing such clean technologies. The
promising applications shown by such catalysts have in turn
been exploited by industry and presently there are more than
100 industrial transformations being catalysed by over 103
solid acid catalysts.1–4 Due to rapid advances in medicinal
chemistry, ever increasing attention has been paid towards the
development of novel clean processes employing nontoxic
reagents, catalysts and solvents as a majority of drug-like
compounds and natural products contain a heterocyclic
nucleus at their core.5–9
Among various heterocycles tetrazoles and their derivatives
represent an important class of N-containing heterocycles. The
close similarity between the acidity of tetrazole group and
carboxylic group has led to their development as potential
medicinal agents10 and compounds like lasortan, irbesartan,
tomelukast, and PTZ (2) (Fig. 1), which have been developed
into drugs, have proven to be successful bioisosteric replace-
ments for carboxylic acid groups. Moreover, 5-substituted tet-
razoles are reported to possess biological proles like potential
drugs against schizophrenia and cerebral ischemia,11 antidia-
betic,12 antiviral,13 antibacterial14 and antihypertensive activi-
ties.15 Also, the role of tetrazoles as important synthons in
synthetic organic chemistry,16 as ligands in coordination
chemistry and applications in material chemistry17,18 has led to
the development of various eﬃcient protocols for their
synthesis.
Many available methods for the synthesis of tetrazoles
include [3 + 2] cycloaddition of azide to nitriles,19 reaction of
primary amines with NaN3 and triethyl orthoformate,20
nucleophilic substitution by an azide anion21 and addition of
NaNO2 to aminoguanidine.22 But [3 + 2] cycloaddition still
remains the most employed method for the synthesis of 5-
substituted tetrazoles. New eﬀorts to develop multicompo-
nent protocols for the synthesis of 5-substituted tetrazoles
have led to the utilization of 2-benzylidenemalononitrile and
sodium azide.23 Water is the most abundant and environ-
mentally benign solvent in nature, but due to low solubility of
organic compounds in water, its application in organic
synthesis is currently limited.24 Recently a great deal of
Fig. 1 Representative drugs based on tetrazoles.
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